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Despite having an effective Anti-Retroviral therapy regimen that improves the quality of life of HIV 
patients, HIV is still a major threat to public health and still is growing. To address this threat, 
UNAIDS has established the policy of the 90-90-90 indicators that needed to be achived. In 2018, 
Thailand’s indicators have become unreasonably high excessing 100%. Therefore, this study aims to 
assess the current data quality using the Ministry of Public Health, exploring the causes, and 
providing recommendations. 
Methods 
Using a mix-methods approach this study analyzes and compares across two databases, the Ministry 
of Public Health (MOPH) and National AIDS Program (NAP) to describe the overall quality and the 
extent of the two data sources difference. The province with the highest difference was selected for a 
field visit and the deployment of the Data Quality Improvement Tools (DQI Tools), jointly developed 
by MOPH and Thai-MOPH-US-CDC Collaborator (TUC) for assessing the HIV data quality. Field 
interviews were conducted using the MEASURE Data Quality Audit (DQA) as a guide to identifying 
the drop-off in the workflow. 
Results 
Thailand's 90-90-90 indicators were calculated using NAP as a default data source giving 105%,72%, 
and 83% respectively. For MOPH, the first indicator was 104% and 52% for the second indicator. The 
third indicator for the MOPH was not available because of a lack of laboratory data.  
NAP data quality gaps were identified including a legacy data migration problem and a difficult data 
correction process. MOPH gaps were related to the lacking of a single unified standard for both 
laboratory and medication, unclear regulation, and lack of incentives for data reporting. Bangkok, 
while having a similar reporting practices to the non-Bangkok province, it also suffers from having 




In this study, NAP suffers from complicated data correction processes, coverage of other health 
schemes, and disincentive, it was a suitable source for the 90-90-90 indicator calculation. MOPH is 
not suitable for indicator calculation from lacking national data standards, unclear regulation, and the 
database structure itself. Bangkok, Thailand's capital city is the area that needs special attention. 
Academic advisor Carlos Castillo-Salgado 
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HIV or Human Immunodeficiency Virus is a virus that is transmitted through body fluids. As the 
name implies, the virus attacks and severely weakened the body's immune system. In the advanced 
stage, the patient progresses to Acquired Immune Deficiency Syndrome (AIDS). HIV has become one 
of the major health public health problems globally since its first report in 1981, as more than 77 
million people have been infected by HIV and more than 10 million deaths from AIDS-related 
illnesses around the world (1). With significant global efforts to address the HIV problem, the 
treatment, the Antiretroviral Therapy (ARV or ARV) has become more and more affordable. As of 
2017, 20.9 million infected patients have access to ARV, a significant increase from 7.5 million in 
2010 (2). 
However, there is still a long way to go. According to the UNAIDS report, there are approximately 
1.8 million newly infected HIV each year. As a result, UNAIDS has established the 90-90-90 goals 
which stand for 90% of patients who know their status, receive Anti-retroviral therapy (ARV), and 
achieve viral suppression. The goals have to be achieved by the end of 2020  to prevent the 
HIV/AIDS epidemic to outrun the ARV intervention. 
Thailand, despite having received international recognition as one of the HIV success stories in terms 
of leadership, financing, civil society, and research, is still facing a severe magnitude of HIV problem. 
According to the Asian Epidemic Model (AEM) estimation, there were 427,332 HIV infected patients 
in Thailand as of 2016. Only approximately 265,525 cases or half of the patients received antiviral 
treatment. There were 4,423 new HIV infected and 15,776 deaths. Thailand has slow progress toward 




Figure 1 Thailand HIV Dashboard showing an AEM estimation of 427,526 while an actual 
reported HIV/AIDS is 450,548 resulted in 105% coverage, which is an illogical number (Source: 
AIDS Zero Portal Dashboard 2018). 
However, we started to observe discrepancies between AEM estimation and the actual number from 
the HIV/AIDS reporting system (Figure 1). The first of the 90-90-90 indicators (Testing Coverage) 
was higher than 100% as the reported cases are higher than AEM estimation. This was important as 
the epidemiologic study, policy, strategic planning, and public communication are based on the AEM 
estimation and reported HIV cases. Having an illogical number can cause distrust and confusion 
among stakeholders and may fail HIV/AIDS planning and control.  
Therefore, in this dissertation, we explored the reporting quality gaps of the HIV reporting system in 
Thailand, assess its impact on the 90-90-90 indicators, and provide data quality improvement 
recommendations to the Ministry of Public Health (MOPH). 
Research questions 
• What are the current quality gaps in Thailand's HIV data reporting?  
• What are the possible key factors in data pipeline and reporting workflow that can cause gaps 
in HIV reporting quality? 
• How would the 90-90-90 indicators improve if we correct the quality gaps? 
Study Aims  
- Aim 1. Determine the difference in the reporting quality between the two main reporting systems 
in Thailand, the National AIDS Program (NAP) and the Ministry of Public Health (MOPH)  
- Aim 2. Assess and identify the causes of quality gaps in the reporting systems  
o Aim 2-1 Identify the facility and provincial level factors associated with reporting quality 
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o Aim 2-2 Identify the loss in Thailand HIV reporting system quality 
o Aim 2-3 Identify the possible drop-off causes in the workflow 
- Aim 3 Assess the impact of having better NAP data quality to 90-90-90 indicators compare to the 
current NAP data quality level. 
Literature review 
Thailand HIV history 
The first AIDS patient in Thailand was reported in 1984. The epidemic at that time was mostly from 
HIV-1 subtype B. The epidemic spread rapidly to people who inject drugs (PWID) in 1998. The 
subtype E was detected among female sex workers (FSWs) and spread widely among them and their 
clients which reached its peaked in the mid-1990s before starting to decline (3, 4). At that time, most 
HIV-infected patients were from the Northern part of Thailand (5). During the same period, HIV 
prevalence among Ante-Natal Clinics (ANCs), male conscripts, and blood donors also raised and 
peaked in the early 1990s before continuously declining since then. At that time, the most common 
opportunistic infection was Tuberculosis, Pneumocystis carinii pneumonia (PCP), cryptococcosis, and 




Figure 2 A. HIV prevalence in Thailand among the key population, 1989-2015 B. HIV 
prevalence among Thailand general population (6) 
As described in Figure 2, the HIV prevalence among all key population groups was decreasing rapidly 
since the mid-1990s. However, there is a significant change in the HIV transmission pathway in 
Thailand as the prevalence among men who have sex with men (MSM) suddenly rising to 7.7% from 
4.1% and have remained high since then. The serosurvey among this population has revealed an 
incidence of 12.2 per 100-person years which is nearly doubled to all-ages incidences of 6.3 per 100-
person years (7). As a result, The Thai Red Cross Society has issued the policy of not receiving blood 
donation from MSM and LGBT since 2008 (8). 
Overall, the annual new infection was declining since 2000 but at a slower rate. Although the new 
infection number largely reduced in 2010 by 65% compared to 2000, the 2014 number shows a 23% 
reduction from 2010 as shown in Table 1In 2015, according to an estimation from the AIDS Epidemic 
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Model (AEM) there were approximately 7,816 new infections, 20,492 AIDS-related deaths, and 
445,504 HIV-infected patients. Among them, females contributed to 39% of adults and 47% of 
children. Among children, Thailand has been doing well since 2014 as there are only 121 children 
with newly HIV-infected or a 41% reduction from 2010. 
Table 1 Key figures of AIDS Epidemic Model (AEM) estimation, Thailand 2000-2014 Source: 
2015 THAILAND AIDS RESPONSE PROGRESS REPORT (9) 
 2000 2005 2010 2012 2014 
Annual new 
infection 
29,619 16,014 10,215 8,877 7,816 
Annual AIDS 
mortality 
55,531 31,211 20,670 20,477 20,492 
People living 
with HIV 
683,841 555,808 493,932 471,811 445,504 
Population 
(million) 
60.6 63.1 63.9 64.5 65.1 
 
However, AIDS-related deaths remained stable during the last 5 years despite achieving a dramatic 
reduction in new infections during 2000-2010. The AIDS deaths were 20,492 in 2014, nearly 
unchanged from 20,670 deaths in 2000. The reason was that after Thailand rapidly strengthening its 
ARV program in 2000 the AIDS-related death, and ARV coverage were both largely increased. 
However, several newly infected patients were brought to the care system for testing and starting 
ARV. Unfortunately, their treatment initiation was very late along with a lack of co-infection 
screening causing several HIV-infected patients to die within the first six months after diagnosis 
despite access to treatment. 
Thailand HIV intervention, control, investment, and success stories 
Thailand's public health action for HIV was initiated in 1984 by the Division of Epidemiology within 
the Ministry of Public Health in 1984, which was later promoted to the Bureau of Epidemiology, 
Department of Disease Control. They started reclassifying HIV as a high priority disease and 
developing the HIV surveillance system.  
In 1987, the Ministry of Public Health (MOPH) launched the National AIDS Program (NAP) and 
established the Center of AIDS Prevention and Control which later become the Division of AIDS 
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under the Department of Communicable Disease, Ministry of Public Health. The surveillance system 
was established in 1989 providing information for strategic decision and resource allocation for the 
government and the MOPH (10). The government also played a critical role during that time by 
devoting a large amount of investment to the HIV control program. The investment went from 
$180,000 in 1988 to $81.96 million in 1996 for HIV control despite being a lower-middle-income 
country at that time (11). Thailand has relied on government funding as the main resource for the HIV 
program until today (Figure 3). The funding from the Global Fund for HIV, Tuberculosis, and Malaria 
(GFATM) has become available since 2003 and contributes 10-15% for the total response budget 
today. The majority of the fund was spent on treatment and prevention for children (< 5 years old) and 
other key populations. 
 
Figure 3 Thailand budget for HIV/AIDS program by funding sources during 1988-2013 (6). The 
government has doubled its budget for the HIV program since 2006 which remains as 
Thailand's main funding source since then. 
One of the important HIV prevention programs is the campaign for 100% condom use which was 
initiated in 1991 and it has significantly raised condom use among sex-worker from 14 in 1989 to 
94%  in 1993 (12). This program plays a critical role in reducing HIV prevalence among other key 
populations especially among male conscripts which were reduced from 2.48 to 0.55 person-years 
during 1991-1995 (13).  
According to the AEM projection, Thailand's intervention has reduced more than 2 million infections 
and the number reached 5.7 million in 2013. The model estimation during that period shows a 
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significant reduction from 168,485 to 28,241 during 1991- 2000 (Thai Working Group on HIV 
Estimation and Projection, 2015) as shown in Figure 4. 
 
Figure 4 The AEM estimation for early prevention impact. The program has prevented 
approximately 2.1 million infections from 1991-2000. FSW stands for Female Sex Worker, STI 
stands for Sexually Transmitted Infection (6). 
In the 2000s, the idea of providing ARV without charge was initiated and was made possible and 
rapidly scaled-up as the Government Pharmaceutical Organization (GPO) begun to locally produce its 
ARV, a combination of stavudine, lamivudine, and nevirapine (NVP). The program was receiving 
large support from the government who doubled its budget for ARV along with the GFATM from the 
Global Fund in 2004 (14). The program was later renamed to National Access to Antiretrovirals 
Program for People Living with HIV/AIDS (NAPHA) manufacturing ARV for adults and children 
(15). The program was completely incorporated into Thailand's main health coverage (Universal 
Health Coverage) in 2006. In 2014, the AEM estimation showed that the NAPHA program already 
averted 196,000 deaths as shown in Figure 4. NAPHA was later renamed to National AIDS Program 




Figure 5 HIV intervention in Thailand during 1990-2015. PMTCT stands for Prevention of 
mother-to-child transmission, NAPHA stands for National access for people living with 
HIV/AIDS to ARV. The NAPHA was funding by the Ministry of Public Health and the Global 
Fund (6) 
Asian Epidemic Model (AEM) 
As we reviewed in the previous section, Thailand has been using the Asian Epidemic Model (AEM) 
for strategic planning and evaluation regarding the HIV/AIDS program, its interventions, and 
investment for several years. The AEM is a mathematical model that mimics HIV transmission and 
spreading in Asia which can provide an insight into whether the interventions induce behavior change. 
The AEM model was developed based on Chin et al research (16) on three main contributions factors 
to HIV spreading in Asia, heterosexual risk behavior patterns, percentage of men visiting female sex 
workers, and the partner exchange among female sex workers. The model received support from the 
United States Agency for International Development (USAID). The AEM only estimates the HIV 
transmission among two age groups: adults (15 years old and older) and children (younger than 15 
years old) infection. The infection occurs through sexual behavior in both homo and heterosexual 




Figure 6 HIV transmission dynamic in Asia. MSM stands for Men who have Sex with Men. The 
transmission circulates within the high-risk population before transmitting to other low-risk 
populations and newborn. 
The model aims to capture HIV spreading in Asia from existing data sources. Initially, the model was 
deployed in Cambodia and Thailand. There are two important key designs in the AEM. First, the 
model is semi-empirical. Second, the input parameters could be input on an annual basis. The design 
allows the user to create an alternative outcome or “what if?” scenario for the decision-makers to 
evaluate the impact of each intervention retrospectively. For example, the AEM estimated that 





Figure 7 The alternative estimation generated from AEM in which the condom use drops to 
60% in 1999 will lead to an HIV epidemic (Thai Working Group on HIV/AIDS Projection) 
Overview of Thailand health system  
The majority of the Thailand Health services were provided by the primary health clinic which serves 
under a community hospital. Each health center services cover approximately 3,000-5,000 population. 
Typical health center personnel consisted of nurses and paramedics of 3-5 people in total. Health 
center provides basic treatment, health prevention, and promotion from nurses and public health 
personnel (17).  
District or Community hospital, typically with 30-150 beds capacity serves approximately 30,000-
50,000 population. Community hospital personnel minimally consisted of 3-4 general practices 
physicians, 30 nurses, 2-3 pharmacists, 2 dentists, and 20 paramedics. The Community hospital 
provides a more complicated treatment service that is still under the primary health practice scope. 
When specialties’ services such as surgery, internal medicine, pediatrics are needed, patients will be 
referred to a general hospital. Each province has at least one general or tertiary care hospital. This 
arrangement was named the “district health system”, a backbone of the Thailand health system.  
 
Figure 8 Overall of Healthcare structure facility in Thailand. Primary care services were 
provided by the District or Community hospital and Health center. Source; Pongsupap, 
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Yongyuth MD, MPH, Ph.D. 10th ASIAN and 7th Perak Health Conference on Primary Health 
Care 
Another hospital classification is by care level (18). There are three main care level facilities in 
Thailand: Primary, secondary, and tertiary.  
Primary care includes all public and private facilities that provide out-patient (OPD) services only. 
Specialists providing services at this level includes family medicine, preventive medicine, 
occupational medicine, and epidemiologist.  
The secondary health care level hospital is a facility of 120-500 bed capacity. Secondary care level 
was broken down further into three subtypes: basic, medium, and advanced level. Basic secondary 
care means all government or private facilities that provide in-patient service in addition to those of 
primary care facilities. The facility can provide services for common health problems. Medium 
secondary care can provide services for more complicated health problems that require several 
additional specialties include obstetrics gynecologist, surgeon, internal medicine, pediatrics, 
orthopedist, and anesthesiologist. Advance secondary care provides further complex health problem 
that requires minor specialty including an ophthalmologist, Ear-Nose-Throat (ENT), psychiatry, 
rehabilitation, and critical care. 
Tertiary care is a hospital with a bed capacity of 500 and over, including large general hospital, 
regional hospital and teaching hospital that provides more service to overly complex health problem 
and require sub-specialists (e.g. dermatologist, pediatric surgeon) (17). 
While Thailand's private hospital is famous and has attracted many foreign patients for medical 
tourists, the private sector still has a small contribution to overall Thailand health service capacity. In 
2015, the private sector contributes 14% of total outpatient visits (OPD) and 11.3% of total admission 
in Thailand. 
There is another hospital class, MOPH- specialized hospital. The term represents the hospitals 
affiliated to MOPH but under a different authority. MOPH- specialized hospitals are designed to focus 
on more specialized services. For example, hospitals specially designed for proving health promotion, 
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occupational services, the hospital specialized for quarantine and treatment of high priority diseases 
(e.g. Ebola, SARS, MERS), and hospital specialized for Sexually Transmitted Diseases treatment. 
While the hospitals are still under MOPH authority, they are considered another department within the 
MOPH to achieve efficient processes necessary for specialized service. 
Thailand Health coverage 
Thailand has established three health care coverage schemes to cover each specific population group. 
The Civil Servant Medical Benefit (CSMBS) was introduced in 1980 specifically for government 
officers. The program covers 4.4 million government officers and their families. The benefit includes 
fee-for-service reimbursement for health care. Other benefits include pension, housing benefit, and 
child allowance are also available. The program is currently managed by Comptroller General’s 
Department, Ministry of Finance. The CSMBS program budget is “Open-ended” which has the 
highest reimbursement per population among the three health coverage programs in Thailand. 
In 1990, the Social Health Insurance (SSO) for private-sector employees was introduced. Social 
health insurance is an important program to address social security problems including pension, 
disability, and funeral grants. Unlike other health coverage program, the funding relies on triparty 
payment contribution (employer, employee, and the government), the budget is managed by Social 
Security Office, Ministry of Labor to purchase health services from both government and private 
providers. The program utilizes the capitation payment model which later was also adopted by 
Universal Health Coverage The program currently covers approximately 10.6 million population. 
In the early 2000s, despite having several health coverages institutions, Thailand's healthcare system 
faced inefficiency and inequity as approximately 30% of the Thai population was uninsured. To 
address this challenge, the last and the most important program is the Universal Health Coverage 
(UC) program which covers the majority of the Thai population of 48 million, and it was established 
in 2001. The program aims to cover the uninsured low-income population as the program slogan 
describes “30 Baht (approximately $1) treat all diseases”. As the slogan implies, a fixed amount of 30 
Baht or approximately $1 was charged as a co-payment from patients for each service from a public 
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hospital. The program was managed by the National Health Security Office (NHSO), an organization 
that was established in 2002 especially to manage the UC program.  
The system also allows for seamless transfer between the three systems. For example, when the 
employees were unemployed, they will be automatically transferred to UC and vice versa. Summary 
and comparison among three health coverage in Thailand were described in Table 2. 
Table 2 Characteristics of the three main health coverage in Thailand. Sources: Thai National 
Health Accounts, 2013, International Health Policy Program (IHPP) and Ministry of Public 
Health 






Legislation Royal decree 1980 Social Security Act of 
1990 
National Health 
Security Act 2002 
Purchaser Comptroller General’s 
Department, Ministry 
of Finance 
Social Security Office, 
Ministry of Labor 
National Health 
Security Office 








Budgeting type Open-ended  Closed-ended Closed-ended 
Expenditure in 2016 
(Thai Baht) 
71.02 billion 37.7 billion 109.3 billion 
Payment method Outpatient, fee-for-
service, in-patient; 
diagnostic-related 
groups (DRG) with 
multiple cost bands 
Out-patient: Capitation 
In-patient: DRG 






within the global 
budget 




For HIV, there are two reimbursement components: ARV and the laboratory. Each health coverage 
scheme has its pathway of data submission for reimbursement. UC is mandated to submit ARV and 
laboratory requests to NAP for reimbursement under NHSO. For SSO, the only laboratory was 
submitted to NAP while the ARV was submitted to the SSO’s Vendor Managed Inventory (VMI) 




Figure 9 Reimbursement data submission pathway for each health coverage schemes. Noted 
that SSO and UC share laboratory reimbursement data from NAP. VMI= Vendor Managed 
Inventory 
HIV reporting system in Thailand 
There are two main reporting in Thailand related to HIV: The MOPH reporting system and the 
National Program on Prevention and Control of HIV/AIDS and STI (NAP) under the NHSO reporting 
system.  
The MOPH Reporting system 
In 2007, Thailand MOPH established its electronic health information standard and health data 
centers for nationwide data exchange for strategic planning and epidemiology studies as EHR 12 or 
12 File system. The reporting system applies a relational database design to store and exchange health 
service data. As the Thailand system was progressing, a new table was added to the system. The 
current version contains 43 tables in total and it was deployed in August 2010. The system consisted 





Figure 10 The overall Structure of the 43-File system. Tables are grouped into 11 sections; each 
line represents one table. 
At the end of the month, each hospital extracts the information from its EHR database, converts, and 
submits to the MOPH server maintained by the Center for Information Technology and 
Communications (ICT), MOPH as shown in Figure 11.  
The server operates on the MOPH’s Cloud infrastructure.  Each of the 77 provincial health offices 
was allocated one instance of the MOPH cloud where the entire dataset resides in the main centralized 
database server that is running on Linux Operating System with Apache Hadoop and Hewlett Packard 
(HP) Vertica.  
At the end of 2016, 11,187 of 11,218 (99.7%) hospitals under the MOPH and 346 other hospitals 
(university teaching hospital, private hospitals, the public hospital not under MOPH) have transferred 





Figure 11  The current MOPH reporting system dataflow. OPD = Out-Patient Department; IPD 
= In-Patient Department; NHSO = National Health Security Office; HDC = Health Data 
Center; P = Province, ICT = Institute of Communicable and Information Technology, MOPH; 
BPS = Bureau of Policy and Strategic Plan, MOPH; ID = Personal Identification Code; MCH = 
Maternal and Child Health Department; NCD = Non-Communicable Disease Control 
Department; EPI = Expanded Program in Immunization. Source: https://hdcservice.moph.go.th 
 
MOPH Dashboard system  
The MOPH dashboard components describe the current Thailand health services situation and MOPH 
Key Performance Index (KPIs) as shown in Figure 12. It has been used for program monitoring at 
national, regional, and provincial levels. Several data visualization platforms including Power BI, 
Tableau, and KNIME are also available.  
It is important to emphasize that the dashboard component application is still limited to non-
communicable disease (NCD) monitoring, the expanded program for immunization (EPI), and 
maternal and child health (MCH). The dashboard component section for communicable disease and 
HIV/AIDS is still under development. 
HDC - MoPH
BPS
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Figure 12 MOPH Dashboard system. (Left) The overall situation of Thailand Health services, 
the number is updated monthly. (Right) Choropleth map of Health Key Performance Index 
(KPIs) allows comparison between provincial at the national level at a glance. Source: 
https://hdcservice.moph.go.thปอ  
 
National Program on Prevention and Control of HIV/AIDS and STI (NAP)  
When Thailand's national access to the ARV program was initiated, several data infrastructures were 
deployed to support program logistics, supply chain management, laboratory, including monitoring 
and evaluation. To monitor the program effectively, the National Access to Antiretroviral Program for 
People Living with HIV/AIDS (NAPHA is a Thai word means “Sky”) was developed and deployed in 
2001.  
Later, as Thailand's HIV/AIDS program developed and become freely available under the UC 
program, NAP was established to address the limitations of NAPHA. The NAP system is now under 
NHSO authority since 2008 for the ARV and HIV laboratory reimbursement purpose. However, 
database migration from NAPHA to NAP did not succeed. The personnel decided to directly re-enter 
all paper-based data from the NAPHA program into NAP manually which resulted in several data 
quality problems among the historical data before 2008 (Source; Thailand MOPH-US CDC 
collaboration). 
Currently, NAP is being utilized by NHSO for HIV/AIDS-related care reimbursement for all UC 
beneficiaries. However, Civil Servant Medical Benefit (CSMBS), and Social Health Insurance (SSO) 
data entry are not mandated and were not be reimbursed. 
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Designated users at hospitals have received a username and password to enter data into NAP using the 
web-based data entry platform available on the website which was updated monthly. Currently, the 
users need to enter data into the NAP system manually, there are no automatic tools to connect the 
EHR database to NAP (Figure 13 and Figure 14). 
Users can use the NAP dashboard to see an overall summary of the HIV/AIDS situation from NAP 
data and download an Excel file of de-identified individual records on the user’s affiliated province. 
Users could not see or download data outside of their affiliated hospitals. 
NAP data entry workflow 
When a patient visits a hospital or was requested to be tested for HIV, the patient received a special 
generated NAP ID and is registered in the NAP database using a NAP Web-based application on 
NHSO Website (Figure 13).  NAP ID is used as an identifier for all patients in the NAP system. NAP 
ID does not link to the patient SSN for security reasons. While the user can search through the NAP 
database using the NAP ID, the NAP system does not return the patient SSN (CID). 
 
 
Figure 13 NAP Data entry application. The application is web-based and available on the 
NHSO website. Source: http://napdl.nhso.go.th/NAPWebReport/main_care.jsp 
There are four main activities in the NAP web-based system. Data entry (Figure 14), data viewer 
(Figure 15), patient referral, and the dashboard (Figure 17). The third activity, the referral process is 
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the most complicated and require the HIV clinic personnel’s attention. HIV clinic personnel need to 
select the “Refer” option (1), (2) specify the referral hospital, and (3) save to complete the referral 
process as shown in Figure 16. Any missing steps could result in the referral failure causing 
destination hospital personnel unable access or modify the NAP patient record. Patients, despite being 
follow-up at the destination hospital they remain in the original hospital in NAP. 
 
Figure 14 NAP Data entry system. Both figures show the data entry mainly for ARV and 




Figure 15 NAP Data viewer. The figure shows a historical visit, ARV regimen, and treatment 
details including complications and adverse effects. Unfortunately, the system does not show a 
complete medical record nor SSN for that visit. 
 
Figure 16 NAP Patient-refer-out system. HIV clinic personnel need to select “Refer” option (1), 
(2) Select destination for referral, and (3) Save.  
 
Figure 17 NAP Web-based online dashboard. The figure shows an overall statistic for the 
national level. Source: http://napdl.nhso.go.th/NAPWebReport/main_care.jsp 
Important consideration between NAP and MOPH 
While both NAP and MOPH Reporting systems store HIV/AIDS patient data, there are several 
different aspects of their deployment.  First, NAP covers both public and non-public hospitals (e.g. 
teaching hospitals, private hospitals, and clinics) which are not covered by the MOPH reporting 
system. Second, NAP contains HIV related information that they are not included in the MOPH 
reporting system. Key Population identified, Voluntary Counselling and Testing (VCT), and historical 
data before 2008 (Figure 18).  
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The MOPH reporting system has a couple of advantages over the NAP. NAP suffers a couple of 
drawbacks, first, the MOPH system covers all health coverage scheme databases including CSMBS, 
SSO, private insurance, and migrant workers which NAP did not cover. Second, the MOPH allows 
data linkage with HIV coinfection (e.g. Tuberculosis and Hepatitis) while NAP does not.  
 
Figure 18 Current overlapping of MOPH and NAP database. While both NAP and MOPH data 
also reside from hospital EHR, NAP contains specific HIV/AIDS-related data (e.g. Voluntary 
Counselling and Testing Key Population) that do not exist in the MOPH database.  
 
Thailand data standard 
Thailand does not have a single unified standard. Each health coverage scheme defined and deploy its 
standard for reimbursement and data submission. There is two health coverage scheme using data 
standard for laboratory and medication: UC and CSMBS. UC use DRGs through ICD-10TM as the 
main reimbursement pathway and NAP manual data entry for HIV related reimbursement. SSO use 
manual data entry for both HIV medication and laboratory.  
MOPH data standard 
For MOPH submission, there are two main data standards besides ICD-10TM, 24-digits medication 
system, and 7 digits ICD-10TM laboratory coding. The laboratory database was stored in a seven 
characters long format.  
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Table 3 MOPH 7-digits HIV-related laboratory coding (20) 
Laboratory test MOPH ICD-10TM 7-
digits laboratory code 
Possible results Remark 




HIV DNA PCR 0749100 0= Negative 
1= Positive 
 
CD4 0703001 Actual value Exclude “<” and”>” 
Viral Load (VL) 0749300 Actual value Use Log10 value 
Exclude “<” and ”>” 
Input 0 for 
“Undetectable” 
 
The 24 digits structures consisted of the following components.  
1. Medication category (1st digit) 
2. Medication identifier (2-11th digits) 
3. Dosage (12-16th digits) 
4. Form (17-19th digits) 
5. Manufacture (20-24th digits)  
An example of 24 digits among ARV (See Appendix). Normally only 2-11th digit is required to 
identify the medication. For example, Lamivudine's full 24 digits are '124884000004121121781336’ 
but practically, 24884000000 (2-11th digits) were used for drug identifier.  
Table 4 An example of 24-Digits system among ARV 
No Class Drug Name 24 Digits ID (2-11th digit)  Drug abbreviation 
1 NRTIs Lamivudine 2488400000 3TC 
2 NRTIs Tenofovir 4433449300 TDF 
 
However, the 24 digits system suffers the ambiguity problem that unable to determine the package, 
prescribing, and dispensing which are particularly important for CSMBS, a fee for service scheme 
needs to have a more rigorous treatment cost monitoring. For example, the 24 digits code 
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101804000050160241581620 means any of Alcohol 70% 1000 ml, Alcohol 70% 240 mL, Alcohol 
70% 60ml, and Alcohol 70% (ear drop) 60 mL. Therefore, they jointly developed their data standard, 
Thai Medical Terminology (TMT) based on SNOMED CT.  
Thai Medical Terminology (TMT) 
 
Figure 19 Thai Medical Terminology (TMT) and its linkage to SNOMED CT (Source: 
http://www.this.or.th/tmt.php) 
The following table shows a comparison between the 7 digits system and TMT for Alcohol 70%. 
Noted that both were Alcohol 70% with a different package, while their 24 digits codes are similar, 
their TMT codes were different allowing packaging to differentiate and more specific than the 24 
digits system. TMT codes are the current medication data standard for the CSMBS reimbursement 
submission.  
Table- 5 Comparison of TMT and 23 Digits coding for Alcohol 70% 
Medication 24 Digits TMT 
Alcohol 70% 60 mL 101804000050160241581620 766081 




CSMBS currently deployed in-house developed a 5-digits laboratory coding for their laboratory 
expense reimbursement (21). To receive reimbursement, hospitals have to convert their laboratory 
code to CSMBS’ before submission. 
Table 6 An example of CSBM Laboratory code for HIV 
Laboratory CSMBS Lab code 
CD4 Count 30509 
HIV Viral Load 36362 
 
In summary, as Thailand did not have a single unified standard, several standards were deployed by 
each health coverage scheme. There were two codings for the medication (TMT and 24 digit system) 
and another two (CSMBS 5 digits and ICD-10TM) for the laboratory involved in the HIV reporting 
system. 
Thailand health data system IT infrastructure, Electronic Health Record 
(EHR) 
Up until now, there is no official survey or research project on the extent of the implementation of the 
EHR in Thailand. The only information available so far is the Thai Medical Informatics Association's 
annual meeting report (22) and the results of one Thai student’s Ph.D. Dissertation (23). In overall, 
the EHR market share was dominated by HOSxP, an EHR developed by Bangkok Medical Service 
company higher than 50%, only 15.87% still using their own developed EHR. Like EHR in the United 
States, the vendor does offer several modules and components to be added-on including data 
warehouse, preventive medicine, and epidemiology service, etc. However, the majority of the public 
hospital in Thailand is still using EHR only for Out-patient department (OPD) services, while In-




Figure 20 Thailand’s most popular EHR, “HosXP’. The image shows the physician working 
screen for the Out-patient Department (OPD) Source: https://hosxp.net/joomla25/ 
HIV/AIDS Goals and Performance indicators. 
UNAIDS indicators assessing the ’90-90-90’  
In 2015, the new Sustainable Development Goals (SDGs) was initiated and replace the 2015 
Millennium Development Goals (MDGs). One important goal is SDG 3 which aims to end the AIDS 
epidemic as a public health threat by 2030. To be able to achieve the goal, UNAIDS has initiated a 
Fast-Track strategy, that aims to help low- and middle-income countries to meet SDG 3 target by 
2030. The reason is, without any rapid scaling up, the HIV epidemic is going to progress faster than 
intervention and the epidemic ไรสส continue to progress (24). 
Several experts and stakeholders were gathered to set up the new goal for the post-2015 era to ending 
the AIDS epidemic, and the “90-90-90” goals target was established (25). 
1. By 2030, 90% of all people living with HIV know their HIV status. 
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2. By 2030, 90% of all people with diagnosed HIV infection receive sustained antiretroviral 
therapy. 
3. By 2030, 90% of all people receiving antiretroviral therapy achieved have viral suppression. 
While several countries have already achieved these targets and the newly infected HIV patient are 
dramatically decreasing during the last decade, there is still a long way to achieve a global 90-90-90 
target (26). As of 2017, 75% of people living with HIV knew their status, 79% of people who know 
their status have access to treatment (24). And only 81% among those who have access to treatment 
were virally suppressed. Despite some regions, especially the Middle East and North Africa which are 
lagging far behind the target due to their continuously involved in a war (27). Europe also faces a 
challenge in reaching the target as there are wide disparities in the HIV continuum of care as Western 
subregions are closing to achieve the 90-90-90 target while the rest are far behind (28). The most 
common challenges in achieving targets are limitation of data reporting due to the absence of focal 
data sources, lacking funding, personnel, stigmatization, and lack of expertise (28, 29). 
Methods 
Study design  
In aligning with the study the aims, this study uses a mix-method design and it was organized into 
three parts; The first part (aim 1 and aim 2.1) seeks to recognize the quality gaps at the national level 
in the reported data by describing the overall difference between MOPH and NAP databases and by 
identifying the study sites for a field visit in the second part. The Second part (aims 2.2 and 2.3) aims 
to identify the workflow gaps in the study sites that cause the data quality gaps in the manner of 
providing useful information to stakeholders to improve service in the study sites. The third part was 
designed to provide the analytical results and inferences about the findings back to the authorities of 
the national level and to provide the study recommendation.  
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The statistical analysis, data management, and qualitative data coding and analysis were conducted 
using the software R 3.5.3, R Studio 1.2.5, R Qualitative Data Analysis (RDQA) 0.2-8, Python 3.7, 
and Anaconda 1.9.7. 
Population and sampling strategy 
There were three data sources involved in this study: the MOPH database, the NAP, and the EHR 
obtained during the field visits.  
For the MOPH and hospital EHR, all available records were queried based on ICD-10 of B20, B21, 
B22, B23, B24, B200-B213, B217-B222, B227, B230-B233, B238, B240, Z21, Z210, and O987, 
Laboratory (Anti-HIV, CD4, and HIV Viral Load) and ARV prescription codes (See ARV 
Prescription code in Appendix) regardless of the period. The following variables were extracted from 
MOPH and EHR; demographic data, hospital visit date, appointment date, ARV prescription, health 
coverage scheme, first and last HIV-related laboratory (Anti-HIV, CD4, VL) results, and the date. 
Summary statistics were obtained from NAP and MOPH at the national level. No access to individual 
records was allowed at the national level nor the study sites because of privacy and confidentiality 
reason. 
The study included 25 hospitals across 4 provinces given available resources and approved project 
timeline. The project personnel consisted of two teams of 2-5 members each. The provinces were 
identified according to the results from aim 2.1. The provinces that receive PEPFAR funding were 
preferred as there already established HIV activity cooperation and stakeholder connections to 
streamline the processes in the area (30).  
Data quality assessment framework 
Weiskopf’s data quality framework 
This research utilized Weiskopf’s data quality framework for assessment (Figure 21). Due to 
limitations in accessing individual record data, we focused on measuring three dimensions of the 




Figure 21  Weiskopf’s data quality framework 
Concordance and plausibility 
According to Weiskopf’s, concordance was defined in the study as an agreement between data 
elements within or among multiple data sources (31). Plausibility was defined as the data agreement 
with general medical knowledge and information.  
Ideally, the patient’s records should be the same regardless of data sources. Therefore, in this study, 
we assessed concordance and plausibility by comparing summary statistics (patient demographic, 
total record number, and follow-up status) between two data sources.  
Using two data sources the difference of patient count was challenged in comparing between 
provinces as large provinces have far more patients count than small provinces. Therefore, using 
percentage was more reasonable in comparing across provinces. However, as several provinces may 
report having NAP patients count more than EHR, the percentage becomes negative causing the 
interpretation to be difficult. As our main interest was the magnitude of difference rather than the 
direction, we use the absolute percentage of two data sources difference in this study to allow better 
interpretation. The percentage of two data source differences were calculated using the formula 
below.  
% Two data sources difference = |(EHR – NAP) / NAP| x 100 
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The plausibility dimension was asses using the DQI Tools application results. The DQI Tools 
integrate both data sources and identify patients' records that were unreasonable given the current HIV 
knowledge. For example, assume that all HIV patients were diagnosed based on having positive Anti-
HIV laboratory results. It was impossible to have no HIV results in the hospital database. Also, having 
negative Anti-HIV results could not be diagnosed with HIV.  
Currency 
Due to the sensitivity of HIV patient data, the only available timeliness data is the last follow-up date. 
Thus, in this study, we use the distribution of loss-follow-up patients counts by loss follow-up length 
to represent the currency dimension.  
The reason is, as the number of loss follow-up patients largely contribute to the drop in Thailand's 
second 90-90-90 indicator, the study needed to explore whether the loss-follow-up number was valid 
and represented the current Thailand situation.  
The 90-90-90 indicators were calculated based on alive HIV patients. Loss-follow-up patients, 
assuming not receiving any treatment for several years have an exceptionally low survival rate (32) 
and should be excluded from 90-90-90 indicators calculation. Not excluding dead patients results in 
overestimate the loss-follow-up patient number and underestimate the second 90-90-90 indicator.  
Another possible cause of loss-follow-up patients reported is the patient is silently transferred to 
another hospital without updating the databases. In this case, the patient was counted as loss-follow-
up despite regular follow-up at the hospital underestimating the second 90-90-90 indicators.  
We determined the loss-follow-up length by calculating the duration since the last visit date was 
calculated from the difference between the last follow-up date and September 30, 2019. Patients with 
a duration longer than 180 days were classified as loss-follow-up.  




Aim 1 Determine the difference in the reporting quality between two main 
reporting systems in Thailand, the National AIDS Program (NAP) and the 
Ministry of Public Health (MOPH)  
The summary statistics necessary for calculating the 90-90-90 indicators and patient demographic 
data in 2018 were obtained from both data sources. There are six data elements for the 90-90-90 
indicators as described below. 
• Number of confirmed HIV patient (Patient Living with HIV or PLHIV) 
• Number of confirmed HIV patient receiving Anti-retroviral therapy (ARV) 
• Number of confirmed HIV patients receiving ARV that achieved viral suppression 
(VL < 1,000 copies) 
• Percentage of confirmed HIV patients to Model estimation (1st UNAIDS 90-90-90 
indicator) 
• Percentage of confirmed HIV patients receiving ARV (2nd UNAIDS 90-90-90 
indicator) 
• Percentage of confirmed HIV patients receiving ARV that achieve viral suppression 
(3rd UNAIDS 90-90-90 indicators) 
The study assessed the difference in the national level summary statistics of the patient’s 
characteristics, the distribution between two data sources as a proxy of reporting quality gaps or 
“concordance” according to Weiskopf’s data quality framework (Figure 21) and assessed on how the 




Aim 2-1 Identify facility and provincial level factors associated with 
reporting quality 
The purpose of this aim was to explore and identify the facility-level and provincial-level factors that 
associate with the difference in two data sources, as a proxy for reporting quality gaps.  The absolute 
percentage difference in HIV patients count between the two databases (NAP and MOPH database) 
was calculated as the dependent variable in the linear regression model. 
Several facility factors that could impact reporting quality were identified. The higher care level and 
the bed capacity tend to have a more complex workflow. Having high workflow complexity is more 
prone to errors in the reporting process. However, there are several hospitals with similar care levels 
and bed capacity but a different affiliation (e.g. MOPH affiliated and the non-MOPH affiliated 
hospital). Each affiliation has a different process, workflow, and regulation. For example, the 
submission of patient medical records to the MOPH server from the non-MOPH affiliated hospital is 
not mandated but rather voluntary based. On the contrary, the submission of patient medical records 
was mandated for MOPH hospitals.  
Another potential factor is funding as funders often require hospital personnel to deploy a specific 
intervention under the technical support from the funders. Thus, hospitals receiving external funding 
were more likely to have more resources, better reporting quality, and strong collaboration internally 
and externally.  In Thailand, there were several external funding related to HIV, and PEPFAR is one 
of the most important sources.  
PEPFAR funding requires several data quality measures to be submitted according to PEPFAR 
Monitoring, Evaluation, and Reporting (MER) 2.0 indicator (33). Provinces receiving PEPFAR 
funding were expected to have more intensive HIV activities and better data reporting system as 
PEPFAR provided support to the provinces to give better access to HIV testing and treatment 
especially among key populations (e.g. Men who have Sex with Men or MSM and Transgender or 
TG) in terms of training, funding and technical support (34).  
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Therefore, we identified the following facility level as independent variables; hospital class 
(community, general, regional, teaching), Ministry of Public Health affiliated (yes/no), receiving 
PEPFAR funding (yes/no). The error in data management practices causes data reporting quality 
problems in terms of currency, plausibility, and concordance as described in Figure 22. Univariate and 
multivariate linear regression was conducted to identify statistical associations with our dependent 
variable. 
 
Figure 22 Conceptual framework 
The study utilized the results of the linear regression model to identify the study sites for the field 
visits in aim 2-2 and 2-3. Twenty-five hospitals were selected with a purposive sampling strategy 
based on multiple regression outcomes along with the following considerations: logistically feasible, 
local personnel’s capacity, cooperation, urban/rural area, and high HIV patient coverage.  
A short-list of hospitals was submitted to each designated Provincial Health Office (PHO) for final 
approval and coordination for the field visit. Anonymous hospital name was used in the final report. 
Aim 2-2 Identify the loss in Thailand HIV reporting system quality 
UNAIDS MEASURE Data Quality Audit (DQA) tool 
In Aim 2-2, the study aimed to assess the factors of the data management practice at the hospital level 
that can impact on the HIV reporting quality using the UNAIDS MEASURE Data Quality Audit 
(DQA) tool. The UNAIDS MEASURE DQA is a standardized tool that was deployed for HIV data 
quality assessment in several countries including Kenya (2). The tool contains five components: 1) 
M&E structures, functions, and capabilities 2) definition of the indicators and reporting guidelines 3) 
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data collection forms and tools 4) data management processes, and 5) links with the national reporting 
system. (See Appendix) 
Several studies had explored HIV services quality and the success of deploying an electronic 
reporting system, however only a few explored the reporting quality: data auditing of hospitals in 
South-Africa (35) and data quality assessment (DQA) using MEASURE Tools in Malawi (36).  
Initially, our study was designed based on WHO data quality assessment implementation tools using 
MEASURE DQA Tools. However, the Thailand HIV reporting system was unique compared to other 
countries implementing the tools. While WHO guidance recommends to recount HIV medical record 
and compare to the national HIV database, the method was not feasible in Thailand unique healthcare 
system as there were several reporting systems across three health coverage schemes overlapping on 
each other. The MOPH had no authority on all health coverage schemes reporting systems. Therefore, 
we cast our doubt on whether deploying the WHO guidance was feasible and sustainable for scaling 
up at the national level in Thailand. Unfortunately, recounting methods were not allowed in our study. 
Therefore, only the MEASURE DQA Tools were deployed as a standardized tool to assess data 
management practice.  
Information was obtained by conducting field interviews during the field visits without voice 
recording, filling the responses in the DQA Tool Excel File (Figure 23). The Excel file template 
calculated the scores on each section and visualization using a spider chart as described in Figure 24. 
The score presented the current data management practice in hospitals and identified the components 









Figure 24 UNAIDS MEASURE DQA Tools score and visualization 
Data Quality Improvement tools (DQI Tools) 
In addition to the MEASURE DQA Tool, reviewing and analyzing the HIV medical records at the 
hospital during field visits as required to gain insight into the hospital workflow and to provide 
recommendations to the hospitals. However, as access to the HIV individual records was limited, we 
decide to indirectly obtain the summary statistic from the hospital during the field visit by providing 
the application to the local personnel to install and obtain summary statistics from the application 
instead. With this approach, no HIV patient records were brought outside hospitals while allowing 
local personnel to directly control our access to their EHR database.  
Therefore, the Data quality improvement tools (DQI Tools) were developed by Thai-USCDC 
Collaboration (TUC). The function of the DQI Tools is to provide the necessary summary statistics 
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for assessing the reporting quality gaps and to generate additional reports requested by local personnel 
necessary to improve their HIV service.  
The DQI Tools is a desktop application that was developed by TUC using Delphi as a programming 
language and Microsoft Access ® as a database. The application is still a prototype for field testing.  
The application starts by importing the NHSO NAP database of individual HIV/AIDS records then 
matching with the MOPH reporting system using SSN (CID) as a primary key. The matching process 
was kept hiding as the NAP system currently does not allow direct matching between two databases 
using SSN for security and patient privacy reasons. Before the DQI Tool was developed, tracking and 
matching patient using SSN between two databases was difficult and prohibited by NAP. This caused 
the HIV/AIDS database utilization very challenges difficult for local personnel in the past. DQI Tools 
allow this process possible at the local hospitals by hiding sensitive processes from the local personnel 
while allowing the request of patient identity matching (Figure 25).  
 
Figure 25 Summary workflow of DQI Tools. The DQI Tools obtain data from NAP and MOPH 
database, excluding deaths, then extract the current loss-follow-up patient list then generate 
four excel files; 1. Invalid SSN/CID, 2. Need to Verify Diagnosis 3. Following at the same 
hospital, 4. Following at other hospitals and 5. truly loss or unreachable. The meetings were 
held along with the files to decide the action and recommendation to improve the process. 
 
The DQI Tools provide a report describing the characteristics of Loss-follow-up patients including 




Figure 26 DQI Tools summary statistics report 
The tools also generate the four Excel Files for each type of case that was forward to local personnel 
to verify, contact, and recruit patients back to the care system (Figure 25). Five excel tables and its 
subcategory was described below. 
1. SSN (CID) Invalid or not existed 
2. Existed in NAP only, Not found in MOPH Reporting system 
a. Diagnosed HIV/AIDS and lost follow-up > 180 days 
b. Not diagnosed with HIV but still follow-up  
c. Not diagnosed with HIV and loss follow-up > 180 days 
3. Still follow-up at the same hospital 
a. Diagnosed HIV and still follow-up with ARV 
b. Diagnosed HIV and still follow-up without ARV 
c. Not diagnosed with HIV but still follow-up  
4. Still follow-up at other hospitals 
a. Diagnosed HIV and still follow-up with ARV 
b. Diagnosed HIV and still follow-up without ARV 
5. Truly lost/Unreachable patients 
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Each table has a set of similar variables set consisted of NAP ID, SSN (CID), healthcare coverage 
scheme, laboratory data, and result, ARV date, and regiment, last visit data, and lost 1-3 (Figure 72). 
Lost 1-3 variables were generated from the NAP based on the following criteria. 
1. Lost1: HIV positive but was not registered to NAP 
2. Lost2: Registered to NAP but did not initiate ARV 
3. Lost3: Lost follow-up after starting an ARV 
Local personnel verifies and contact each patient in each Excel file. Unreachable patients were 
remarked in an excel file and reimported to DQI Tools. Those unreachable patients were excluded 
from the indicator calculation. This information is useful for local personnel to exclude unreachable 
patients to focus their efforts on those still reachable.  
Aim 2-3 Identify the possible drop-off causes in the workflow  
A field interview was conducted during the fieldwork on 1-3 personnel of each key informant of the 
following professional: physician, nurses, IT personnel, administrative personnel, medical coders, 
HIV division directors among 12 of 25 study sites. For privacy reasons, an anonymous name was used 
in the final report. The interview questions were based on our conceptual framework and the 
MEASURE Data Quality Audit tool, the dataflow mapping results, and other findings during the 
fieldwork that is relevant to research aims. Field notes were developed during the interview and serve 
as the main data sources for the qualitative analysis and results as audio recording and full official 
interview with consent form were not allowed under the IRB exemption category of this study. 
Thematic analysis was conducted in this section. The coding was done on field notes with R 3.5.3 and 
the Qualitative Data Analysis Package (RDQA) 0.2-8 without prior coding categories.  
Aim 3 Assess the impact of having better NAP data quality on the 90-90-90 
indicators compared to the existing NAP data quality situation. 
In this aim, we utilized findings in aim 2-1 to 2-3 of the study and extrapolate the change in NAP data 




The fieldwork duration was 1-2 days per visit for each of the selected 25 study sites to minimize strain 
on local personnel. While the DQI Tools application from aim 2-2 was conducted on all 25 study 
sites, the DQA MEASURE tools activity of aim 2-2 and field interview activities in aim 2-3 were 
conducted on 12 of the 25 study sites. based on their progress, cooperation, and logistics and with 
guidance and permission from the provincial health office. 
Ethical and IRB approval 
The study was categorized as a government project for service improvement under the IRB exemption 
category and receive approval from the US-CDC Center for Global Health (CGH) and Division of 
AIDS, TB and, STIs, and Division of Epidemiology, Department of Disease Control, MOPH. The 
US-CDC approval was under the CDC Division of Global HIV and TB Data Quality Assessments in 
PEPFAR Supported Countries project. (See Approval Letters in Appendix) 
Results 
Descriptive Statistics from NAP database 
In 2018, Thailand reported 450,548 alive HIV patients to NAP. Among them, the majority were male 
(55.76%) in the 25-49-year-old age group (68.71%). Table 7 and Figure 27 described the 




Figure 27 Demographics of HIV patients reported by NAP in 2018, Thailand 
 
 
Figure 28 NAP reported HIV patient per 100,000 population, 2018, Thailand 
Overall, the prevalence of HIV per 100,000 was concentrated in the northern and central areas of 
Thailand as described in Figure 28. Thailand's national HIV prevalence was 631 per 100,000 
population with the highest provincial prevalence of 1,622 per 100,000 and the lowest of 203 per 
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100,000 population. Provinces with the lowest prevalence are in the southmost region of Thailand 
while the highest are in the northern and central regions. 
When stratifying by health coverage scheme, Universal health coverage (UC) had the highest 
prevalence with 65.25%, followed by Social security (SSO) and Civil Servant Medical Benefit 
(CSMBS) with 29.79% and 4.09% respectively. The rests were from migrant workers and others (e.g. 
fee for service). Except for other and migrants, male contributed to the majority of HIV patients 
across the three main health schemes (Table 8). The most common age group is 25-49 (68.71%), >50 
(23.42%), and 20-24-year-old (5.32%) respectively. The age group distribution is similar across most 
health coverage schemes except for migrants from having the lowest number of reported cases. Table 
8 describes the sex distribution of HIV patients in the NAP database across health coverage schemes. 
Table 7 NAP Health coverage scheme by age group composition, 2018, Thailand (n=450,548) 
Age 
group 
UC (%) CSMBS 
(%) 
SSO (%) Migrant 
(%) 
Other (%) Total 
(%) 
0-14 3,762 (1.28) 53 (0.29) 1 (0.00) - 37 (0.95) 3,853 
(0.86) 




























16 (0.00) 3,895 (0.86) 450,548 
 
Table 8 Sex distribution among NAP patients by health coverage scheme, 2018, Thailand 
Health coverage 
scheme 
Male (%) Female (%) 
UC 156,833 (53.34) 137,188 (45.66) 
SSO 81,335 (60.61) 52,867 (39.39) 
CSMBS 11,435 (62.10) 6,979 (37.90) 
Migrants 5 (31.25) 11 (68.75) 
Other 1,616 (41.49) 2,279 (58.51) 
Total 251,224 (55.76) 199,25324 (44.24) 
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Descriptive Statistics from the Ministry of Public Health (MOPH) database  
In the MOPH database, 445,551 HIV patients have been reported in 2018. The majority are male in 
the 25-49-year-old age group. Male patients contributed to the majority of patients of all age groups. 
Table 9 described the demographic distribution of HIV patients in the MOPH database. When 
stratified by health coverage scheme, UC contributed the highest proportion of 65.69% followed by 
SSO (18.09%) and others (10.31%) respectively. Male patients remained as a major contribution to 
the total patient across all health coverage schemes except for migrants (Table 10). Unfortunately, 
cross-tabulation between the age group and health coverage scheme was not possible with the MOPH 
database report system as of July 2019. 
Table 9 MOPH reported HIV patients to stratified by age and sex, 2018, Thailand 
Age group Male (%) Female (%) Total (%) 
0-14 4,483 (50.30) 4,430 (49.70) 8,913 (2.00) 
15-19 3,947 (49.33) 4,054 (50.67) 8,001 (1.80) 
20-24 13,403 (59.52) 9,116 (40.48) 22,519 (5.05) 
25-49 156,358 (54.31) 131,545 (45.69) 287,903 (64.62) 
50+ 64,663 (54.70) 53,552 (45.30) 120,884 (27.13) 
Total 242,854 (54.51) 202,697 (45.49) 445,551 
 




Male (%) Female (%) Total (%) 
UC 157,195 (53.71) 135,473 (46.29) 292,668 (65.69) 
SSO 45,683 (56.67) 34,932 (43.33) 8,0615 (18.09) 
CSMBS 10,988 (58.20) 7,891 (41.80) 1,8870 (4.24) 
Migrants 3,190 (42.80) 4,264 (57.20) 7,454 (1.67) 
Other 25,799 (54.87) 20,140 (42.83) 45,939 (10.31) 




According to the MOPH database, the prevalence of HIV (People Living with HIV or PLHIV) was 
concentrated in the northern, central, and upper southern areas of Thailand. Thailand's national HIV 
prevalence (PLHIV) was 681 per 100,000 population with the highest provincial prevalence of 1,835 
per 100,000 and the lowest of 164 per 100,000 population.  Provinces with the lowest prevalence were 
in the southmost region of Thailand while the highest were in the central region as shown in Figure 
29. 
 




Asian Epidemic Model (AEM) Estimation 2018 
The AEM has estimated the total alive HIV patients in Thailand as 427,526 patients or 661 per 
100,000 population in 2018. The model estimation showed that the trend was decreasing since 2010 
from 514,837 in 2010 to 314,053 in 2030 (Figure 30).  
 
Figure 30 AEM HIV patient trend estimation 2010-2030, Thailand 
The adult population (15+ years old) contributes to most of AEM estimation (99.34%), with the rest 
to children (<15 years old) estimation (0.66%). The estimation of the majority of patients was male in 
both age groups; 55.4% and 50.74% respectively as shown in  Table 11. 
Table 11 AEM HIV patient estimation stratify by sex and age group, 2018 
AgeGr2 Male (%) Female (%) Total 
15+ 235,294 (55.40) 189,404 (44.60) 424,698 
<15 1,435 (50.74) 1,393 (49.26) 2,828 
Total 236,729 (55.37) 190,797 (44.63) 427,526 
 
The lowest prevalence province resided in the central area (295 per 100,000) while the highest 
prevalence province was in the north region of Thailand (1,387 per 100,000). A similar pattern was 
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Figure 31 AEM HIV prevalence per 100,000 estimations, Thailand 2018 
 
Thailand 90-90-90 Indicators (NAP) 
Thailand uses NAP as a data source for 90-90-90 indicators calculation. In 2018, NAP reported 
450,548 HIV patients, among them 323,637 receive treatment. Among HIV patients receiving 
treatment, 268,256 patients achieved Viral-Load (VL) suppression. Therefore, as of 2018, Thailand 
achieved the 90-90-90 indicators of 105%, 72%, and 83% respectively. Among patients knowing their 
HIV result, 126,911 did not receive treatment and 55,381 patients failed to achieve VL-suppression. 
Figure 32 broke down the HIV treatment cascade from the first indicator (having the HIV diagnosis), 
the second indicator (ARV coverage), and the third indicator (achieving VL suppression) along with 




Figure 32 NAP 90-90-90 and treatment cascade, 2018 
Generally, the first indicator level was well over 100% in most provinces with an average of 106.69% 
(range 50.86-156.27%). North region indicators were slightly lower than the rest of the country. One 
important characteristic was the lowest three provinces are clustered in Thailand south-most region as 
shown in Figure 33. Figure 34 described Thailand's 90-90-90 indicator using the boxplot. Thailand's 
first 90 indicators average was 106.69% ranging from 50.85% to 156.28%. The indicator had much 
higher variability (SD =16.04) compared to other indicators.  
 
Figure 33 NAP 90-90-90 at the province level, (Left) First 90 indicator, (Middle) Second 90 
indicator, (Right) Third 90 indicator 
The second indicator showed a much lower value in general, with the low indicator in provinces 
clustering across the north and central region of Thailand. Thailand's second indicator was 76.19% 
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ranging from 47.46% to 86.67%. Compared to the first indicators, the second indicator had much 
lower variability and range but slightly more than the third indicator (SD = 7.69).  
There were four outlier provinces for the first 90-90-90 indicators, two in the upper and two in the 
lower. Six provinces were identified as lower outliers for the second indicator. Two provinces were 
identified as the lower side outliers for the third indicator.  
Only one province has categorized as an upper side outlier for the second indicator was a lower side 
outlier of the second indicator. There was no relation between outliers between the second and the 
third indicators.  
Bangkok was identified as a lower side outlier for the second indicator only. 
 
Figure 34 NAP 90-90-90 indicator distribution boxplots, Thailand, 2018  
The third indicator did not show any prominent clustering pattern in any region of Thailand except for 
one province with the lowest indicator value in the south-most area of Thailand. Thailand's third 
indicator was 82.81 on average ranging from 47.08 to 93.25%, its variably was the lowest among the 
three indicators (SD=6.45). 
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MOPH 90-90-90 Indicators 
In 2018, MOPH reported of 445,551 HIV patients. Among them, 229,165 received treatment. 
However, the MOPH database only had a 5,537 VL record count without a result. The numbers only 
indicate the number of tests conducted without specifying the Viral Load results, therefore calculating 
the third indicator was not possible. Therefore, we only provided the first two 90-90-90 indicators for 
the MOPH database of 104% and 52% respectively. Figure 35 described Thailand first and second, 




Figure 35 Thailand 90-90-90 indicators using the MOPH database. The third indicator is not 
available as the database did not store the Viral Load (VL) result. 
Figure 36 and Figure 37 described the distribution of Thailand's first and second 90-90-90 indicators 




Figure 36 MOPH 90-90-90 at the province level, (Left) First 90 indicator, (Middle) Second 90 
indicator, (Right) Third 90 indicator which is not available. Bangkok is the only province that 
does not have the second indicator because no data was submitted to the MOPH. 
 
Overall, the majority of provinces achieved the first indicator level higher than 100% with an average 
of 128.03%, ranging from 11.99% to 225.50% and with high variability (SD=30.97%). Northern and 
southern region distinctly achieved the lower indicator value. Bangkok indicators were remarkably 
low achieving the first indicator of 11.99% far lower than the second-lowest province that achieved 
53.58%. For the second indicator, Thailand achieved 53.61% on average with much less variability 
(SD=9.43%) ranging from 18.52% to 70.60%. There was no clustering pattering presented in 
Thailand's second indicator at the provincial level. It is important to emphasize that Bangkok was the 
only province without ARV coverage data available. 
There were 3 outlier provinces on each indicator. For the first 90-90-90 indicators, one province was 
an upper side outlier and two provinces as the lower side outlier. In the second 90-90-90 indicators, all 
three outliers provinces were on the lower side. Bangkok was the only one outlier (lower side) in the 
first indicator also a lower side outlier in the second.  
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Bangkok was the only province having identified as an outlier (lower-side) on the second 90-90-90 
indicator in both NAP and MOPH. No additional provinces were identified as outliers in the same 
indicator across two data sources. 
 
Figure 37 MOPH 90-90-90 distribution boxplot, Thailand, 2018. Noted that the third indicator 
is not available from lacks Viral Load Results data 
 
MOPH-NAP Difference 
Both databases reported a very similar total HIV number at the national level of 445,551 for MOPH 
and 450,548 for NAP. On average, MOPH had 650 patients less than NAP at the provincial level. The 
difference ranged from MOPH having 61,569 patients less than NAP and NAP to having 3,194 more 
than MOPH. The standard deviation was a very high of 7,249 patients. Assessing the two data sources 
difference distribution at the provincial level identified Bangkok having the highest number of 61,569 
patients, far higher than the rest of the country. When calculating two data sources percentage 
difference.  
We calculated the two data sources difference in percentage to address the difference in the total 
patients of each province. On average, Thailand MOPH reported 20% higher than NAP ranging from 
MOPH having 87.03% less than NAP to having 108.45% higher than NAP with a standard deviation 
of 25.42%. Two data sources percentage difference identified Bangkok (MOPH patient count 87.03% 
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less than NAP) and Ranong (MOPH patient count 108.45% more than NAP) as provinces with the 
highest difference as shown in Figure 38. 
 
Figure 38 (Left) Patient count difference between NAP and MOPH. The difference is prominent 
in Bangkok. (Right) The percentage difference between NAP and MOPH. For percentage 
calculation, Bangkok remains the highest province having a MOPH patient count proportion 
less than NAP. Ranong, on the contrary, has more MOPH patient count proportion than NAP. 
Identifying Bangkok as an outlier 
The absolute percentage difference between the two data sources is presented in Figure 39 at the 
provincial level. On average, the absolute patient count difference is 1,935 patients ranging from 12 to 
61,569 patients (SD=6,982). Bangkok remained as the province with the highest two data sources 
difference with 61,569 patents while the Ranong absolute difference on patients count difference was 
1,219. Absolute percentage difference calculation shows an average difference of 26.23% ranging 
from 0.80% to 108.45%. Ranong had the highest absolute difference percentage of 108.45% followed 
by Bangkok of 87.03%.  
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For NAP 90-90-90 indicators, Bangkok achieved 92-57-76. Bangkok 2nd-90-90-90 indicator is the 
fourth-lowest in Thailand and 7th lowest for the 3rd 90-90-90 indicator. The Ranong 90-90-90 
indicator was much better than Bangkok in an overall of 108-81-78.  
For the MOPH 90-90-90 indicators, only the first indicator was available for Bangkok of 11.99%. 
Bangkok is the only province where the second MOPH 90-90-90 indicator was not available due to 
lacking  ARV prescription data. Ranong, while its MOPH first 90-90-90 value was extremely high of 
225.50%, Ranong's second MOPH indicator was available of 45.07%.  
Moreover, Bangkok was identified as a lower-side outlier of the second MOPH 90-90-90 indicators 
and the first and the second NAP 90-90-90 indicators. Ranong, on the contrary, was identified as the 
higher side outlier of the first NAP 90-90-90 indicators.  
As a result, Bangkok was recognized as an outlier. The finding required the need for a field visit to 
explore factors explaining its outlier status and to re-analyzing the results without Bangkok data. 
 
Figure 39 (Left) Absolute patient count difference between NAP and MOPH. The difference is 
prominent in Bangkok. (Right) Percentage absolute difference between NAP and MOPH. For 
percentage calculation, Bangkok remains the highest province having a MOPH patient count 
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proportion less than NAP. Ranong, on the contrary, has more MOPH patient count proportion 
than NAP. 
Redoing analyses excluding Bangkok 
At this stage, Bangkok was identified as an outlier province that may distort the Thailand HIV 
situation. Therefore, we re-examined the two data sources difference by excluding Bangkok to 
explore any changes in the distribution pattern. The analysis was done without Bangkok and presented 
in Figure 40. 
Excluding Bangkok, the average two data source difference was MOPH has 745 patients more than 
NAP, ranging from MOPH having 6,432 less than NAP to 3,194 patients more than NAP 
(SD=1,462.45).  
In terms of two data sources percentage, on average, the difference was 21.87% ranging from MOPH 
having 46.42% less than NAP to having 108.45% more than NAP.  
While excluding Bangkok from calculation allow us to explore the finding in other provinces, there 
were no changes in overall distribution across the percentage of choropleth maps (Figure 41). No 




Figure 40 (Left) Patient count difference between NAP and MOPH excluding Bangkok. (Right) 
The percentage difference between NAP and MOPH, excluding Bangkok. Ranong remains as 
the province with the highest MOPH patient count proportion than NAP. 
 
 
Figure 41 (Left) Absolute patient count difference between NAP and MOPH, excluding 
Bangkok. (Right) Percentage absolute difference between NAP and MOPH excluding Bangkok. 
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For percentage calculation, Ranong remains the province with the highest absolute percentage 
difference 
Bivariate analyses of the main independent variables 
In this section, we explore the possible contributing factors in the two data sources difference before 
analyzing with the univariate and multivariate linear regression model. The outcome variable was the 
absolute percentage difference, the second and the third 90-90-90 indicators, and the initial 
independents variables selected included bed capacity, PEPFAR funding, care level, and hospital 
class. 
Two data sources difference 
Of the 1,323 hospitals in Thailand, 1,021 hospitals submitted data to either database as of 2018. 
Among them, only 835 hospitals specified their care level. There were only 1 private hospital and 1 
public non-MOPH hospitals that specified their care level as shown in Table 12.  
Several hospitals only described care level and several hospitals only described hospital type causing 
inconsistency in the analyses on either care level or hospital type alone. Therefore, we explored 
whether the care level or the hospital class were better variables for the analyses.  
Table 12 Cross-tabulation hospital type and care level, Thailand hospital 2018 
  Hospital type 




























1 0 16 56 0 0 
Tertiary (39) 0 1 0 13 25 0 
 
Of 1,021 hospitals submitted to one of the databases (NAP or  MOPH), 900 hospitals submitted HIV 
patients data to both databases. Only 121 hospitals submitted data to NAP only and no hospital 
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submitted data to MOPH without also submitting data to NAP. Using the median, hospitals submitted 
data to the NAP of 194 patients and 188 to MOPH. The median difference of 17 patients and 32.34%.  
Table 13 described the two data sources difference stratified by hospital type. Private hospitals submit 
data to NAP far more than MOPH causing their two data sources difference to be the highest. This 
was expected as private hospitals were not reimbursed by NAP. 
For public hospitals, MOPH Specialized hospitals had the highest two data sources difference 
percentage. MOPH general hospitals had the lowest difference percentage of all hospital affiliations.  
Regional MOPH hospitals, despite submitting the highest number, had the second-lowest two data 
sources difference percentage. 
Also, the MOPH community, general and regional hospitals reported HIV patients to MOPH more 
than to NAP. The MOPH specialized and public non-MOPH reported most patients to NAP rather 
than MOPH because of having different management structures and regulations.  
Table 13 Thailand two data sources difference at hospital level stratified by hospital type, 2018 




















360.5 (2-2,801) 93.27 % (0.45-
6,900.0) 
387 (1-5,626) 26 (0-7,187) 
MOPH Specialized 
(17) 
15.0 (3-6,491) 46.88 % (7.5-
520.0) 




27.0 (0-1,714) 15.79 % (0.0-
3,600.0) 
171 (2-4,438) 198 (7-5,554) 
MOPH General 
hospital (69) 
















Private hospital (113) 288.0 (0-2,995) 100.0 % (0.0-
700.0) 
288 (0-2,995) 0 (0-590) 
 
When stratified by care level, all secondary and tertiary level hospitals submitted data to MOPH more 
than NAP. Their two data sources' difference percentage did not vary much from each other. 
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However, the two-primary care hospitals had a much higher two data source difference of 525% and 
submitted most data to NAP rather than to MOPH (Table 14). Possible reasons were a small number 
of primary care hospitals were available and one primary care hospital was private that did not submit 
data to MOPH. 
Table 14 Thailand two data sources difference at hospital level stratified by care level, 2018 
















Primary (2) 197.5 (19-414) 94.95 (100.0-
950.0) 
208 (2-414) 11 (0-21) 
Secondary (small) 
(522) 
20.0 (0-1230) 13.99 (0.0-3600.0) 143.0 (2-1455) 163 (9-2,511) 
Secondary 
(medium) (199) 
32.0 (2-1714) 11.47 (0.45-
390.48) 
279.0 (7-1088) 311 (7-2,631) 
Secondary 
(advance) (73) 
210.0 (3-2382) 25.39 (0.44-
225.42) 
827.0 (240-4438) 1,037 (300-5,554) 
Tertiary (39) 426.0 (17-
2764) 




In the results, we identified a remarkable wide range of values. For example, the 0.45 -6,900 range for 
the median absolute percentage of two-data sources difference of Public non-MOPH hospital in Table 
13. Those are the results from several hospitals that have a high number of data submissions to one 
database while having a very low data submission to another result in a ‘0’ in the lower-end range of 
both NAP and MOPH patient count. Having a disproportionately low number distorted our percentage 
of two data sources difference.  
Normalization and case threshold definition 
In the previous section, we identified several hospitals with a low number of HIV patients or only 
submitting to NAP alone causing the two data source percentages difference to become remarkably 
high. In Figure 42, we used a log function to normalize the two data source difference percentage on 
each hospital type and15 upper side outliers were identified. With normalization, the MOPH 
specialized and MOPH regional hospitals did not have any outliers. This is important as the MOPH 
58 
 
specialized hospital type has a wide range of two data sources difference. However, even with the log 
transformation, the distribution of two data sources difference was still remarkably different across 
hospital types. 
 
Figure 42 Normalized Two data sources difference percentage by hospital type. There were 15 
upper side outliers and 41 lower side outliers 
From our data set, we found that using the 50 cases as inclusion criteria eliminate most of the outliers. 
The hospitals that reported at least 50 cases were responsible for most of the lower side outliers and 
only three upper side outliers remained as described in Table 15. In other words, the hospital with the 
50 cases threshold was more likely to have less two data source differences. 
The two data source difference distribution became more consistent across hospital types (Figure 43). 




Figure 43 Normalized Two data sources difference percentage by hospital type among hospitals 
with at least 50 cases. There were 2 upper side outliers from MOPH Community hospitals. Of 
21 lower side outliers hospitals, 17 were MOPH Community, 3 were MOPH General, and 1 
from Public Non-MOPH hospitals. 
The distribution of the two data sources difference distribution of 75 hospitals that reported less than 
our thresholds of 50 cases by each hospital type is shown in Figure 44. Their distribution was 
remarkably less consistent than those having more than 50 cases. They were responsible for 12 of the 
15 upper sides two data source difference outliers. In other words, they were more likely to have a 




Figure 44 Normalized Two data sources difference percentage by hospital type among hospitals 
with less than 50 cases. There were 5 upper side outliers, 2 were from MOPH Community, 2 
were from Public non-MOPH, and 1 from a private hospital. There were 4 lower side outliers 
from private hospitals  













Upper 0 6 4 0 5 0 
Lower 3 21 3 0 14 0 
Above 50 cases thresholds 
Upper 0 2 0 0 1 0 
Lower 3 21 3 0 10 0 
Below 50 cases threshold 
Upper 0 4 4 0 4 0 
Lower 0 0 0 0 4 0 
 
Of 75 hospitals that reported less than 50 HIV cases, most were community hospitals and private 
hospitals. None of the large hospitals (MOPH General and MOPH regional) were included, which 
were reasonable as they were more likely to submit more cases from having a larger capacity. 
61 
 
Table 16 described the two data sources difference among hospitals submitting less than 50 cases to 
both NAP and MOPH. The two data sources percentage were largely different across from hospital 
type from 0 in Public non-MOPH to 100% of private hospitals. Beside from MOPH community 
hospitals, there were several hospitals reported 0 patients to MOPH and NAP.  
Table 16 Two data sources difference by hospitals submitting less than 50 cases stratified by 
hospital type, 2018 








between two data 
sources 
Median NAP 





0.0 (2-35) 0.0 (17.65-3500.0) 10.5 (1.0-48.0) 10.5 (0-49) 
MOPH Specialized  
(10) 
10.0 (3-35) 42.55 (20.69-
520.0) 




4.0 (3-38) 15.38 (7.32-950.0) 26.0 (2.0-49.0) 30.0 (7-48) 
Private hospitals 
(21) 
9.0 (0-39) 100.0 (0.0-700.0) 9.0 (0.0-39.0) 0.0 (0-34) 
 
Therefore, we redid the analysis which includes only hospitals reporting at least 50 patients to both 
databases. 
Table 17 Thailand two data sources difference with at least 50 patients submission to MOPH 
and NAP at hospital level stratified by hospital type, 2018. 






































































Of 801 hospitals that submitted at least 50 patients to both databases. The private hospital number had 
the largest drop in the hospital number from 113 to 11 hospitals followed by the Public Non-MOPH 
hospitals from 58 to 23 hospitals.  
We observed a large decrease in the two data sources different among Public non-MOPH and private 
hospitals from 93.27% to 1.55% and 100% to 5.74% respectively. However, it was important to 
emphasize that the hospital number of both types were remarkably excluded by our threshold number 
of 50 cases. 
On the contrary, the percentage difference was increased from 46.88% to 86.99% among MOPH 
Specialized hospitals. Similar to private hospitals, it was important to emphasize that the MOPH 
specialized hospitals largely decreased from 17 to 4 hospitals.  
When stratified by the care level, with the case threshold of 50 cases, several remarkable changes 
were observed. All primary care facilities were excluded. The highest value of the two data source 
difference of the secondary (medium) level facilities was greatly decreased from 3,600.00% to 
328.35%. 
Table 18 Thailand two data sources difference with at least 50 patients submission to MOPH 
and NAP at hospital level stratified by care level, 2018 






































Tertiary (39) 426.0 (17-
2764) 





Kappa and two data sources agreement 
In this section, we calculate the data sources agreement and Cohen’s kappa to address the two data 
sources concordance of the Weiskopf data quality framework among those submitted at least 50 cases 
to both data sources.  
Table 19 Two data sources agreement and Cohen’s Kappa among hospital submitted at least 50 
cases stratified by hospital type 
Hospital Type  Agreement Cohen’s Kappa 
Public Non-MOPH  0.99 0.98 
MOPH Specialized  0.57 0.13 
MOPH Community hospital  0.94 0.87 
MOPH General hospital 0.86 0.72 
MOPH Regional hospital 0.91 0.83 
Private hospital 0.97 0.95 
 
The agreement and kappa were consistency with the two data sources different stratified by hospital 
type in the previous section, MOPH Specialized hospitals remain the hospital type with the lowest 
agreement and kappa. 
Table 20 Two data sources agreement and Cohen’s Kappa among hospital submitted at least 50 
cases stratified by care level 
Care level Agreement Cohen’s Kappa 
Secondary (small) 0.94 0.87 
Secondary (medium)  0.94 0.88 
Secondary (advance)  0.9 0.8 
Tertiary  0.92 0.84 
 
When stratified by care level, the agreements and cohen’s kappa were more consistent across the care 
level. The tertiary care level, while its agreement and cohen’s kappa was the lowest on the contrary to 
the two data source agreements, the difference is narrow compared to other care levels.  
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As Bangkok was identified as an outlier, we focus on exploring the Bangkok two data source 
differences in the next section. 
Bangkok area 
Of the 138 hospitals in Bangkok, only 59 hospitals submitted to NAP. Among them, 9 hospitals 
submitted to both databases and 50 hospitals submitted to NAP only. No hospitals submitted to 
MOPH without also submitted to NAP.  
Table 21 described the characteristics of hospitals in Bangkok. Most hospitals in Bangkok were 
private and public non-MOPH hospitals. Only one hospital had care level data available. Therefore, 
analysis of the two data sources difference stratified by care level for Bangkok hospitals was not 
possible.  
Table 21 Bangkok two data sources difference at the hospital level, 2018 





































Using the median, no hospitals in Bangkok submitted data to MOPH while submitting 791 to NAP. 
The median difference percentage was 100%. 
Table 21 shows the differences between the hospitals based on their type. On the contrary to the 
findings of all hospitals in Thailand, Bangkok hospitals submitted data to NAP more than to MOPH in 
every hospital type. No private hospitals submitted data to MOPH. The public non-MOPH and 




In all three hospitals' types, the two data source differences were nearly 100%. The public non-MOPH 
and private MOPH two data sources difference percentages were nearly identical to the Thailand 
average in Table 13. This finding implied that both hospital type data submission policies were 
different from MOPH hospitals.  
When including only hospitals reporting at least 50 patients to both NAP and MOPH, only 8 from 59 
hospitals remain (Table 22). All private hospitals and most of the public non-MOPH hospitals were 
excluded by our criteria. The finding suggests that most hospitals in Bangkok did not submit data to 
MOPH. No private hospital submitted data to MOPH at all.  
Table 22 Bangkok two data sources with at least 50 patient’s submission to MOPH and NAP 
difference at the hospital level, 2018 
































As Bangkok was considered in our study as a very important outlier, we explored in the next section if 
removing Bangkok altered Thailand's findings. 
Non-Bangkok area 
In this section, we explored the two data sources difference in non-Bangkok hospitals. After 
excluding Bangkok, 891 hospitals submitted to both NAP and MOPH. There were 71 hospitals 
submitted data to NAP only. No hospitals submitted to MOPH without also sending data to NAP.  
Removing Bangkok only eliminates one MOPH Specialized hospital from care level and hospital-type 
crosstabulation as shown in Table 23. In other words, nearly all hospitals that specified their care level 
in the database were outside of Bangkok.  
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With only 1 of 835 hospitals missing, we assumed the results to be identical to Table 14 and did not 
further conduct any analysis on two data sources difference stratified by care level among non-
Bangkok hospitals. 
Table 23 Cross-tabulation by hospital type and care level, excluding Bangkok, Thailand 
hospitals 2018 
  Hospital type 




























1 0 16 56 0 0 
Tertiary (38) 0 0 0 13 25 0 
 
After excluding Bangkok, the MOPH community, general and regional hospitals still reported to 
MOPH more than NAP with the lowest two data sources percentage difference than other hospital 
types. Private hospitals percentage difference remains the highest across non-Bangkok hospitals as 
described in Table 24. 
Table 24 Thailand two data sources difference at hospital level stratified by hospital affiliation, 
excluding Bangkok, 2018 














MOPH (39)  







































The analysis with only hospitals submitted at least 50 patients to both NAP and MOPH of non-
Bangkok hospitals presented in Table 25 was nearly identical to those of Thailand level in Table 17 
except for the specialized MOPH hospitals. Thus, the finding supports our hypothesis that hospitals 
that report only a few HIV cases or did not report to both databases are causing the two data source 
difference percentage to become remarkably large.  
Table 25 Non-Bangkok two data sources with at least 50 patient’s submission to MOPH and 
NAP difference at the hospital level, 2018 














MOPH (18)  



































The hospital level of 90-90-90 indicators 
Because the AEM, a denominator of the first 90-90-90 was not available at the hospital level, only the 
second and the third indicator were available. The median was 80.66% and 84.21% for the second and 




Table 26 Thailand second and third 90-90-90 at hospital level stratified by hospital type, 2018 
Hospital Type (n) Second 90-90-90 Third 90-90-90 
Public Non-
MOPH (58)  
72.75 (0.0-100.0) 71.65 (0.0-100.0) 
MOPH 
Specialized (17) 



















65.24 (0.0-100.0) 0.0 (0.0-100.0) 
 
In both second and third 90-90-90 indicators, no hospital achieved a level of higher than 100%. 
However, several private hospitals report an indicator of 0%. Of 35 hospitals report 0% of the second 
90-90-90 indicators, 32 were private hospitals. Of 78 hospitals report 0% of the third 90-90-90 
indicators, 59 were also private hospitals. There was 35 hospitals report both indicators of 0%, 32 of 
them were private hospitals.  
This was consistent as the private hospital did not have a  reimbursement of laboratory and ARV 
expenses from NAP. While they still reported the HIV patients’ number to NAP, they did not report 
the patients receiving ARV and those who achieve the viral suppression level. Thus, the second and 
third 90-90-90 indicators were not available. 
Table 27 The second 90-90-90 Indicators categories stratified by hospital type, Thailand 2018 
 The second 90-90-90 indicators 
Hospital Type (n) 0-50 (%) 51-75 (%) 75-100 (%) 
Public Non-MOPH (58)  15 (25.86) 16 (27.59) 27 (46.55) 
MOPH Specialized (16) 7 (41.18) 1 (5.88) 9 (52.94) 
MOPH Community hospital (741) 7 (0.94) 132 (17.81) 602 (81.24) 
MOPH General hospital (69) 2 (2.9) 15 (21.74) 52 (75.36) 
MOPH Regional hospital (25) 0 (0.0) 6 (24.0) 19 (76.0) 




We broke down the second and the third indicator by hospital type in Table 27 and Table 28 
respectively. When stratified into the 90-90-90 indicators progress category of 0-50, 51-75 and 75-
100% respectively, the three-hospital type of public non-MOPH, MOPH specialized and private 
hospitals had the lowest 75-100% category percentage across both second and the third indicators.  
Table 28 The third 90-90-90 Indicators categories stratified by hospital type, Thailand 2018 
 The third 90-90-90 indicators 
Hospital Type (n) 0-50 (%) 51-75 (%) 75-100 (%) 
Public Non-MOPH (50)  17 (29.31) 15 (25.86) 26 (44.83) 
MOPH Specialized (11) 8 (47.06) 3 (17.65) 6 (35.29) 
MOPH Community hospital (736) 16 (2.16) 108 (14.57) 617 (83.27) 
MOPH General hospital (69) 0 (0.0) 12 (17.39) 57 (82.61) 
MOPH Regional hospital (25) 1 (4.0) 2 (8.0) 22 (88.0) 
Private hospital (54) 65 (57.52) 22 (19.47) 26 (23.01) 
 
The highest number and percentage of the 0-50 category of both second and third indicators, were 
private hospitals and the MOPH Specialized hospitals. 
All MOPH hospitals, except for the MOPH specialized, had an exceptionally low hospital count in the 
0-50 category of both indicators. MOPH community hospitals achieve the highest hospital count 
proportion of the second 90-90-90 indicator 75-100 category while the MOPH regional hospitals 
count proportion is the highest in the third 90-90-90 indicators.  
Bed capacity 
When stratified by hospital type, MOPH regional hospitals had the largest bed capacity. Public Non-
MOPH had 322.47 bed capacity on average but their capacity varies greatly from 10 – 1,792 beds. 
MOPH community hospital had the smallest capacity of all (42.84 beds on average). The private 
hospital had 130.22 bed capacity on average ranging from 10-600 beds. Table 29 summarized the bed 
capacity across hospital types. 
Table 29 Hospital bed capacity stratified by hospital type, Thailand 2018 (Only those submitted 
data to at least one databases) 




Public Non-MOPH (58)  322.47 (10-1,792) 
MOPH Specialized (17) 242.06 (15-909) 
MOPH Community hospital (740) 42.84 (6-269) 
MOPH General hospital (69) 336.29 (120-600) 
MOPH Regional hospital (25) 703.24 (370-1,039) 
Private hospital (113) 130.22 (10-600) 
 
There were care level data available for 834 hospitals. The Primary care hospital had a 100 beds 
capacity. However, the number was from a single primary care hospital in the database. Three classes 
of secondary level had an average bed capacity of 363, 54.98, and 269.93 beds for small, medium, and 
advanced classes, respectively. Tertiary care had the largest average bed capacity of 615.79 beds as 
shown in Table 30. 
Table 30 Hospital bed capacity stratified by care level, Thailand 2018 
Hospital care level (n) Average Bed capacity 
(Lowest-Highest) 
Primary (1) 100 (100-100) 
Secondary (small) (522) 363 (6-120) 
Secondary (medium) (199) 54.98 (10-152) 
Secondary (advance) (73) 269.93 (60-578) 
Tertiary (39) 615.79 (200-1,039) 
 
At the provincial level, Bangkok bed capacity was far higher than the rest of the country (31,241 beds 
vs the country average of 1,869.49 beds). Before excluding Bangkok, the figure clearly shows bed 
capacity concentration in the Bangkok area (Figure 45).  After excluding Bangkok, the figure show 
concentrate on Northern, North-Eastern, and southern where a large regional city exists. The 
provincial bed capacity average also dropped to 1,483.3 beds. 
At this point, we determine that using the care level data for the hospital category was not feasible as 
several hospital data were missing. As higher care levels also had more bed capacity, we assume that 
the hospital treatment capability was taken into account by the bed capacity. Therefore, only hospital 




Figure 45 Provincial total bed capacity (Left) With Bangkok (Right) Without Bangkok  
In several previous two data sources difference tables, each hospital type shows a remarkable wide 
range. These findings provide a clue about the different nature of each hospital type internally, which 
needed to be explored in the field visit. Therefore, we explored whether stratified bed capacity by 
quartiles may reveal the pattern of the two data source difference.  
Table 31 Thailand two data sources difference at hospital level stratified by hospital bed 
capacity, 2018 










HIV patient count 
Median MOPH 
patient count 
1-30 (495) 33 (0-940) 30.69 % (0-3600) 121 (0-746) 142 (0-1,305) 
31-100 (311) 70 (0-1,714) 31.69 % (0-6900) 262 (0-1,503) 257 (0-2,631) 
101-500 (167) 264 (2-2,995) 49.19 % (0.45-
281.82) 
796 (2-5,626) 497 (0-7,187) 
501-1,000 (44) 754 (17-6,491) 35.44 % (18-100) 2,141 (90-6,491) 2,201 (0-6,495) 
>1,000 (5) 791 (148-
2,801) 




 Bed capacity available for 1,022 hospitals and they were classified into 5 categories to replicate the 
care level categories. More than 75% of hospitals had less than 100-bed capacity. Approximately half 
of the hospitals were classified into 0-30 beds.  
The largest hospital category (>1,000 beds) had the highest two data source difference. The reason 
was 3 of 5 >1,000-beds hospitals were Public non-MOPH hospitals, the other two hospitals were 
MOPH hospitals. In other words, only 2 hospitals in this category were bound to submit data to 
MOPH causing the two data sources difference to be exceptionally large. 
The second largest two data source difference came from the 100-500 beds hospitals. While their two 
data sources difference were less than the >1,000 beds category, they have more impact on Thailand 
from their higher number of 44 hospitals compared to 5 hospitals from the >1,000 beds category. 
When stratified the second and the third indicator by bed capacity categories (Table 32 and Table 33), 
the hospital with a bed capacity of 100-500 had the lowest hospital counts that achieved both 
indicators of 75-100%. The results from the largest hospital's capacity of >1,000 beds fluctuated very 
high from its low hospital counts of 5 hospitals. The difference between the other hospital bed 
capacity categories was narrow. 
Table 32 The second 90-90-90 Indicators categories stratified by bed capacity, Thailand 2018 
 The second 90-90-90 indicators 
Bed capacity (n) 0-50 (%) 51-75 (%) 75-100 (%) 
1-30 (495) 9 (1.82) 90 (18.18) 396 (80.0) 
30-100 (311) 32 (10.29) 52 (16.72) 227 (72.99) 
100-500 (167) 34 (20.36) 34 (20.36) 99 (59.28) 
500-1000 (44) 2 (4.55) 7 (15.91) 35 (79.55) 
>1000 (5) 0 (0.0) 3 (60.0) 2 (40.0) 
 
 
Table 33 The third 90-90-90 Indicators categories stratified by bed capacity, Thailand 2018 
 The third 90-90-90 indicators 
Bed capacity (n) 0-50 (%) 51-75 (%) 75-100 (%) 
1-30 (495) 20 (4.04) 78 (15.76) 397 (80.2) 
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30-100 (311) 47 (15.11) 44 (14.15) 220 (70.74) 
100-500 (167) 36 (21.56) 32 (19.16) 99 (59.28) 
500-1000 (44) 2 (4.55) 7 (15.91) 35 (79.55) 
>1000 (5) 1 (20.0) 1 (20.0) 3 (60.0) 
 
PEPFAR Funding 
As of 2018, 33 hospitals across 5 provinces in Thailand received funding and support from PEPFAR. 
Ten hospitals were in Bangkok. The majority of the hospitals were MOPH community hospitals and 
other MOPH hospitals type. There were Public non-MOPH hospitals and no MOPH specialized 
hospitals.  
Table 34 described two data sources difference among PEPFAR funded hospitals. Among them, 29 
hospitals submitted data to both databases. Four hospitals submitted to NAP only, and no hospitals 
only data to MOPH. Using the median, the hospitals submitted data to the NAP of 589 and 531 
patients to the MOPH. The median difference was 41 patients or 26.86 %. 
Unlike the rest of the study, PEPFAR funded MOPH general hospitals submitted data to NAP more 
than MOPH with the exceptionally low two percentage difference of less than 10%. However, the 
number was from only one hospital.  
While there was no MOPH specialized receiving PEPFAR funding, the public non-MOPH achieved 
the highest two data sources difference among PEPFAR funded hospitals (Table 34).  
Table 34 PEPFAR hospitals two data sources difference at hospital level stratify by hospital 
affiliation, 2018 


























32.5 (12-713) 7.33 % (2.73-
212.84) 






















For the second and the third 90-90-90 indicators, only two of the PEPFAR funded hospitals achieve 0-
50% of the second indicators and no hospitals achieve 0-50% of the third indicators. PEPFAR funded 
hospitals, overall achieved much better of the third 90-90-90 indicators than the second indicator 
(Table 35 and Table 36).  
Table 35 The second 90-90-90 Indicators categories stratified by bed capacity, PEPFAR funded 
hospitals, Thailand 2018 
 The second 90-90-90 indicators 
Bed capacity (n) 0-50 (%) 51-75 (%) 75-100 (%) 
1-30 (11) 1 (9.09) 2 (18.18) 8 (72.73) 
30-100 (18) 0 (0.0) 3 (16.67) 15 (83.33) 
100-500 (1) 0 (0.0) 0 (0.0) 1 (100.0) 
500-1000 (3) 0 (0.0) 2 (66.67) 1 (33.33) 
>1000 (11) 1 (9.09) 2 (18.18) 8 (72.73) 
 
Table 36 The third 90-90-90 Indicators categories stratified by bed capacity, PEPFAR funded 
hospitals, Thailand 2018 
 The third 90-90-90 indicators 
Bed capacity (n) 0-50 (%) 51-75 (%) 75-100 (%) 
1-30 (11) 0 (0) 2 (18.18) 9 (81.82) 
30-100 (18) 0 (0) 1 (5.56) 17 (94.44) 
100-500 (1) 0 (0) 0 (0.0) 1 (100.0) 
500-1000 (3) 0 (0) 0 (0.0) 3 (100.0) 
>1000 (11) 0 (0) 2 (18.18) 9 (81.82) 
 
Analysis of possible association factors for the two data sources difference with 
multivariate linear regression 
In this section, we explored the potential associated factors of the two data sources difference using 
multivariate linear regression. The dependent factor was defined as an absolute percentage of two data 
sources difference while bed capacity, PEPFAR funding, and hospital classes were included as 
75 
 
independent factors, the results are described in Table 37. Only hospitals submitting more than 10 
patients to NAP were included in the regression.  
Table 37 Multivariate linear regression of two data sources potential associate factors, hospital 
level  
Contributing factors Co-efficiencies p-value 
Bed capacity  0.01 0.64 
PEPFAR Funding  -7.17 0.46 
Hospital type   
- MOPH Community hospital 19.49 0.18 
- Public Non-MOPH 42.56 <0.05* 
- MOPH Specialized 39.37 <0.05* 
- MOPH General hospital 13.52 0.32 
- MOPH Regional hospital Ref  
- Private hospital 70.13 <0.05* 
 
Using MOPH regional hospitals as a reference, Public non-MOPH, MOPH specialized, and private 
hospitals show a statistically significant association of having a higher two data sources percentage 
difference. Having PEPFAR support is the only contributing factor that reduces the two data sources' 
difference. However, the PEPFAR support association was not statistically significant.  
Table 38 Multivariate linear regression of two data sources potential associate factors, hospital-
level excluding Bangkok 
Contributing factors Co-efficiencies p-value 
Bed capacity -0.001 0.68 
PEPFAR Funding -6.73 0.56 
Hospital type   
- MOPH Community 
hospital 
8.21 0.67 
-     Public Non-MOPH 26.70 0.14 
-     MOPH Specialized 25.39 0.31 
- MOPH General hospital 7.27 0.63 
- MOPH Regional hospital Ref  
- Private hospital 57.43 <0.05* 
 
After Bangkok was excluded, only private hospitals association remain statistically significant.  
We explored further by switching the unit of analysis to the province to facilitating site selection as 
the final selection for the qualitative assessment needed to be approved by provincial authority. 
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Absolute two data sources percentage difference remained as the dependent variable and total bed 
capacity, PEPFAR funding as the independent variables.  
Table 39 Multivariate linear regression of two data sources potential associated factors, 
provincial level 
Contributing factors Co-efficiencies p-value 
Bed capacity 0.02 <0.05* 
PEPFAR Funding -37.70 <0.05* 
 
 Table 39 describes potential associated factors to two-data source difference, with hospital and 
province as a unit of analysis respectively, we found bed capacity was positively associated with the 
absolute two data sources percentage difference. Having PEPFAR funding negatively associate with 
the two data sources difference. In other words, the finding provides a clue that PEPFAR support may 
contribute to the discrepancies reduction between the two data sources. However, the association 
completely changed after excluding Bangkok as described in Table 40. 
Table 40 Multivariate linear regression of two data sources potential associate factors, 
provincial level, excluding Bangkok 
Contributing factors Co-efficiencies p-value 
Bed capacity 0.001 0.84 
PEPFAR Funding 8.73 0.32 
 
The finding is remarkable considering that PEPFAR funding also supports several capacities 
including training, technical support, and funding. However, having PEPFAR support did not shows 
statistically significant association regardless of the hospital or provincial level. The changes in the 
results after removing Bangkok show the magnitude to what extent the impact it had on the national 
situation interpretation and the importance of conducting the Bangkok field visit in this study. 
Considering the limited time and logistics challenge, the team decided to focus on PEPFAR funded 
province (Bangkok is one of the provinces receiving PEPFAR funding) as PEPFAR funded province 
have much better cooperation as PEPFAR is one of the dissertation’s stakeholder.  
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Analysis of possible association factors to the second and the third 90-90-90 indicators 
with multivariate linear regression 
This section explored the possible association factors to the second and the third 90-90-90 indicators 
using multivariate linear regression.  
Table 41 Multivariate linear regression of the second 90-90-90 indicators and possible 
contribution factors 
Contributing factors Co-efficiencies p-value 
Bed capacity 0.0002 <0.05* 
PEPFAR Funding 0.06 < 0.05* 
Hospital level   
- MOPH Community 
hospital 
0.16 <0.05* 
- Public Non-MOPH -0.17 <0.05* 
-  MOPH Specialized -0.27 <0.05* 
- MOPH General hospital 0.07 0.06 
- Private hospital -0.37 <0.05* 
   
 
In Table 41, most independent factors achieved statistically significant to the second 90-90-90 
indicators. While most factors association were positive, public non-MOPH, MOPH specialized, and 
the private hospital have a negative association. Only MOPH general hospitals did not have a 
statistically significant association.  
Although having more bed capacity was associate with a higher second 90-90-90, the association is 
very weak. Having PEPFAR funding, also improve the second indicators. In comparison to MOPH 
regional hospital, the MOPH community hospital type has a much higher second indicator while the 
private hospitals achieve the lowest. MOPH General hospital achieves a similar level of the second 
indicator compared to the MOPH regional hospitals. 
Table 42 Multivariate linear regression of the third 90-90-90 indicators and possible 
contribution factors 
Contributing factors Co-efficiencies p-value 
Bed capacity 0.0001 <0.05* 
PEPFAR Funding 0.09 <0.05* 
Hospital level   





-     Public Non-MOPH -0.14 <0.05* 
-     MOPH Specialized -0.26 <0.05* 
- MOPH General hospital 0.09 0.06 
- Private hospital -0.36 <0.05* 
   
 
For the third 90-90-90 indicators in Table 42, the direction and strength of the association were 
identical to those of the second indicators. A possible reason was for the calculation of the third 
indicator we used the number of patients receiving ARV as the denominator. The patient receiving 
ARV, however, was the nominator of the second indicator calculation.  
The additional analysis was conducted using univariate linear regression and found that the second 
and the third indicators association is strong with a statistically significant coefficient of 0.83.  
The value of 0.83 is the same as the third 90-90-90 indicator of 83%. This is because the patients who 
achieve the VL suppression level are those who receive ARV and were used to calculate for both the 
second and the third indicators. Therefore, we imply collinearity and did not include the second 
indicator as to the independent variable for the third indicator multiple linear regression.  
Normalized multiple linear regression 
In the previous section, the analysis was conducted using linear regression when the assumption of 
normality holds per requested from stakeholders. However, we discovered that the distribution was 
not normal and there was needed a normalizing of the two data sources using the log function.  
In this section, we re-did the multiple linear regression using the log absolute two percentage 
difference as dependent factors 
Of all hospitals in the study, we identify the public non-MOPH, MOPH specialized, and the private 
hospital was statistically associated with higher normalized two data source differences. 




Table 43 Multivariate linear regression of normalized two data source difference and possible 
contribution factors 
Contributing factors Co-efficiencies p-value 
Bed capacity -0.001 0.29 
PEPFAR Funding -0.16 0.47 
Hospital level   
- MOPH Community 
hospital 
0.005 0.99 
- Public Non-MOPH 1.14 <0.05* 
-  MOPH Specialized 1.11 <0.05* 
- MOPH General hospital 0.04 0.89 
- MOPH Regional hospital Ref  
- Private hospital 1.31 <0.05* 
   
 
Of hospital submitting more than 50 cases, no factors were statistically significantly associated with 
the normalized two data sources difference.  
Table 44 Multivariate linear regression of normalized two data source difference and possible 
contributing factors among hospital submitted more than 50 cases 
Contributing factors Co-efficiencies p-value 
Bed capacity -0.001 0.51 
PEPFAR Funding 0.03 0.89 
Hospital level   
- MOPH Community 
hospital 
-0.09 0.84 
- Public Non-MOPH 0.10 0.80 
-  MOPH Specialized 0.46 0.48 
- MOPH General hospital 0.05 0.89 
- MOPH Regional hospital Ref  
- Private hospital -0.10 0.86 
   
 
Among hospitals submitting less than 50 cases, bed capacity remains non-statistically significant, non 
of the PEPFAR funded hospitals were among this group. It was important to emphasize that no 
MOPH regional hospitals submitted less than 50 cases, therefore, we could not use the MOPH 
regional hospitals as a reference group and we switched to MOPH community hospital instead. 
MOPH specialized and private hospitals were statistically significantly associated with having a high 
two data source difference. The finding supports our hypothesis that the hospital submitted less than 
50 cases largely contribute to the association with the two data source difference.  
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Table 45 Multivariate linear regression of normalized two data source difference and possible 
contributing factors among hospital submitted less than 50 cases 
Contributing factors Co-efficiencies p-value 
Bed capacity -0.001 0.83 
PEPFAR Funding - - 
Hospital level   
- MOPH Community 
hospital ** 
Ref.  
- Public Non-MOPH 1.24 <0.05* 
-  MOPH Specialized 0.78 0.07 
- Private hospital 0.84 <0.05* 
   
**Because there was not MOPH Regional hospital that submitted less than 50 cases, the reference group was 
switched to MOPH Community hospital instead. 
DQI Results 
Patients and hospital characteristics 
Of the 26 hospitals that agreed to participate in the study, one hospital was excluded from DQI Tools 
implementation due to a technical problem, therefore 25 hospitals across 5 provinces were included in 
the study. The excluded hospital remained to participate in our field visits and field interviews.  
This section focused on the DQI Tools report generated from the hospital database during the field 
visit. While DQI Tools also provide local health personnel with several reports for HIV care services, 
discussing their usability was not within the study scope.  
Overall, hospital characteristics were shown in Table 46. There were 7,213 beds capacity in total or 
288.52 beds on average covering 36,115 MOPH and 35,947 NAP HIV patients with an average 
absolute two data sources difference of 499% according to both database reports. When stratified by 
hospital type, 11 hospitals were community and 10 were non-MOPH hospitals. There were 11 
secondary hospitals, 4 tertiary hospitals, and one primary care hospital included in the field visit. The 
rest did not specify their care level nor hospital type in the database.  
Table 46 Participated Hospitals by  characteristics from NAP and MOPH national level, 2018 
Characteristic Number 
Total Bed capacity 






- MOPH Community hospital 
- Public Non-MOPH  
- Private 
- MOPH General hospital 









- Secondary basic 
- Secondary medium 















MOPH HIV Count 





- Median 1,048 





The DQI Tools reports provided a  total of 63,721 HIV patients including 10,810 deaths from the 
NAP database among 25 study sites, several of them do not have demographic data (36,997 or 
58.6%). Among them, males remained as a major patients population (21,615 or 58.42% ). Patients 
older than 50 years old were responsible for the highest percentage across both sexes (33.18%) as 
shown in Table 47. The highest patient count population was male patients older than 50 years old. 
Unfortunately, analyzing more details on the entire HIV database at study sites were not allowed. 
Table 47 NAP patient demographic among 25 study sites 
Age group Male (% Column) Female (% Column) Total (%) 
<15 98 (0.56) 87 (0.45) 185 (0.50) 
15 TO 19 107 (0.82) 126 (0.5) 233 (0.63) 
20 TO 24 791 (3.50) 538 (3.66) 1,329 (3.59) 
25 TO 29 1,849 (5.40) 831 (8.55) 2,680 (7.24) 
30 TO 34 2,550 (6.77) 1,041 (11.80) 3,591 (9.71) 
35 TO 39 2,703 (10.12) 1,557 (12.51) 4,260 (11.51) 
40 TO 44 3,129 (16.67) 2,564 (14.48) 5,693 (15.39) 
45 TO 49 3,420 (21.49) 3,306 (15.82) 6,726 (18.18) 
50+ 6,950 (34.62) 5,325 (32.15) 12,275 (33.18) 
UNKNOWN 18 (05) 7 (08) 25 (07) 




DQI Tools Loss-follow-up Output 
There were 7,991 loss-follow-up patients among 25 study sites from the NAP database. However, the 
number includes 499 duplicated records. There were 5 records with invalid SSN and 96 records 
without SSN in the NAP database among study sites, which were also excluded. At this point, 7,391 
loss-follow-up HIV patients remained. 
Among remaining patients, only 3,337 (45.1%) have sex data, and males remained to be the majority 
of patients of 1,927 or 57.75%. Patients older than 50 years old (50+) remained as the highest 
contribution age group for both sexes as shown in Table 48.  
Table 48 NAP loss-follow-up patient demographic among 25 study sites 
Age group Male (% Column) Female (% 
Column) 
Total (%) 
0 TO 15 3 (0.16) 3 (0.21) 6 (0.18) 
15 TO 19 8 (0.42) 13 (0.92) 21 (0.63) 
20 TO 24 111 (5.76) 80 (5.67) 191 (5.72) 
25 TO 29 229 (11.88) 129 (9.15) 358 (10.73) 
30 TO 34 286 (14.84) 165 (11.70) 451 (13.52) 
35 TO 39 247 (12.82) 170 (126) 417 (12.50) 
40 TO 44 226 (11.73) 201 (14.26) 427 (12.80) 
45 TO 49 212 (110) 249 (17.66) 461 (13.81) 
50+ 601 (31.19) 397 (28.16) 998 (29.91) 
UNKNOWN 4 (0.21) 3 (0.21) 7 (0.21) 
Total 1,927 1,410 3,337 
 
We explored further on loss-follow-up characteristics. NAP has three loss-follow-up patient 
categories. 
- Lost1: HIV positive but was not registered to NAP 
- Lost2: Registered but no ARV was given  
- Lost3: Lost follow-up after ARV. 
Of 25 study sites, NAP reported 7,991 lost follow-up patients. Among them, 499 duplicated were 
identified and removed by the DQI tools, along with 96 invalid SSN and 5 without SSN. At this stage, 
7,391 loss-follow-up were left for further analysis. 
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Among 7,391 patients, there were 1,043 patients with HIV positive but did not register to NAP 
(Lost1), 1,978 patients when registered but did not receive ARV, and 4,372 who lost follow-up after 
ARV initiation. Sixty-eight patients were found to be dead. After removing 68 deaths, there were 
7,323 lost-follow-up patients remained (Table 49).  
Table 49 NAP Loss-Follow-up by loss follow-up category and alive/dead status among 25 
hospitals, after removing duplicate 
Alive/Dead Lost1 Lost2 Lost3 Total 
Alive 1,039 1,948 4,336 7,323 
Dead 2 30 36 68 
Total 1,041 1,978 4,372 7,391 
 
There was 7 patient status generated from DQI Tools: “Currently on ARV”, “Follow-up without ARV 
at other hospitals”, “Lost follow-up after ARV”, “Lost follow-up before ARV initiation”, 
“Misdiagnosis (negative HIV test or Inconclusive)”, and “need HIV result verification”. We started by 
looking at DQI tools generated list of patients' status and compared to NAP Lost 1-3 category in 
Table 50. 
Table 50 DQI Tools generated final patient status by NAP lost patient categories 
DQI Output Patient Status Lost1 Lost2 Lost3 Count (%) 























Lost-follow-up after ARV    3,120 (42.61) 














Need HIV result verification 
   
1,780 (24.31) 








There were 886 patients reported from NAP who remained on ARV treatment and regularly follow-up 
with their physician.  There were 390 patients remained on ARV in other hospitals and 5 patients 
regularly follow-up without ARV in other hospitals. In other words, 1,281 from 7,323 (17.49%) lost 
follow-up reported by NAP were still receiving their treatment regularly. 
The “Need HIV result verification” category consisted of 1,780 patients and it was important as they 
had absolutely no HIV-related laboratory nor ARV prescribing history in both NAP and MOPH. 
Moreover, 920 of 1,780 were labeled as Lost1 or never registered to NAP (no patient ID) but were 
existed in the NAP database. One important concern was patients in this category have no patient ID, 
recruiting them back to the HIV care system was impossible.  
Two patients were identified as misdiagnosis or having negative HIV results but were recorded to 
NAP as HIV positive patients.   
The number of confirmed loss-follow-up was 4,260 from Lost follow-up after ARV had the highest 
number of 3,120 (42.61%) and Lost-follow-up before ARV (1,140 or 15.57%).  
At this point, among 7,323 lost follow-ups, 6,040 (82.48%) were identified by the DQI Tools (1780 
Need to confirm HIV laboratory result and 4,260 confirmed as loss-follow-up) as a list to verify their 
HIV laboratory results and recruit back to the HIV care system or as potential excluded from the 
calculation of the 90-90-90 indicators.  
So far, the number of confirmed loss follow-up patients was 4,260 or 58.17% of the total reported as 
loss-follow-up by NAP. In other words, only 58.17% of NAP reported loss-follow-up is a real loss. 
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The overall summary of DQI Output is visualized in Figure 46. 
 
Figure 46 TUC DQI Tools results of 23 hospitals break down by output category. NAP reported 
of 7,991 lost-follow-up patents.  After cleaning with DQI Tools, 7,391 were left for analysis. 
Starting from NAP reported loss-follow-up of 7,991 patients, the number where stakeholders obtained 
before DQI Tools. We were able to identify duplicated invalid data and provide the list of patients 
among “Lost follow-up” and “Need HIV result verification” from whom hospitals have to work on 
medical record reviewing and recruit them back to the HIV care system. This was extremely useful 
for the hospital HIV personnel as they only needed to look at 4,260 lost follow-up patients instead of 
7,991 or a 46.69% reduction in their workload. However, among the “Need HIV result verification” 
category, the MOPH and NAP may have to decide on what extent records of this category should be 
removed from the indicator calculation. 
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DQI Loss-follow-up length 
We explored the DQI results further by assessing the loss-follow-up length from NAP as presented in 
Table 51.  Most loss-follow-up patients were in the “0-1 years” bracket followed by “1-2 “and “> 10 
years”, respectively. Most patients in the “Need HIV result verification” category were diagnosed 
more than 10 years ago. However, from the “Need HIV result” category was from the 7-10 years 
bracket. Also, most patients (1,124 of 1,126 patients or 99.82%) who were in “still follow-up” were in 
the 0-1 years loss-follow-up length reported by NAP. The last patient that was reported of the follow-
up was in the 3-4 years bracket. Among two misdiagnosis cases, the last patient was reported by NAP 
in the 1-2 years bracket. 
Table 51 DQI Status output by NAP loss follow-up length 
DQI Status 
























Still follow-up 1124 1  1        
Lost Follow-up 1797 1187 475 235 151 91 67 30 35 29 182 
-   Lost after ARV 1347 857 356 187 115 73 54 30 35 29 55 
-  Lost before 
ARV 450 330 119 48 36 18 13    127 
Misdiagnosis 1 1          
Need HIV result 
verification 455 252 80 33 23 19 10    984 
Total 3377 1441 555 269 174 110 77 30 35 29 1166 
 
Follow-up chart-review by local personnel 
At the end of the DQI activities, the list of the loss-follow-up patients and those who needed to 
confirm diagnosis were distributed in a list of 6,040 patients (1,780 “Need HIV result verification” 
and 4,260 “Loss follow-up”)  in four Microsoft Excel files for the local personnel along with other 
HIV service reports recruiting back the patients to the HIV care system. The results of 1,488 were 
submitted to the project team within 3 months period after the training workshop and were described 
in Table 52. Of 1,780 “Need HIV result verification” category, 4 patients were confirmed as HIV 
negative, 9 patients had no HIV test results and 30 were unreachable.  
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Table 52 Chart review results from DQI Tools 
Chart review and recruit summary Lost-follow-




Need HIV result 
verification 
Total 
Confirm HIV Negat 1 
 
4 5 
No HIV test 
  
9 9 
Unable to contact 841 262 30 1,133 





Follow-up with ARV at this hospital 93 79 9 181 
Follow-up with ARV at other 
hospitals 






Total 1,035 398 55 1,488 
 
During the reviewing of the chart, we identified 5 additional confirmed HIV negative patients within 
the NAP database. One dead patient was found despite being reported as alive in NAP. Also, 181 
patients were found “regularly following up” at their hospitals while 153 patients reported being 
“follow-up with other hospitals”. Additional 340 patients were confirmed as “HIV negative”, 
“recruited back to care”, “still follow-up up” and “dead” were also excluded. At this stage, the loss-
follow-up number was reduced to 5,700 patients (77.83%) from 6,040. The rest were under review by 
personnel as of December 2019. 
VL Level among loss-follow-up patients 
Among 7,323 patients, 1,276 were reported as a loss by NAP but found to be currently in follow-up 
(Table 53), of the 1,194 patients with information about Viral Load level, and 1,152 (96.48%) 
achieved viral suppression (VL < 1,000 copies). This was important as normally loss-follow-up 
patients were not included in the third 90-90-90 indicator calculation. The viral suppression level 
among both groups was much higher than those of the Thailand national third 90-90-90 indicators of 
83%.  
Table 53 Recent VL Level among NAP loss-follow-up but reported as currently follow-up by 
DQI Tools 
DQI generated patient status <50 50-1,000 >1000 Total 
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Currently on ARV 783 (93.77) 27 (3.23) 25 (2.99) 835 
(69.93) 
Follow-up with ARV in other hospital 327 (919) 15 (4.18) 17 (4.74) 359 (307) 
Total 1,110 (92.96) 42 (3.52) 42 (3.52) 1,194  
 
Assessing DQI Tools impact on 90-90-90 Indicators among study sites 
At this stage, we developed a proposal for adjusting the NAP HIV report and the 90-90-90 indicators 
among study sites. However, as the AEM calculation was available only at provincial levels, 
calculating the first 90-90-90 indicators was not feasible, only the second and third 90-90-90 
indicators are available.  
At first, calculating NAP among 25 study sites yielded the 90-2 and 90-3 indicators of 802% and 
68.68% respectively. We established four scenarios using the DQI Tools application for adjusting the 
HIV cascade and the 90-90-90 indicators. Each scenario has a different interaction with the revised 
AEM 2019 estimation and impacted the90-90-90 indicators for the decision-makers to decide based 
on one of the four scenarios or by requiring additional conditions. 
1. DQI Corrected-1 
This is a default correction by the tools, by integrating both Ministry (MOPH) and NAP 
databases 
2. DQI Corrected-2 
DQI Corrected-1 + excluding patient without HIV results 
3. DQI Corrected-3 
DQI Corrected-1 + exclude loss-follow-up and unreachable patients 
4. DQI Corrected-4 




At the start of the study, 52,912 Patients were Living with HIV (PLHIV) as reported from NAP. This 
number was the only number local personnel could obtain before deploying DQI Tools. As stated in 
the previous section, there were 4 possible data correction scenarios. The tools with the default 
correction (DQI-Corrected-1) removed 101 invalid SSN and 499 duplicated records and reduced the 
loss-follow-up from 7,991 to 6,047, (-1,944 patients), or a 24.32% reduction. That left 52,313 
(98.87% compared to PLHIV reported from NAP or 1.13% reduction) patients at this stage. The 
second scenario (DQI-Corrected-2) further excluded 1,780 patients who needed HIV result 
verification further reducing the PLHIV number to 50,533 and the loss-follow-up patient to 4,267, 
3,724 patients or 46.60% reduction from NAP report. The third scenario excluded 1,103 unreachable 
HIV patients from DQI-Corrected-1, reducing the PLHIV number to 51,210 and loss-follow-up 
patients to 4,944, 3047 patient reduction, or 38.13% reduction from NAP. The fourth scenario 
removed both HIV result verification and unreachable HIV patient from DQI-Corrected-1, giving the 
final PLHIV of 49,430 (93.42% or 6.58% reduction) and loss-follow-up patients to 3,164, reducing 
4,827 patients or 60.41% from NAP. The overall flow and all DQI-Corrected scenarios were 




Figure 47 PLHIV Flow chart from NAP report to DQI-Corrected scenarios 1-4. 
On the contrary to loss-follow-up and PLHIV, the scenarios did not have much impact on both 
patients receiving ARV and VL-suppressed. In addition to the 29,077 patients achieving VL-
suppression from NAP, an additional 1,152 (3.96% increase) patients that also achieved VL-
suppression among loss-follow-up patients were identified and added by the DQI Tools. That resulted 
in 30,229 total patients achieving VL-suppression in the DQI-Corrected-1. The number remained 
unchanged throughout the DQI-Corrected 2-4.  
The DQI Tools also identified 1,276 (31% increase) patients who were receiving ARV but were 
categorized as loss-follow-up in NAP and adding back to 42,339 patients receiving ARV reported in 
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NAP. That gave the final number of 43,615 patients. Similar to the VL-suppression, the number 
remained unchanged through DQI-Corrected 2-4 scenarios as shown in Table 54 and Figure 48.  
Table 54 HIV cascade and 90-90-90 indicators comparison between NAP, DQI-corrected and 










PLHIV 52,912 52,313 50,533 51,210 49,430 
Receive ARV 42,339 43,615 43,615 43,615 43,615 
Loss Follow-up 7,991 6,047 4,267 4,944 3,164 
VL Suppressed 29,077 30,229 30,229 30,229 30,229 
90-2 802% 83.37% 86.31% 85.17% 88.24% 
90-3 68.68% 69.31% 69.31% 69.31% 69.31% 
 
 
Figure 48 HIV cascade comparison across NAP values and the four DQI corrected scenarios 
among 25 study sites  
 
Table 54 described the HIV cascade and the 90-2 and 90-3 indicators across four DQI Corrected 
scenarios compared to the NAP report. With the default DQI Tools correction in scenario 1, both 90-2 
and 90-3 indicators were improved to 83.37 and 69.31% respectively. In scenario 2 of excluding all 
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1,780 lost-follow-up patients without HIV result generated from DQI tools in addition to default 
correction, 90-2 indicator was improved to 86.31%. The 90-3 indicator remained unchanged as all 
lost-follow-up patients without HIV result did not have any ARV prescription therefore the 90-3 
nominator (Receiving ARV) and denominator (VL suppressed) remain the same. Scenario 3 used DQI 
Tools default correction and 1,103 patients unreachable by local healthcare personnel improving the 
90-2 indicator to 85.17% from the NAP Report. The 90-3 indicator, remained unchanged as 
unreachable patients did not have ARV prescriptions as well. The last scenario used the DQI Tools 
default correction along with excluding patients without HIV result and those who were unable to 
contact of 2,883 patients resulting in the 90-2 and 90-3 indicators of 88.24% and 69.31%. The last 
scenario improved the 90-2 indicator to nearly achieving a target of 90%. Overall, the impact of the 
tools was largely on the 90-2 indicators as shown in Figure 49. 
 
Figure 49 Second and third 90-90-90 indicators comparison across NAP value and four DQI-




DQI Scenario at individual study sites level 
With the NAP report alone, none of 25 sites in this study would be able to achieve the second 90-90-
90 indicator goal of 90% or higher. Even with DQI-corrected-1, none of them surpassed the 90% 
target threshold.  
With the standard correction (DQI-corrected-1), the tool reduced the PLHIV by 1.95% on average 
(08-24.24%). The reduction, however, increased in other DQI-corrected scenarios. DQI-corrected-2 
increased the second 90-90-90 indicators for 5.87% (2.11-27.55%) on average. DQI-corrected-3 
increased the second 90-90-90 indicators for 4.59% (0.16-29.52%) and DQI-corrected-4 increased the 
second 90-90-90 indicators for 7.70% (2.11-31.22%) 
DQI-corrected-2 scenario increased the indicator surpassing the 90% threshold among 6 hospitals. 
DQI-corrected-3 increased the number of hospitals surpassing the 90% threshold to 5 hospitals. The 
DQI-corrected-4 scenario was able to achieve 8 hospitals that surpassed the threshold, the highest 
number among all scenarios. 
None of the study sites were able to achieve the threshold level of 90% of the third 90-90-90 indicator 
even with the tool deployed. As stated in the previous section, the third 90-90-90 improvement only 
occurs in the DQI-corrected-1 and remains unchanged through our other scenarios. The DQI-
corrected-1 improved the third 90-90-90 indicator of 0.56 % on average (-0.11-9.58%). Figure 50 




Figure 50 90-90-90 Indicators comparison across NAP report and DQI-Corrected scenarios at 
hospital level among 25 study sites. The green dash line represents a 90% target threshold. 
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Field visit qualitative results 
Of the 25 hospitals in this study 12 were visited for field interviews to assess their data workflow at 
the hospital. The team visited one primary care facility, 4 tertiary care hospitals, and 7 secondary care 
level hospitals. The average bed capacity among 12 study sites was 394.17 beds (1-1,680). Six 
hospitals resided in Bangkok and three hospitals for each of the two provinces. 
As formal interview and voice recordings were not allowed by the health authorities in this study, we 
conducted field interviews among 64 key informants during a one-day field visit. All findings were 
based on team observation and field notes. Most interviewees were nurses, IT personnel, and 
laboratory technicians respectively as presented in Table 55. For privacy reasons, we did not collect 
any details on demographics data. 
Table 55 Characteristics and number of interviewed personnel during field visits 
Interviewed professionals Number 
Physician 6 
Nurses 19 
IT Personnel 16 
EHR Vendors 3 
Pharmacists 5 




MEASURE DQA Tools 
Table 56 described the MEASURE DQA Tools scores to represent the data management practice in 
this study. Overall, hospitals scored 2.62 on average with the highest score on “Links with National 
Reporting System” and the lowest on “Data Management Processes”. The MEASURE score did not 
show much variation between hospitals. The only primary care facility in this study achieved the 
lowest score in nearly all fields. 
Table 56 MEASURE Data Quality Audit (DQA) Tools results from 12 hospitals across two 




































Bangkok 2.33 2.75 3 2.38 3 2.69 



















Bangkok 2.67 2.75 2.25 2.13 3 2.56 






2.67 2.75 2.5 2.13 3 2.61 




























Bangkok 2.67 2.75 3 2.25 2.75 2.68 






2.67 2.75 2.75 2.5 3 2.73 
Average    2.53 2.77 2.73 2.17 2.92 2.62 
 
There were 12 hospitals deployed with the MEASURE DQA Tools, 7 hospitals located in the 
Bangkok area. We did not observe any remarkable nor statistically significant difference in the 
MEASURE DQA scores between Bangkok and non-Bangkok hospitals as presented in Table 57. 
Table 57 Comparing the MEASURE DQL average score of Bangkok and non-Bangkok 


























Bangkok 2.52 2.79 2.75 2.2 2.89 
Non-
Bangkok 
2.54 2.75 2.7 2.13 2.95 
T-test p-
value 




The reason for having a high score on the national reporting system was because Thailand already had 
the infrastructure in place from both MOPH and NAP which already had several protocols that 
conformed to the MEASURE question. The same reason explained the high score on “Indicator 
Definitions and Reporting guidelines” and “Indicator Definitions and Reporting Guidelines” as 
MOPH used direct database extraction and submission while NAP uses manual data entry through the 
NAP’s website. However, there was no quality control process in place for data entry and submission 
of NAP and MOPH causing the Data Management Processes score to be the lowest.  
Thailand HIV workflow 
Hospital workflow 
Among 12 study sites, there were three main workflows categories: “fully paper-based”, “parallel 
paper-based, and electronic-based”, and “full electronic-based systems”. Overall, the patient 
registration processes were similar, the difference was how physicians recorded the patient history 
and stored it in the hospital EHR database.  
The paper-based only system let physician write down into a paper document which was scanned and 
stored in the EHR as an image file. Designated hospital personnel were to read the records either from 
a scanned document or the paper record and manually enter into the NAP system. The paper 
documents were discarded later at the end of the process. Data for MOPH submission were extracted 




Figure 51 An example of the fully paper-based system at tertiary care hospital 
The parallel system (Figure 52) allows the physician to choose whether to write down patient history 
in paper or type directly into EHR. Like the paper-based only system, the paper documents were 
scanned into EHR, and manually entered to NAP by designated personnel, and data were extracted 





Figure 52 An example of a parallel workflow at tertiary care level hospital  
 




All the workflow diagrams presented in these figures were based on the out-patient department (OPD) 
workflow. For the inpatient department (IPD), all hospitals in this study still used paper-based 
medical records for IPD works which were summarized and entered into the EHR for billing when the 
patient was discharged, referred to or expired, and manually to NAP later. 
For HIV laboratory results, Anti-HIV testing was conducted within the hospital laboratory 
departments. However, VL and CD4 required more extensive laboratory equipment and were only 
available in 56 laboratory centers across Thailand. Those laboratory centers were laboratory 
departments within tertiary care level hospitals. There were three laboratory care levels in the hospital 
included in the field visit. 
Non-tertiary care hospitals entered laboratory requests into NAP and forward specimen to one of the 
designated 56 laboratory centers in Thailand. The results were shared with senders depending on the 
laboratory center's technical capacity and policy. The laboratory results, when available, were updated 
to NAP by laboratory centers in the hospitals.  
The hospitals stored the result in PDF format or scan and store as an image file. All non-laboratory 
center hospitals did not store the laboratory in usable numeric or text format as they fear to violate the 
regulation, nor they want to increase the workload burden on their personnel. 
Clerk or nurses at the HIV clinic were assigned to enter data into NAP and were entered as soon as 
possible to obtain reimbursement. With few exceptions, the databases were extracted and submitted to 
the MOPH routinely monthly by the IT department. MOPH data submission was part of a routine 
national reporting system, the entire hospital EHR databases were extracted into the MOPH format 
and submitted. Physicians did not have any involvement in this process. 
External laboratory  
Figure 54 described the flow of HIV laboratory (VL and CD4) among non-laboratory center hospital. 
The flow started by designated personnel at the sender hospital to enter the laboratory request to NAP 
and submitted the laboratory specimen to the assigned laboratory center. The laboratory center 
received specimens, processes, and enter results into the NAP system. The reason was that the 
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laboratory center is the one that receives laboratory reimbursement from NAP directly by entering 
results into the NAP system. Then the result is notified and shared with the sender.  There were three 
different methods the laboratory center returns to the sender: paper-based, electronic document file 
(PDF), and directly update the sender’s laboratory information system (LIS). The sender hospital then 
stored results in its database. Laboratory center hospitals themselves stored the results in the LIS and 
EHR database. 
 
Figure 54 HIV Laboratory (VL and CD4) workflow across hospital sender and laboratory 
center 
Challenges to NAP data quality 
Three main themes were identified during field visits that contribute to the NAP reporting quality 
gaps: legacy system migration, referral problems, and a disincentive for data correction. 
Legacy system migration 
Before NAP existed in 2008, there was an old system called “National Access to Antiretroviral 
Program for People who have AIDS” (NAPHA). In 2008, the NAP to NAPHA database migration 
had a failure and the team managed to manually re-enter entire records from NAPHPA to NAP, 
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compromising historical data before 2008. This was the reason why we found several patients without 
HIV results in the NAP databases.  
“The database migration in 2008, for some reason has a failure. At that time what we know is they 
manually re-enter all data from paper-based documents into the newly established NAP system. The 
process, however, causes several human errors in the process” - Head physician who was involved in 
the migration process. 
Figure 55 shows an example of migration error in the Date of Birth in the NAP database found during 
the field visit. The date of 17th August B.E. 2544 (A.D. 2001) misspelled to B.E544 (A.D. 0001). The 
visit dated before NAP go-live in 2008, and it was not possible in the current NAP system as the data 
entry date was selected from a calendar selection. Therefore, it was more likely a data entry error from 




Figure 55 An example of an error in the NAP system the year B.E. 2544 (A.D. 2001) was entered 
to B.E. 0544 (A.D. 0001) 
Data correction obstacle 
Because of migration failures in 2008, several data problems needed to be corrected. However, the 
NAP system did not allow the hospital to directly update the data. Hospitals needed to submit the data 
correction requests to NAP which further putting an additional burden on the personnel. The request 
process takes an exceptionally long time, usually more than 6 months, and requires several 
administrative paper works. The long and burdensome process caused the personnel to be reluctant to 
submit further data correction requests to NAP. Furthermore, personnel also fear that correcting NAP 
data may impact hospital reimbursement and they might be prosecuted.  
“We’re fear that correcting NAP data may change the reimbursement from NAP. If that the case, we 
are not sure whether one of us is going to get prosecuted or held responsible for it.”-HIV Clinic nurse 
at secondary care level hospital 
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“It’d be nice if NAP allows us and provide an incentive in some way to correct data by ourselves 
because we know all the patients here. That should increase overall NAP data quality”-HIV Clinic 
nurse2 at secondary care level hospital 
“One of the patient’s identities we’re treating is not compatible with what NAP has. But we’re not 
sure what the data correction complication will lead to. The best scenario is that we lost all his 
treatment historical data in NAP”- HIV Clinic nurse at secondary care level hospital 
Not returning necessary information to the hospital 
One of the main complaints about the NAP  observed during the workshop and in nearly all visits was 
that the system did not return the data the hospitals needed the most, the SSN.  
SSN is very important for the hospital as it was the only ID that could link the patient identity from 
the EHR to the NAP record. While the NAP system provided NAP ID and Hospital Number (HN), it 
was the hospital's responsibility to create, store, and maintain their master sheet that provides a 
mapping between NAP ID, HN, and SSN.  
While it’s understandable by the reason of privacy and confidentiality, hospital personnel overcome 
this problem by creating their version of reference table manually, in an excel file a master sheet 
mapping between NAP ID and patient identity, in a paper tally sheet, inside EHR or in front of the 
paper-based copy of the medical record and may increase the concern on hospital personnel.  
“We are very concern about storing NAP ID in our EHR as they increased the risk of a data breach 
or their identity to be revealed.”- HIV Clinic nurses at secondary care level hospital 
Figure 56 showed an example of how the hospital store NAP ID by attaching to the paper medical 
record and stored inside a locked cabinet inside the HIV clinic. Table 58 showed an example of a 
master tally sheet mapping between NAP and EHR. The sheet usually contained SSN, HN, NAP ID, 
risk population, and contact telephone number for contact and reminder. Hospital usually stored the 




Figure 56 An example of NAP ID storage in hospitals with a parallel system. 





























As this is the only way of mapping patient identification between NAP and EHR, losing the mapping 
file means identifying patients and recruiting them back to HIV care were impossible. The only 
solution in this situation was submitting a request to NAP.  
Referral problem 
The referral problem in the NAP system was one of the main problems identified during our survey. 
For example, when patients had been receiving ARV at private non-NAP hospitals for a long time and 
were referred to the public hospital, they were marked as first receiving ARV at the public hospital. 
The first date patient visiting the public hospital was recorded as ARV initiate date, even though 
patients had received ARV from a private hospital for a long time.  
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This causes errors in the inpatient record related to HIV care. For example, when patients from the 
private hospital visited the public hospital for the first time, the patient ARV initiation was recorded. 
However, the hospital had to re-confirm the HIV test results for every new patient which usually takes 
1-2 days after the visit. The HIV results report date was recorded as an HIV diagnosis date. As a 
result, patients had an ARV initiation date before the diagnosis date. 
The same problem happened when the patient initiates ARV at NAP hospital but was referred or 
silently transfer themselves to non-NAP hospital. 
“We have several referred HIV patients here, many from the private non-NAP hospital. We have to 
refill their ARV while waiting for the confirmation of the Anti-HIV test. That’s the reason why many 
patients have started ARV date before diagnosis date.” Nurse at tertiary care level hospital 
The second problem was the failure referral process on the NAP website. Several hospitals reported 
that when they updated their referral state in NAP, the patients often remained under their hospitals 
and was marked as ‘loss-follow-up’ even though patients were referred to destination hospital. This 
caused the destination hospital to unable to see the treatment history from the sender. A similar 
situation occurred when patients switched from a NAP hospital to a non-NAP hospital or switching 
from the UC to a non-UC health scheme, as NAP provides reimbursement for UC only, non-UC 
health scheme data entry to NAP were voluntary-based, causing information before switching to UC 
health scheme to be missing. 
This problem caused that the hospital personnel was unable to know whether patients were lost 
follow-up nor they were receiving treatment regularly at the new hospital and unable to recruit them 
back to the HIV care system effectively.  Moreover, even hospital personnel managed to confirmed 
loss-follow-up patients and manage to recruited back, the patients were marked as loss follow-up at 
the origin hospital and reduce the 90-2 indicator for both provincial and hospital levels. 
Awareness 
None of the hospitals in this study had been visited by an external organization regarding HIV 
reporting quality. All visits from the external organization were mainly on HIV services quality 
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assessment. One nurse state clearly during our field visit that they did not know about data 
management or quality as their duty was to provide service to patients.  
“Your team is the first one that helps us explore our data quality. All hospital HIV related visits were 
about  our HIV service assessment but not data itself and we never have a visit from NAP.”- Nurse at 
secondary care level hospital 
“We are nurses and only provide care to patients. We don’t know much about data management.” 
Nurse at secondary care level hospital 
 
Figure 57 NAP Challenges for data quality thematic map 
The challenge to MOPH data submission 
Legacy system migration 
All 6 Bangkok hospitals in this study use EHR from the same vendor, “EPHIS”. There were 5 EPHIS 
EHR and 1 EHCIS, a primary care variant of EPHIS EHR used by one primary care center in this 
study. EPHIS was an EHR vendor that has the contract to maintain all hospital-affiliated Bangkok 
Health Department (public non-MOPH hospital). EPHIS and its variance, EHCIS is a cloud-based 
EHR. Therefore, all medical records and databases among Bangkok affiliated hospitals in this study 
were stored outside at a 3rd party cloud server.  
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Both two non-Bangkok tertiary care hospitals used different EHR vendors (HomC and Opserv), while 
the rest of the non-Bangkok hospitals' public hospitals use the HosXp EHR vendor. However, while 
most hospitals under the Bangkok Health department had been using EPHIS EHR for several years, 
three secondary care level hospitals in this study were migrated from legacy EHR to EPHIS for less 
than one year. Their old EHR system was not compatible with the MOPH data submission system 
causing the hospital unable to submit data to MOPH. Historical records before EHR migration were 
achieved and can be accessed on-demand. 
While the newly deployed EHR in the hospitals had to overcome several technical challenges to 
submit data to MOPH, the hospitals can still enter data to the NAP system.  
This caused MOPH data among hospitals from newly deployed EHR to be completely missing as the 
technical challenges from newly deployed EHR were preventing hospitals from submitting data to the 
MOPH while legacy EHR did not support MOPH data submission.  
In other words, the hospital could not submit data to MOPH while able to enter data to NAP. This was 
one of the explanations for large two-data source differences in Bangkok.  
“The old legacy system is problematic and could not submit data to MOPH. The new one is much 
better, able us to submit data to MOPH. However, the submission is still incomplete because of newly 
deployed and need more modification.”- IT Personnel at secondary care hospital  
Historical data were archived and can be accessed with the legacy system. However, maintaining two 
systems at the same time was a huge burden to the hospital. As a workaround to reduce the burden, 
physicians summarized historical data from legacy EHR and put it in the new EHR to reduce the need 
for legacy system causing several data  (e.g. first diagnosis HIV laboratory results and date) to be 
missing. 
“I tried my best to summarize patients' records to the new system, but I do this alone so it’s not 
perfect and may miss some details.” – Physician at secondary care level hospital 
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The primary care level hospital in this study also suffered a technical problem from deploying EHR 
forcing the hospital to store patients' medical records in a paper document and a Microsoft Excel file. 
The EHR was used only for administrative tasks. Because of this reason they could not submit data to 
MOPH and unable to deploy our DQI Tools and were excluded from our quantitative results. 
However, they were still entering data manually to NAP regularly. 
“The EHR we are using is slow and very hard to use, we don’t’ like it so we use only it for 
administration. Our HIV data resides in paper records and NAP.” – Physician at primary care level 
hospital 
Vendor dependence 
Eleven of twelve hospitals in the field visit study purchased EHR systems from vendors. Only one 
hospital developed its EHR.  
Purchasing EHR limit hospitals to modify their systems to accommodate additional data storage, (e.g. 
NAP ID) deploying the MOPH data submission system by themselves, or solving arising technical 
problems. Hospitals needed to contact vendors to do that with additional cost.  
Tertiary care hospitals receive more priority as they have stationed a vendor’s developer that could 
apply the change in a short time. On the contrary, smaller secondary care level hospitals, face more 
challenges as vendors usually did not station a developer at the hospital. Moreover, the smaller 
secondary care level hospital could not afford to make costly EHR modifications. 
“Unlike large teaching hospitals, our software is less mature and slower to apply the change. They 
only station IT Support here, not a developer so the change is much slower.” IT Personnel at a 
secondary hospital 
“Because our LIS is older than other hospitals, EHR integration will cost additional money and we, a 
small hospital could not afford it.” IT Personnel at a secondary hospital 
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Sensitive records were only available in paper-based 
Sensitive records including those among the vulnerable populations (e.g. prisoner) were routinely 
stored in the NAP database. However, storing in the EHR and obtaining the MOPH submission was 
far more challenging. 
In hospitals with a parallel system, sensitive records were stored in paper-based medical records only 
to reduce the risk of the data breach. The EHR  contained only the visit number without any medical 
record data. In addition to the data breach risk, there were several factors to store sensitive patients' 
medical information in paper-based only.  
First, the detention facility did not allow any electronic device inside. One of the hospitals in this 
study also covered HIV patients in the detention facility, which does not allow them to bring any 
electronic devices. Physicians and care teams had to record the prisoner’s medical records in a paper 
document. The record was reentered to NAP but not to EHR to minimize workload causing data to be 
missing from the MOPH submission system.  
The second challenge was when patients were released from the detention facility, there was no way 
the hospital could track patients whether he or she went to the follow-up at other hospitals and was 
marked as a loss follow-up in the hospital EHR. 
“Our hospital has a contract with detention facility. Because the facility does not allow electronic 
devices, all medical history has to be noted in the paper record. While we have visit date in the 
hospital EHR, we did not re-enter data there, so they only exist in medical records. ”- HIV clinic 
nurse at secondary care level hospital 
Third, all hospitals in this study also stored patient records in another source for internal 
communications. Most of the time, this source existed before the EHR and contains historical data 
that did not exist within the EHR and even NAP (e.g. First HIV diagnosis data, first ARV start date, 
CD4 level at ARV initiation from 15 years ago). Figure 58 shows an example of the separated paper 
medical records for internal communication, several data including initial ARV regiment, HIV 
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diagnosis date (masked) that were not available in NAP nor EHR were recorded there. The record also 
contains NAP ID, SSN, and HN but was masked for privacy reasons.   
“Besides from EHR, we have our separated HIV paper record for internal communications. I 
summarized important data like ARV start date some of those do not exist in EHR.” – HIV Clinic 
nurse at secondary care level hospital 
 
Figure 58 An example of the HIV separated paper for internal communications. The record 
contains initiation ARV regimen and date and visits summarize. NAP ID, SSN, and HIV 
diagnosis date were masked for privacy reasons.  
Unclear regulation in storing laboratory data 
A major challenge in the MOPH database was nearly empty of VL laboratory results causing the third 
90-90-90 indicator calculation to be not possible.  
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We found that every hospital was concerned with an unclear regulation whether the laboratory result 
that was done outside of the hospital (laboratory center hospital) could be stored in EHR as free 
text/numeric or not. Therefore, most hospitals scanned and stored with images and PDF file formats 
that were not compatible with the MOPH database. As a result, the results were not submitted to 
MOPH.  
The team also discussed with the hospital on whether they were able to input laboratory data into 
EHR if we can confirm that the entering data was valid. While most hospitals agreed to enter data, 
one hospital declined concerning the increasing workload among their personnel as MOPH did not 
provide reimbursement for submitting the result.  
“My boss does not want our hospital to do that because it increases our workload for nothing. We’re 
busy enough already.”- Laboratory technician at secondary care level hospital. 
“We want to store them so we can analyze. However, we concern whether doing that is legal, so we 
only keep them as a scanned image.”- HIV Clinic nurse at secondary care level hospital 
On the contrary, the laboratory center hospital did keep results in their LIS and submit only their 
results to MOPH. Results of the HIV laboratory requested from the non-laboratory center hospital 
were not submitted to MOPH and were left in the database.   
No single unified national laboratory data standard across health schemes 
As Thailand did not has a national laboratory standard similar to LOINC, the hospitals deployed their 
local code system instead and mapped to the standard as required by the reimbursement organizations 
(MOPH and CSMBS). While MOPH used its own 7 digits ICD-10TM laboratory coding system, the 
CSMBS deployed its 5-digits laboratory coding system.  
In other words, hospitals had to map four coding systems including laboratory procedures and 
laboratory results together for HIV reimbursement alone. The mapping process was labor-intensive 




Another challenge was the MOPH laboratory coding has been changing several times in the past. For 
example, the MOPH results only available at 0, 1, 2 while hospital laboratory results format is four 
digits numeric such as 300, 400. The different coding systems between the hospital and MOPH 
causing data submission to be a failure and the hospital had to repeatedly do the mapping process and 
increase the workload among hospital personnel.  
“The MOPH database coding has changed several times in the past. Our data in the hospital 
database does not valid anymore and it did not go through.” IT personnel at tertiary care level 
hospital. 
No single unified medication data standard across health coverage schemes 
The low percentage of the second 90-90-90 indicated that several ARV medication records were 
missing. The reason was an incompatible medication coding system between MOPH and hospital. 
MOPH used its own 24 digits medication coding system maintained by the Food and Drug 
Administration (FDA Thailand) while NAP did not require any coding as data directly entered into 
the NAP system. On the contrary to MOPH, the most hospital used Thai Medical Terminology 
(TMT), a medication code derived from SNOMED CT to receive reimbursement from the CSMBS 
health scheme among government officers. 
It was important to emphasize that the NAP and CSMBS health scheme provided reimbursement to 
hospitals while MOPH did not. As a reason, all EHR in this study supported TMT but did not fully 
support MOPH 24 digits and require additional mapping works to submit to MOPH.  
“We never do it before because unlike TMT we are not getting more money from this (mapping 
medication coding to MOPH 24 digits.)”- IT personnel at a tertiary care center. 
For example, we found one of the main ARV medications in Thailand, TEEVIR (Tenofovir 
Disoproxil Fumarate/ Efavirenz/ Emtricitabine) along with several ARV did not have MOPH 24 digits 
code in the EHR causing data submission to MOPH to be missing. The hospital personnel thought that 
the code system was deprecated and did not receive enough Maintainance from FDA (See “Thai FDA 
ARV medication coding ID” in Appendix). Unfortunately, as reviewing the medication code was not 
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feasible in this study from minimum resources and logistic constraints, we were unable to determine 
the contribution of this problem to the MOPH reported ARV prescription and the second 90-90-90 
indicator. 
No reimbursement nor incentive for deploying data standard 
As the data mapping process from hospitals local data standard to MOPH is a resource-consuming 
process, most hospitals allocate their resources to mapping only those that provide the reimbursement,  
the CSMBS health scheme (TMT and CSMBS laboratory data standard), the MOPH 24 digits 
medication, or the MOPH ICD-10TM laboratory standard receive less priority as there was no 
reimbursement provided.  
“You have to understand, with our resources available, coding that receives reimbursement receive 
priority.”- IT Personnel at tertiary care hospital. 
That was the reason why we did not identify hospitals submitting data to MOPH alone, despite being 
the primary source of Thailand's healthcare and surveillance system. On the contrary, several hospitals 
only submit data to NAP for the same reason.  
The finding was supported by the MOPH dashboard as seen in  Figure 59. As of July 2019, the 
dashboard number only provides the record counts without stratifying results in positive, 
inconclusive, or negative. As a result, we could not calculate the 3rd indicator as mentioned earlier in 




Figure 59 MOPH HIV dashboard showing the number of records with Anti-HIV, CD4, and VL 
without stratifying by results (Accessed July 2019) 
 
To submit data to MOPH while minimizing cost and workload to their personnel, several hospitals 
that were using the same EHR vendor pool their modification request together, submit to the vendor 
in bulk to save cost. The EHR modification to support new MOPH laboratory coding from one vendor 
was expected to go-live by the end of 2019. Unfortunately, hospitals with different EHR vendor 
systems that could not pool the request had to do mapping on their own. 
“We are lucky that our public hospital in this province uses a similar version of the same EHR vendor 
so it’s easy to negotiate to make a change. Otherwise, it’s going to be a big challenge.” IT personnel 
at tertiary care level hospital  
Technical difficulties in deploying the MOPH reporting system in Bangkok 
Bangkok hospitals and stakeholder structure 
While most hospitals in this study affiliated with the Bangkok Metropolitan Administration (BMA) 
already submitted data to MOPH, other affiliations did not as there were several reasons and 
challenges to overcome.   
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First, deploying the MOPH data submission from scratch was a very complicated process in hospitals 
that never submitted data to MOPH before and without any reimbursement in return.  
While several Bangkok hospitals in this study deployed the popular EHR like EPHIS and HosXP, 
several EHR vendors were being deployed in Bangkok or even in-house developed EHR. There was 
no official survey on the number of EHR vendors. 
Therefore, pooling modification together was not possible in several Bangkok hospitals, not even with 
the support from the Bangkok Health Department as negotiations had to be made with numerous EHR 
vendors. 
“There never a survey to know how many of them, but what we’ve seen so far, our best guess is 
several dozen not mentioning the variation across different versions of the same vendors. We’ve been 
trying to implement the MOPH system for 2-3 years without success.”- BMA Personnel 
According to data provided by BMA Health Department during the Bangkok field visit, only 13 of 
155 hospitals or 8% of all hospitals in Bangkok are bound to submit date to MOPH, the rest submitted 
voluntarily. There were 142 hospitals not affiliated with the MOPH.  
Among the other 142 hospitals, 107 are private hospitals, 10 under other ministries (e.g. Ministry of 
Justice, Ministry of Defense, etc.), 12 hospitals affiliated with BMA, 9 specialist hospitals, and 4 
university hospitals as shown in Table 59 as of December 2019.  
Table 59 Distribution of hospitals in Bangkok Source: Bangkok Metropolitan Administration, 
December 2019* 




- Other ministries 10 
- Local authority 12 
- Excellence center 9 
- University hospital 4 
Total 155 
*BMA data was more updated than our hospital database from MOPH. However, we only have access 
to hospital affiliation data.  
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“Many stakeholders, many hospital affiliations put challenges on coordinate for data submission as 
most hospitals in Bangkok are not affiliated with us or MOPH” -BMA Personnel 
Figure 60 described the current state of Bangkok data submission. As some hospitals only submit data 
to NAP and few submitted to both systems. BMA, despite having authority over BMA affiliated 
hospitals had no control over the dataflow causing a data stewardship concern.  
 
Figure 60 Current Bangkok problem. Some hospitals only submit data to NAP while some 
hospitals submit data to both systems. 
The complicated change request process 
Several small BMA affiliated hospitals that had migrated recently to a new EHR  were under “Single 
HER policy". The policy was to make all change requests by one hospital also applied to other 
hospitals allowing the request to be pooled, reducing EHR variability and cost. However, the policy 
also slows down the EHR modification process to suit each hospital workflow as the request needed 
to go through the joint committee and forward it to the vendor. In addition to the fact that small 
hospitals barely could modify an EHR on their own, further slowing down the process. 
“The process takes so much time for our change suggestion to be made and deployed in our EHR”- 
IT Personnel at secondary care level hospital 
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“We feel that we did not receive much attention from the vendor as the vendor team at this hospital 
could not apply much change for us, unlike the larger hospital that can develop and deploy their 
change” – IT Personnel at secondary care level hospital 
Moreover, ARV medications were found in the same category with non-ARV medication (e.g. 
dyslipidemia medication) across a newly deployed EHR in three hospitals but not among their mature 
counterpart EHR. The finding supported hospital IT staffs’ response that their EHR was much less 
mature compared to the counterpart in a larger hospital and needed more resources to overcome 
technical challenges for deploying the MOPH reporting system. Having an ARV medication group in 
the non-ARV medication may cause errors in data submission to MOPH.  
 
Figure 61 the MOPH Challenges thematic map 
Discussion 
Overall Thailand HIV progress 
Thailand's progress in UNAIDS 90-90-90 indicators in 2018 was 105%, 72%, and 83% for the 90-90-
90 respectively. Even though Thailand did not achieve all 90-90-90 indicators, the progress was 
slightly higher than the aggregated value of  79%, 78%, and 86% according to the UNAIDS report 
from 60 countries in 2018 (38).  
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The majority of HIV patients in Thailand were older than 50 years old. The age group proportion was 
consistently higher than 20% across the NAP and MOPH database and higher than the UNAIDS 
projected number for developed countries of 21% in 2020 (37). A similar finding was reported from 
several Low-Middle Income Countries (LMICs) since 2000 and was expected to continue through 
2020 (37). As ARV treatment allows patients to have a similar life expectancy to normal people, the 
demographic findings supported that the Thailand HIV program and service have made progress in 
improving patient life-expectancy.  
However, one remarkable finding was the first 90-90-90 indicators that were higher than 100%, much 
higher than the highest value reported in the UNAIDS 2019 estimation of 92%. We doubt the first 
indicator might not be accurate as Thailand still face the HIV stigma problem causing several HIV 
patients to not visit hospitals, as reported by the literature as a major challenge of HIV care access in 
Thailand (39-41). A similar finding of HIV stigma was also reported from India as one of the 
important barriers to achieving the 90-90-90 indicator goals (42). 
As the first 90-90-90 indicator was based on a model estimation (AEM for Thailand), using a 90-90-
90 indicator to monitoring HIV intervention directly depended on the reporting quality and the model 
itself. For example, duplicated records or not excluding dead patients can overestimate the indicator. 
Also, underestimation from the model overestimates the indicator. A similar finding was reported 
from UNAIDS Report in 2019, as a result, several countries have recognized the data quality impact 
on the indicators and started improving reporting data quality. However, only a few reports regarding 
the impact of data quality improvement activities to 90-90-90 indicators were available (43).  
AEM Modeling estimation was also an important concern to be considered as Cambodia has been 
using the same model for their HIV patient’s estimation. Any changes to the model in Thailand may 
also impact Cambodia. However, model validation was not within the scope of this dissertation as the 
Thai MOPH had a dedicated division for modeling, the concerns, and recommendation of model 
validation and revision was provided to MOPH modeling division.  
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Therefore, in the study, we focused on exploring reporting quality gaps in selected relevant data 
elements, especially the second and third 90-90-90 indicators that did not use the AEM estimation for 
calculating the indicators.   
The first data element, “Patient Living with HIV (PLHIV)” as a nominator for the first 90-90-90 
indicator and denominator for the second indicator was obtained from the HIV reporting system. 
There were two HIV reporting systems in Thailand, NAP, and MOPH. While both data sources had 
different reporting mechanisms, their data input was from hospitals. Therefore, at the beginning of the 
study, we expected both databases report numbers to be very close.  
According to our findings, the total Thailand PLHIV number from two data sources was remarkably 
close as expected to cause the first 90-90-90 indicators difference between two data sources to be 
narrow. However, we identified two important concerns regarding the interpretation of the number.  
First, the Bangkok HIV report number was remarkably low from the MOPH database. The number 
was illogical low given the fact that Bangkok was the capital city of Thailand hosting approximately 
more than 10% of Thailand population. Second, the NAP report number was far higher than MOPH in 
Bangkok causing the two data sources difference between them to be the highest in Thailand. The two 
data sources difference were large enough to identified Bangkok as an outlier. 
For the second 90-90-90 indicators, the gaps were remarkably wider between the two data sources. 
Bangkok was the only province without the second 90-90-90 indicators from the MOPH database 
from lacking the ARV data, a numerator for the calculation of the indicator. 
The problem was furthermore remarkable for the third 90-90-90 indicators as VL data were not 
available at all from MOPH causing the third 90-90-90 indicators calculation to be not possible. We 
also explored the potential associated factors to two data source differences including the PEPFAR 
funding and the bed capacity. Initially, both factors showed a statistically significant positive 
association. However, removing an outlier (Bangkok) changed all associations to non-statistically 
significant. We also explored a possible association between hospital class and the two data sources 
difference. However, only a few Bangkok hospitals were available in the database. Thus, while we 
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found Public non-MOPH hospitals had a statistically significant association with two data source 
differences, the finding only applied for non-Bangkok provinces.  
The finding, in addition to the first and second 90-90-90 indicators, confirmed the abnormality and 
importance of Bangkok's contribution and warranted a field visit for exploration. Therefore, Bangkok 
was selected along with two provinces for the field visits. 
Besides from the illogical value of the first 90-90-90 indicators, the large drop in the second 90-90-
90-90 was also important to explore.  
Loss-follow-up or dropped-out patients 
The second 90-90-90 indicators suffered a large drop from 105% to 72%. The larger drop resulted 
from the loss-follow-up patients that contribute 28% of total HIV patients. Lost follow-up patients did 
not receive ARV causing the drop in the second 90-90-90 indicator.   
The loss follow-up percentage was far higher than reported from seven ARV programs in Asia 
(8.95%) (44). This was important as the loss-follow-up patients' mortality rate was much higher and at 
more risk of developing drug-resistance (45). Therefore, loss-follow-up patients were a particularly 
important challenge from achieving 90-90-90. Reducing the loss-follow-up patients were prioritized 
by several countries including in Sub-Saharan Africa, Georgia, and Thailand to achieve the 90-90-90 
goal (46, 47) (48). The intervention to address loss-follow-up patients was tracking and recruiting 
back to HIV care service by a cell phone call or home visit. The intervention effectiveness was 
supported by a meta-analysis study concluding that care retention was higher with tracking and 
recruitment activity (44). 
There were four categories of loss-follow-up patients; “death”, “alive without ARV”, “silently 
transfer to other clinics”, and “still receiving ARV without being reported”. Each category required 
different interventions. Three out of four categories of interventions were related to improving the 
quality of the reporting system. Alive without ARV was the only category that required personnel 
intervention (home visit and recruiting).  
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According to a systematic review consisted of 9 studies across Sub-Saharan Africa, only 1,094  of 
7,377 loss-follow-up (14.8%) were still alive without ARV (46). However, recruiting patients back to 
the care system by conducting home visits and phone calls tracing methods were not efficient as there 
were only 14.8% alive patients among loss-follow-up to be recruited. Allocating resources on tracking 
and recruiting patients were not feasible in developing countries with constrained resources.  
Therefore, providing personnel with a tool that could identify alive patients from a loss-follow-up 
pool can improve the recruiting process overall. 
Data Quality Improvement (DQI) Tools  
To provide a shortlist of “alive loss-follow-up” patients for recruiting, integration of multiple data 
sources across NAP, MOPH, and hospital EHR were needed. However, several legal authorization 
documents were required to obtain access permission to all databases. After all data sources were 
obtained, additional data management skills were also required for preprocessing before integration. 
The additional skill and workload were not feasible for the already overwhelmed HIV clinic nurses 
and other local personnel in Thailand.  
To streamline the data management process and minimize the burden on local personnel, a DQI Tools 
application was jointly developed by MOPH and Thailand-MOPH-US-CDC collaboration (TUC). 
The application aimed to integrate multiple data sources and generate recruiting lists for HIV 
personnel while minimizing additional workload. The application also generates a summary report of 
service and data quality for stakeholders to improve their service.  
The “loss-follow-up” lists were generated based on four loss-follow-up categories (“loss-follow-up”, 
“dead”, “silently transfer to another hospital” and “regularly follow-up”) and two additional categories 
that were not previously referred in the literature were added: “Need HIV verification result” and 
“Misdiagnosed”. Both additional categories were created as Thailand had reported of misdiagnosis 
HIV patients in the past (49). To our extent of knowledge, we could not find any report from other 
countries containing categories of “Need HIV verification result” and “Misdiagnosed” from the 
literature search.  
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The initial deployment of the DQI Tools alone was able to reduce the number to nearly half of those 
reported from NAP initially. According to the DQI Tools report, approximately half of loss-follow-up 
reported from NAP were true loss-follow-up (53.8%), dead (0.85%), silently transfer to other 
hospitals (4.94%), and regularly follow-up without ARV (<0.1%). The percentage of loss-follow-up 
was cut by half making the Thai loss follow-up percentage lower than those of Sub-Saharan Africa 
without any additional intervention nor investment.  
However, the proportions were completely different from Sub Saharan Africa report of 31.8%, 21.8%, 
14.8%, and 22.6% respectively. A large gap represents a unique characteristic of the HIV reporting 
system of Thailand and it addresses the importance of the loss-follow-up problem as the Thai number 
is much higher despite having better resources and infrastructure. 
Moreover, there were patients with misdiagnosis and several of those who needed HIV laboratory 
results confirmation. The decision had to be made at the policy level as to what extent they should be 
excluded from the indicator calculation and if any intervention might be necessary. 
After the patient lists were generated and forward to the HIV personnel, this personnel have to verify, 
update, recruit, and submit the updated data back to us on the follow-up “lessons learned” meeting. In 
this study, 1,488 patients were reviewed, corrected, traced, and recruited back to HIV care by the local 
personnel. Unfortunately, most patients from the generated list (1,133 of 1,488 or 76.15%) were 
unreachable.  
Among those unreachable patients, most of them had the last visit date longer than 5 years ago and 
longer than 10 years for the diagnosis date. Searching the medical record and patient identification 
was very difficult for patients having last hospital visits longer than 5 years as several old records 
were discarded. Therefore, the decision should be made at the policy level on whether to excluded 
unreachable patients from the indicator calculation.  
While the DQI Tools were able to reduce loss-follow-up patients’ number, the tools did not have 
much impact on the number of patients having a viral suppressed level, and the third 90-90-90 
indicators. These findings were explored further in the qualitative result section. 
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To our extent of knowledge, our study was the first in initiation the deploying of the tools that 
integrate several data sources at local health providers to give informative insight to every level of 
stakeholders ranging from local hospital personnel, national-level decision-makers to an international 
organization. The closet report was “KenyaEMR”, a Kenya customized version of OpenMRS with 
DHIS2 for submitting reports to national aggregation. Uganda HIV reporting quality was improved 
from deploying DHIS2 (50). 
However, the Kenya and Uganda report focuses on streamlining the reporting process for improving 
the data quality, not patient tracking, and recruiting process. Moreover, as hospitals in Thailand had 
been using EHR from several vendors without national data standard coding, the interoperation 
problem was prominent. Moreover, hospitals could not modify EHR on their own, the modification 
request was required to submit to vendors with an additional charge. Therefore deploying an 
automatic reporting system from EHR directly was not feasible for Thailand at this stage (51).  
Weiskopf’s data quality framework 
At this state, we addressed Weiskopf’s data quality framework in terms of concordance, plausibility, 
and timeliness dimensions. The concordance was straight forward on comparing the two data sources 
on patients count on each category and the 90-90-90 indicators. Timeliness and plausibility were 
discussed on whether the patients who loss-follow-up length longer than 5 years were excluded with 
the assumption of death based on HIV survival literature and current data management practice.  
Cohen’s kappa and data sources agreement were also calculated to assess the concordance dimension 
regarding Weiskopf’s framework. Both parameters allow us to gain insight into tho the two data 
sources difference. We found that, despite the fact of having a very large difference in certain hospital 
types, their agreement and kappa were very high and higher than those with less two data sources 
difference. This implies the systematic factor that causing one database to be reported more than 
another among those hospitals. Possible systematic factors were different regulation, policy, and 
specific administration structure which will be discussed later in the study.  
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Loss-follow-up patients were also representing timeliness dimension considering the criteria of not 
visiting the hospital for longer than 180 days. Local healthcare personnel was expected to reach and 
recruit loss-follow-up patients back to the care system or update their current status, the activity 
facing a challenge and, overburdened as discussed.  
A large proportion of loss-follow-up patients was found to be unreachable or outdated. As a reason, 
we considered loss-follow-up patients as a proxy to assess concordance, plausibility, and timeliness of 
the reporting system in this study.  
We did not exclude the possibility that the loss-follow-up patients might represent the local personnel 
practices rather than the data and reporting system. However, assessing their HIV practices without 
resolving the challenges of reporting systems was not possible and not within our study objectives.  
MEASURE Data Quality Assessment (DQA) Tools 
 
The UNAIDS MEASURE DQA score difference between hospitals was narrow in every section 
regardless of hospital type and provinces. Hospitals in this study obtained the highest score on the 
links with the national reporting system section of the MEASURE DQA Tools. This is expected as the 
tools’ section focused on using national data tools for data collection. Both MOPH and NAP were 
considered as national tools causing the score in this section to be remarkably high. 
On the contrary, the lowest score was in the data management process section as the MEASURE 
DQA focus on the existence of the written data backup procedure and duplicate record identification. 
All hospitals in our study use the automated back-up procedure on the cloud server. While the 
activities were automatically stored in the cloud server log, there was no written document decreasing 
the score of this section in all hospitals. Despite having the back-up system in place, the hospital's 
score was low.  
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While the tools focus on assessing the hospital practice, it did not capture the national tools’ problem. 
Without taking the national tools problem into account, the hospitals were achieving high scores even 
though several problems of both MOPH and NAP were identified in this study.  
In summary, while the MEASURE DQA tools provided an overall framework for guiding our 
approach to reporting quality assessment in this study, the tools did not provide specific information 
enough for the stakeholders to take action. This is an important issue to our study feasibility as our 
one-day visit needed to provide useful information and recommendations to the hospital personnel 
while able to provide recommendations at the national and international levels to maintain hospital 
cooperation.  
We believed the DQI Tools were able to provide more specific guidance for the HIV clinic personnel 
on whom should they verify, and recruit in Thailand settings allowing personnel to work more 
effectively and efficiently. Having addressed the Thailand settings, we believe the tools could easily 
scale up the approach as reported to facilitate success in 90-90-90 achievement in the future (52).  
What was the province with the highest two-data sources difference? 
The province with the highest two-data sources difference was Bangkok. The difference was 
remarkable enough to classified Bangkok as an outlier even though Bangkok was one of 300 fast-
track cites that participated in the 2016 United Nations Political Declaration on Ending AIDS by 2030 
(53). Moreover, Bangkok is the only province lacking ARV prescription data in the MOPH database. 
As Bangkok 90-90-90 was still available from NAP, the remarkable two-data sources difference 
implies the problem in the reporting system to MOPH.  
In other words, the data were available but were not submitted to MOPH. 
The finding was supported by the MEASURE DQA scores that hospitals in Bangkok hospital data 
management practices were similar to non-Bangkok. This is an important matter as Bangkok covered 
more than 8.2 million population or 12% of the Thailand population. Lacking Bangkok data alone 
could distort the overall situation at the national level. For example, we identified bed capacity and 
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PEPFAR funding as having a statistically significant association with two data sources difference at 
the provincial level, both associations lost their statistical significance after excluding Bangkok from 
the analysis.  
Bangkok unique hospital management structure 
In Thailand, most hospitals were MOPH affiliated and were bound to submitting data to the MOPH. 
This was not the case in Bangkok where hospitals were not affiliated with MOPH as Bangkok is a 
special authority province (54).  
Most Bangkok public hospitals were affiliated with the Bangkok Metropolitan Administration 
(BMA), a special authority governing the Bangkok city under the Ministry of Interior. The MOPH had 
no direct authority on BMA hospitals and were categorized as Public non-MOPH hospitals.  
The majority of hospitals in Bangkok were private hospitals. They have different challenges from the 
government hospitals as hospitals under MOPH and BMA tends to use the same EHR vendors, 
private hospitals use different EHR vendors from each other causing the change made to EHR not 
applicable to other hospitals. 
Deploying the MOPH data submission system required the hospital to negotiate and make changes 
with the vendor. The processes were challenging as several small hospitals lack negotiation power 
compared to larger tertiary care hospitals. As MOPH and BMA affiliated hospitals use similar EHR 
vendors, pooling their change together, and negotiate with vendors. This was not the case for private 
hospitals.  
As private hospitals did not submit data to MOPH before the A.D. 2015 regulation was enacted, they 
had to start deploying the MOPH reporting system from scratch. Deploying the MOPH reporting from 
scratch had more technical challenges requiring a huge amount of resources without any incentive nor 
reimbursement in return.  
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Patients privacy was more concerned in a private hospital as compromising patients' private directly 
impact private hospital revenue and reputation. The concern was more intense among the vulnerable 
population, HIV patients.  
Besides, most private hospital patients used private insurance or pay from their own pockets. Because 
of that the hospitals did not need reimbursement from NAP and did not submit data to both databases. 
As a result, cooperation from private hospitals was very limited in this study.  
Lacking data submission from several affiliations in Bangkok to MOPH caused the large two-data 
source difference in Bangkok. The gaps were reported in many non-HIV public health surveillance 
systems (e.g. Non-communicable diseases, Dengue), therefore addressing the gaps will also improve 
the effectiveness of the surveillance system for other diseases in Bangkok. 
What was the problem on the MOPH side? 
The public non-Bangkok hospital challenges were different as they were bound to submit data to 
MOPH regularly. Public non-Bangkok hospitals were using the EHR from a few selected vendors 
providing hospital personnel with a large and mature community to seek help.  
Even of that, a large amount of missing data of ARV prescription and VL results were missing from 
the MOPH database. Two problems were responsible for the missing data.   
Regulation problem 
There was a statement from the Thailand Medical Technology Standard: 2017 4.2.4. “Outside 
laboratory results must be stored inside the database without any edit or copy.” (55). We believed the 
“copy” statement is unclear and the user may understand that “copy” includes re-entering data into the 
hospital database. The finding was reported from all non-laboratory center hospitals indicating a 
national level problem that needs to be escalated and to issue an official announcement.  
Therefore, as most hospitals could not conduct CD4 and VL tests, they had to send a specimen to the 
outside laboratory center. Returned results were stored in the database in PDF/Image format that 
could not submit to MOPH. The procedure applied to all non-HIV laboratory results that were 
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conducted by a laboratory outside the hospital which was utilized in several public health surveillance 
systems.  
Lacking unified single national data standard coding 
Before the A.D. 2015 act was enacted, Thailand reimbursement was based on DRG (UC) and fee-for-
service (CSMBS). DRGs used the ICD-10 code for reimbursement in the UC health scheme. As 
Thailand did not have a national data standard coding for medication, and laboratory, hospitals create 
their local code for internal use. However, when CSMBS announced in 2015 their medication data 
coding standard, the Thai Medical Terminology (TMT), hospitals were forced to adopt and deploy the 
TMT coding system to receive reimbursement from CSMBS. MOPH coding received lower priority 
from lacking incentive and reimbursement.  
Moreover, the MOPH laboratory data coding standard was revised from 2 digits to 7 digits system in 
2017 causing several failures in laboratory data submission to MOPH. Frustration and technical 
problems arose and were discussed by several hospital IT personnel (56, 57). Revising data standard 
coding also compromised historical data.  
Only 21 laboratory results were supported by the 2 digits system. The support laboratory results were 
mostly Non-communicable disease (NCD) related (See Appendix). No HIV laboratory was supported 
until the 7 digits system was deployed in 2017. 
As the HIV laboratory code was not supported by the 2 digits system, all HIV laboratory data before 
2017 were missing entirely from the MOPH database. Even after the 7 digits system was implemented 
in 2018, HIV laboratory data were still poorly available from implementation lag-time.  
Lacking a single unified data standard of historical data, in addition to the fact that the MOPH 
reporting system was initiating in 2015 severely limiting our ability to obtain historical data.  
Why don’t we just use a NAP? 
NAP was established under NHSO with the purpose of UC health scheme reimbursement only. 
NHSO/NAP functions were similar to the Center for Medicare and Medicaid Services (CMS) in the 
130 
 
United States. Their function, capacity, and organization structure were designed to accommodate 
reimbursement functions.  
The MOPH functions in Thailand were similar to the Department of Health and Human Services and 
US-Center for Disease Control and Prevention (US CDC) in the United States, the main authority for 
an epidemiology study, and implementing public health interventions.  
While directly under MOPH function and responsibility, the MOPH database and reporting system 
suffered several problems and could not be used as a primary source for HIV 90-90-90 indicators 
calculation as discussed in the previous section.  
NAP was a better source for 90-90-90 indicators calculations from having a better reporting quality. 
The main reason was, NAP provides reimbursement while MOPH did not. MOPH submission solely 
depended on the A.D. 2015 Communicable Diseases regulation.  
When the national data sources were not reliable, other stakeholders started developing and deployed 
their separated reporting systems and their results in several data silos. Similar findings were reported 
in South-African from their failure of DHIS-based reporting system implementation (35).   
However, using a NAP as a primary source in the long term was questionable as it may cause conflict 
among two organizations functions and decrease efficiency. NAP was established for reimbursement 
purposes but had to allocate resources for non-reimbursement tasks. The situation was similar to US-
CDC asking CMS to also do US-CDC jobs.  
In the long run, after the MOPH reporting system was more mature, the primary data source for 
indicator calculation had to be shifted back to MOPH to alleviate NAP from non-reimbursement tasks 
and improve Thailand's HIV reporting efficiency. Also, NAP had its challenges to overcome. 
What causes the NAP problem? 
As NAP was centralized data entry, it did not suffer data standard problems like MOPH. NAP 
challenges were more on management and policy issues.  
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While the system provided reimbursement for UC and laboratory reimbursement for SSO, that cover 
the majority of HIV patients in Thailand, non-UC patients were not included by the NAP reporting 
system (e.g. SSO ARV data did not available in NAP). Depending on data entry and not covering 
non-UC patients were causing data error, inconsistency, and problems of currency in NAP.  
However, the NAP did not have the responsibility to integrate and update the patient’s data from non-
NAP sources. Also, data quality was not under NAP responsibility as hospitals were responsible to 
enter correct data or not receiving reimbursement.  
Solving the problem by NAP alone was not possible as it needs hospital input to verify, update, and 
cleaning the data. However, the data correction request was complained as too difficult by the 
hospitals. Without the hospital's active participation, the NAP reporting quality was compromised due 
to lacking a data validation mechanism as NAP required information from the hospitals to correct 
those records. 
This was important as the historical NAP data suffered from data quality problems from failure 
migration from NAPHA in 2008. As an example, several “loss-follow-up” patients were in 2008 
records or beyond. Having a difficult data correction process might further posing obstacles to the 
data quality improvement attempt.  
While it was understandable that firm pieces of evidence were necessary for data correction in 
sensitive information like HIV patients records, archiving, and excluding compromised records from 
the indicator calculation could be an option. 
Overall Gaps in-hospital workflow  
Regardless of a partial or electronic-based health record system (EHR), the hospitals manually re-
enter data to NAP by a clerk or nurse. On the contrary, MOPH submission was extracted by the 
database administrator or IT personnel and submitted.  
We believe the NAP processes were more prone to human error from manually re-entering data. 
Unfortunately, limited fieldwork time and several of the external factors discussed in the previous 
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section (e.g. lacks single unified standards for MOPH and failure of the legacy system migration for 
NAP) prevented us from fully assessed the impact of the hospital workflow on the reporting quality in 
both systems.  
However, the impact of hospital workflow became more prominent when local personnel was 
requested to verify the patients' HIV status, or the HIV related laboratory by reviewing old medical 
records. 
In a partial paper-based system, most medical records were kept as scanned image files for internal 
communication or an archive database. Several hospitals kept separate copies of the HIV patients' 
information in addition to EHR, mostly were in paper-based documents and Microsoft Excel 
spreadsheet files. The information was kept across several silos risking data loss and violating 
patients' privacy. Moreover, paper-based documents, images, and spreadsheet files were not 
searchable making the old medical record searching for reviewing very challenging, time-consuming 
as the person must go through the records one by one to identify the relevant records. 
It was very challenging for hospitals to improve the old medical record data quality. All hospitals in 
the study were focusing on transitioning to the fully EHR system requiring a huge amount of their 
resources. Considering the current resource constraints they were facing, allocating resources on 
maintaining the archive data was not feasible, especially on loss-follow-up patients who did not visit 
the hospital for several years.  
As HIV was a sensitive diagnosis, we believe excluding patients from the analysis and the indicators 
calculation without record deletion was more feasible. This option allows data analysis and indicators 
to better represent the current performance without putting much burden on medical records 




Hospitals and Provincial Health Office (PHO) 
Hospitals and the PHO in this study were encouraged to use the DQI Tool for providing a shortlist of 
truly loss-follow-up patients to reach out and recruited back to the care system. 
For other categories (regularly follow-up at the hospital or other hospital, death, and invalid records) 
generated from the DQI Tools, we encouraged personnel to take action provided in the hierarchical 
visualization given by the tools and to submit the data update requests to NAP if required. The 
visualization was generated in the application in the hierarchical chart as shown in Figure 62. The 
color-coded represent the action that local personnel has to proceed for each category.  
 
Figure 62 DQI Tools visualization. Violet cells mean personnel must correct data. Brown cell 
means personnel has to verify patient HIV diagnosis, Green means patients regularly follow-up. 
Violet color cells represent the need for updated NAP data. Brown color tells the local personnel 
to verify HIV diagnosis evidence and green color cells are patients that personnel has to recruit 
back to the HIV care process. The visualization and report can be export in an Excel 
spreadsheet format.  
If retrieving old medical records were not possible, the local personnel should add a remark on the 
record in the DQI Tools. The remarked records were excluded from the Tools’ processes but were 
archived and still are accessible.  
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Revising Asian Epidemic Model (AEM), 2019 
In the previous section, we discussed the possibility of overestimating the first 90-90-90 indicator of 
105%. The indicator level was expected to be less than 100% as HIV patients were less likely to visit 
the hospital because of stigmatization thus receiving less report number (nominator) to NAP and MOPH 
while the AEM estimation (denominator) addressed those population not seeking care.  
Considering the time constraint and logistics difficulties, the recommendation was provided to the 
MOPH modeling department at the beginning of the study in parallel to our data collection and field 
visit. The revision was concluded in November-December 2019 with a 14.3% increase in HIV 
estimation compared to the original AEM estimation as shown in Figure 63. 
 
Figure 63 Old and New (Revised) AEM comparison 2010-2030 estimation.  
The revised AEM reduces the 2018 first 90-90-90 indicator from 105% to 94%. The DQI Tools 
further reduced the first 90-90-90 indicator to below 90%. The distribution of Thailand's first 90-90-
90 indicator remains unchanged as described in Figure 64. The indicator value decreased in general 




Figure 64 NAP First 90-90-90 indicator at the provincial level distribution between old and 
revised AEM estimation 
Policy Recommendations 
The DQI Tools did provide important information for analysis and insight into the current reporting 
gaps and facilitate local personnel works. To solve the gaps, the interventions need to be provided 
according to their findings, incorporating also the qualitative findings and proposing them to the 
national level, especially to NAP.  
We analyzed and discussed the insight obtained from the DQI Tools results during the “lesson 
learned” session with the hospitals that participated in this study to propose the recommendations to 
relevant stakeholders.  
Recommendation for intervention regarding the loss-follow-up category in NAP 
We summarized the findings and recommendations for each of the loss-follow-up patient categories 
identified by the DQI Tools. The recommendations were expected to be proposed in the stakeholder 
meetings to achieve the 90-90-90 indicators goal level. As NAP was a data source for 90-90-90 
indicators, this section focused on the loss-follow-up in the NAP database. 
1. Patient without HIV result evidence 
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Most patients in this group were diagnosed more than 5-10 years ago causing the recruiting and 
gathering of their evidence incredibly challenging. Despite the effort done by the local personnel, 
most patients were unreachable.  
Taking into account the loss-follow-up and unreachable patients for the calculation of the indicator 
severely underestimated the current situation in Thailand and the current performance of the hospitals, 
strongly disincentivizing the local personnel.  
Therefore, while the current recommendation was to initiate a better NAP database update request by 
allowing the hospital to directly corrected patient records from the current NAP data entry system to 
encourage hospitals to update the current patients status, we proposed that the Thailand archive 
excluded patients without HIV laboratory evidence for the calculation of the HIV-related indicator to 
better represent the Thailand situation and the local personnel performance. Those excluded were to 
be archived and are obtainable if the evidence were recovered in the future.  
2. Invalid /duplicated SSN 
It was not possible to identify records with invalid SSN, causing the recruitment of patients back to 
the HIV care system not possible. We recommended invalid SSN records to be excluded from the 
calculation of the HIV related indicators.  
For duplicated SSN records, as NAP could not make a decision on which record to be kept and how to 
merge them, the decision had to be made by the hospitals and the local personnel. Therefore, for 
duplicated SSN records, hospitals had to decide on whether to keep or combine the record. Discarded 
records were archived and excluded from the HIV-related indicator calculation. All records were to be 
archived without any deletion. 
3. Receiving ARV without VL result 
In Thailand, as the reimbursement was maintained and oversee by NAP, it was unlikely that patients 
with VL results did not have ARV prescribed. Even in the case of ARV adverse effects or severe 
allergic reaction when patients were tested for VL but did not prescribe ARV, the patients were still 
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follow-up regularly with the physician. The patients remained in the care system and satisfied the 
indicator purpose of assessing the follow-up.  
Therefore, if the ARV prescription date were not available in the database, the VL results report date 
could be used for the calculation of the indicator instead.  
4. Lost-follow-up but regularly follow-up at other hospitals 
Patients receiving care at other hospitals without a referral command from the origin were classified 
as lost-follow-up in NAP. Unlike the data correction process, it was possible to update by the origin 
hospitals. The origin hospitals, however, needed information on the current follow-up patients and the 
current hospital location to proceed. 
Therefore, a collaboration network among hospitals was necessary to initiate the referral process. A 
possible solution was to establish a notification system to detect the patient receiving care at other 
hospitals without a proper referral process. A notification and patient list were generated and sent to 
both hospitals (senders and receivers) to fulfill the proper referral process. One of our 
recommendations for Bangkok, the Bangkok Smart Monitoring System (BSMS), was an example of 
the collaboration network and could be deployed in other provinces. 
5. Loss-follow-up length exclusion criteria 
Many patients were lost-follow-up for a long time and unable to recruited back. Also, we need to 
consider the fact that the survival of patients not receiving ARV was low at 5 years and of the data 
management practice in several hospitals that discarded loss-follow-up records older than 5 years. 
Taking long-time loss-follow-up patients into the indicator calculation did not represent the current 
Thailand HIV progress and may put an unnecessary burden on the health personnel. Retaining this 
patient group also impacts the local personnel activity as they could not focus on constrained 
resources on whom to recruit back as pointed out by the DQI Tools report that able to reduce the 
recruiting list in half.  
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However, removing loss-follow-up patients also negatively impact the first 90-90-90 indicators. 
Removing too many loss-follow-up patients might reduce Thailand's first 90-90-90 indicator to below 
90%. Therefore, we applied our DQI Tools findings from the study sites to the national level into 4 
possible scenarios for the decision-makers, for excluding loss-follow-up patients from the indicator 
calculation in the next section. 
DQI Tool's data correction scenario on loss-follow-up patients 
In this section, we applied our four loss-follow-up scenarios (DQI Corrected 1-4) using the study 
findings back to the national level to assess their impact on Thailand's 90-90-90 indicators and in the 
interaction with the Revised AEM 2018 estimation in Table 60, Figure 65, and Figure 66.  
When taken the revised AEM 2018 into account, the DQI-Corrected 2 and 4 scenarios reduced 
Thailand's first 90-90-90 indicators to below 90% due to excluding too many patients from the 
nominators (loss-follow-up patients) and with the increased denominator from the revised estimation.  
Therefore, our suggestion was to deploy the DQI-Corrected 1 scenario with a revised AEM 2018 
estimation. Deploying the first scenario was easier to deploy, requiring minimal workload from local 
personnel while maintaining Thailand's first 90-90-90 indicators above 90%. 
With the AEM estimation at the beginning of the study in 2018 of 427,526, 450,548 were reported to 
NAP (105% of the first 90-90-90 indicator). The DQI-Corrected-1 scenario reduced the nominator 
(PLHIV) by 1.13% to 445,447 (104.19% of the first 90-90-90 indicators). DQI-Corrected-2 reduced 
the nominator by 4.50% to 420,290 (100.65%). DQI-Corrected-3 reduced the nominator by 3.22% to 
436,055 (1020%) and DQI-Corrected-4 reduced the nominator by 6.6% to 420,898 (98.45%). 
However, the revised AEM estimation increased the total number of HIV patients to 479,652 causing 
a large reduction in Thailand's first 90-90-90 indicator from 105.38% to 93.93%. This change also 
impacted all four DQI-Corrected scenarios as described in Figure 65. With the revised AEM, only the 
DQI-Corrected 1 and 3 were able to achieve the 90% percent level first 90-90-90 indicators, as 
described in Table 60. 
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The second 90-90-90 indicators were increased in all DQI corrected scenarios. Patients receiving 
ARV were only increased by 31% in the DQI-Corrected-1 scenario and remained stable in other 
scenarios. On the contrary, the denominator (PLHIV) was decreasing in scenario 2-4 raising 
Thailand's second 90-90-90 indicators from 71.83% to 74.84%-79.21%.  
The third indicator was minimally improved from 82.89% to 83.65% in the DQI-Corrected 1 scenario 
and remained stable as described in Figure 66. As the second and third 90-90-90 indicators did not use 




Figure 65 First 90-90-90 indicators comparison across four DQI-Corrected scenarios, by AEM 
and revised AEM inference at the national level 
Table 60 PLHIV, AEM, Revised AEM and 90-1 calculation across four DQI-Corrected 
scenarios, Thailand, 2018 








PLHIV 450,548 445,456.8 430,273.3 436,040.4 420,901.9 
AEM 2018 427,526 427,526 427,526 427,526 427,526 
AEM Revised 2018 479,652 479,652 479,652 479,652 479,652 
90-1 AEM 2018 105.38% 104.19% 100.64% 101.99% 98.45% 
90-1 Revised-AEM 2018 93.93% 92.87% 89.71% 90.91% 87.75% 
Receive ARV 323,637 333,378.47 333,378.47 333,378.47 333,378.47 
90-2 71.83% 74.84% 77.48% 76.46% 79.21% 
VL Suppressed 268,256 278,878.94 278,878.94 278,878.94 278,878.94 





Figure 66 The second and third 90-90-90 indicators comparison across NAP and four DQI 
Corrected scenario inference at the national level 
Time threshold for loss-follow-up exclusion 
Another consideration was to determine the time threshold lost-follow-patients to be excluded from 
the calculation of the indicator.  
The important finding was that there were no additional patients receiving care at other hospitals, and 
patients recruited back to the care system on 4-5 years brackets and above (Table 51).  
The finding is consistent with a study reporting the survival rate among patients without 
ARV/HARRT was 26% for 4 years and 18% of 6 years period (32). Another possible reason was the 
availability of old medical records. While there was no exact duration on how long the hospitals 
should keep the medical records, many hospitals disposed of medical records of patients that did not 
visit hospitals for 5 years or above (58, 59). Some hospitals even discarded medical records after 3 
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years (60). The report from Sub-Saharan also used the threshold of 4 years duration threshold to take 
action for loss-follow-up patients (46).  
Therefore, we propose 5 years as a cut-off threshold as there was no additional evidence or patients to 
be recruited back after 3-4 years brackets. The results had been supported by TUC HIV experts and 
were presented to a stakeholder meeting in 2020 to make the final decision. We also recommended all 
patients compatible with these categories to be excluded from HIV related indicator calculation only, 
archiving the records without any deletion. 
Deploying DQI Tools at the nation level  
As discussed in the previous recommendation, the DQI Tools were able to provide information for 
relevant decisions and to support decision making that has a direct impact on the national HIV 
indicators without intensive investment while generating a useful report to the front-line personnel. 
Therefore, we recommended expanding the application to non-study sites to generate more impact 
and to follow the achievement of the 90-90-90 indicators.  
The national deployment plan was proposed as a centralized web-based application on the MOPH 
infrastructure. Having a centralized web application could streamline the deployment processes by 
skipping the installation process and software compatibility issues. The centralized system also will 
allow MOPH and NAP to have more control and to monitor to ensure satisfying the security and 
privacy levels. System maintenance was also easier to manage in the long term. 
As of February 2020, the DQI Tools phase 2 proposal was approved by stakeholders. The phase 2 
target sites included 74 more hospitals (99 hospitals in total) across 35 provinces. The phase was 
expected to be initiated in early-August 2020. 
MOPH database improvement initiative 
The study findings and local feedbacks regarding the MOPH reporting system were forwarded to the 
MOPH and received a well-support from the MOPH. The newly developed dashboard database 
system was developed and deployed in November 2019.  Figure 67 describes the improved MOPH 
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dashboard with the stratified results of Anti-HIV and VL. The VL submission had increased to 24,571 
records, much better than 5,537 records before the intervention.  
Of 1,128 hospitals under the MOPH HIV database, 62 hospitals had submitted VL results in 2018. 
The number had increased to 139 in 2019 as of November 2019. There were 24,571 VL results 
submitted to MOPH, with 23,623 records achieving the VL-suppressed level (96.14%). 
Unfortunately, MOPH ARV data will not be available until mid-2020. Thus, assessing the 
improvement on the MOPH side is not possible until late 2020. However, we expect the number to 
rapidly increase as the data were already in hospital databases to be extracted and submitted when the 
MOPH side was ready.  
 
Figure 67 Improved MOPH HIV Dashboard. Notice the orange box shows the VL result and 
Anti-HIV results were stratified by their results and level. With this, calculating the third 90-90-
90 indicator is now possible. Noted that the Anti-HIV results are for newly tested only not a 
cumulative number while the VL must be tested annually.   
Regulation issues 
Four regulation issues were requiring the MOPH to clarify and to take action: storing laboratory 
results from the outside laboratory, mandate VL and CD4 results submission, strengthen the 
Communicable Disease A.D. 2015 Act enforcement, and working with NAP to improve data 
correction processes.  
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First: As discussed, the terms “copy” in the Thailand Medical Technology Standard 2017 was 
responsible for the confusion of not able to store results from an outside laboratory. Personnel was not 
sure whether they could store laboratory results from the laboratory center inside their LIS/EHR in 
text/numeric format. As a result, several laboratory data were unable to submit and were difficult to 
utilize as they were stored in PDF or Image file format. The MOPH had to confirm that storing data 
inside LIS/EHR as numeric and text was legit but with a remark that the results were from 
laboratories outside of the hospitals. 
During the field visit, the research team discussed with local personnel whether storing laboratory 
results from laboratory centers was possible with the remark as ‘outside laboratory result’ to not 
violating Thailand Medical Technology Standard 2017 and it was acceptable. While most hospitals' 
responses were acceptable, the concern of increasing the data entry workload remained.  
Second: The concern led to the second regulation issue as Thailand Communicable Disease Act 2015 
did not state clearly whether to only report the case or including follow-up laboratory VL and CD4. 
Therefore, the MOPH should clarify with the hospitals on whether the Thailand Communicable 
Disease Act 2015 mandate VL and CD4 submission. 
Third: Even though the Thailand Community Disease Act A.D. 2015 had been enacted since 2016, 
several hospitals were still struggling to comply with challenges reported in this study. The MOPH 
also needed to provide support in terms of resources and technical assistance to the hospital to 
comply.  
Moreover, while MOPH hospitals were bound to follow the MOPH direction, non-MOPH hospitals 
may require their authority approval to follow (e.g. BMA for BMA Affiliated hospital). Thus, the 
MOPH has to agree to follow the A.D. 2015 Act and provide support as needed.  
Forth: Reassuring the local personnel to correct data in the NAP database. One of the hospitals was 
concerned whether correcting NAP data will cause the change in reimbursement and they might be 
prosecuted. While this was not directly under MOPH authority, the MOPH had to work with NAP on 
behalf of hospitals to ensure the legitimacy of the personnel’s action.  
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Bangkok Smart Monitoring System (BSMS) 
While hospitals in Bangkok included in this study had good data management practice, they could not 
submit data to MOPH for several reasons: deploying the MOPH reporting system from scratch was 
costly and technically difficult, the existence of several stakeholders and affiliation, no incentive 
available, and privacy concerns. These problems have been causing the reporting gaps in Bangkok 
across several Thailand Public Health Surveillance systems for a long time. Therefore, addressing 
Bangkok gaps also will benefit other Thailand Public Health Surveillance systems. 
To address the challenges, the Department of Health, Bangkok Metropolitan Administration (BMA) 
had proposed the idea of creating a Datawarehouse system especially for HIV reporting in Bangkok, 
Bangkok Smart Monitoring System (BSMS)  (Figure 68). 
 
Figure 68 BSMS Dataflow diagram. The BSMS system, under the BMA cloud server, will act as 
a storage for BMA internal use. (Bangkok Metropolitan Administration or BMA) 
The BSMS system was deployed on the BMA cloud server. NAP data were mirrored and integrated 
with submitted data from BMA hospitals. Non-BMA affiliated hospitals could decide whether to 
submit a batch data file, manually enter data to BSMS or voluntarily deploy the MOPH reporting 
system and connect to BSMS. Having these three options available for hospitals could address several 
of the challenges observed in the study and improve the hospital's cooperation. For example, hospitals 
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facing the technical difficulty of deploying the MOPH reporting system could instead submit batch 
files or manually enter data to BSMS. Hospitals with low HIV patient count often preferred to enter 
data to BSMS directly.  
 
Figure 69 Overall BSMS workflow. Data from NAP, MOPH, and hospital choice of data entry 
or submission will be integrated. Hospital personnel will update as needed. 
Figure 69 described the personnel workflow of BSMS. The system started by mirroring Bangkok 
NAP data and integrate with hospital data either by batch-file or manual data entry. Hospital 
personnel only needed to updated new visit data, missing data, SSN data that NAP did not mirror to 
BSMS, and additional variables required by BMA that did not exist in NAP nor MOPH e.g. Maternal 
HIV risk factor. At this stage, only patients who have visit data in NAP during the last one-year data 
were mirrored from NAP to BSMS to not overwhelming personnel with data entry workload, the rest 
will be mirrored to BSMS in the next phase.  
The BSMS allowed BMA to had more control over the data flow and to provide report customization 
to address hospitals and BMA needs (Figure 69). Hospitals also had more control over their data to 
ensure that only the necessary data were submitted. This was very important for the private hospitals 
where customer privacy received priority allowing the BSMS to address the data stewardship conflict 
between MOPH and BMA by providing data to MOPH and allowing BMA to have control over the 
data flow. 
The control over the data submission in addition to the three available data submission options 
provides the BSMS system with far greater flexibility for hospitals in Bangkok. The flexibility allows 
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the BSMS system to address different regulations across several hospital affiliations in Bangkok. 
Thus, it was more likely to obtain participation from several hospital affiliations.   
While entering data to NAP were still required, the system reduced the burden of MOPH reporting 
and the Thailand Communicable Disease Act 2015 compliance by relieving the technical challenge of 
deploying the MOPH reporting system from hospitals. 
Currently, BSMS only supports the HIV reporting system. Additional support of Sexual-Transmitted 
Disease (STD) and tuberculosis (TB) were being developed and will be deployed in the next phase. 
The BSMS also could accommodate other priority diseases of the Thailand Community Disease Act 
A.D. 2015 in the future, providing potential solutions for filling the Bangkok gaps in several Thailand 
public health surveillance systems. 
The BSMS development was funded by the BMA Health Department of approximately $167,000 U.S 
Dollars including maintenance contracts for 3 years. As of January 2020, the working prototype 
software was ready and prepared for field tests before go-live in March 2020 but was temporarily 
postponed from the COVID-19 pandemic. 
As of December 2019, 92 of 155 hospitals in Bangkok agreed to participate in the BSMS (Table 61). 
The number was much higher from 13 hospitals that were submitting data to MOPH before BSMS. 
Thirty-seven hospitals were preferring manual data entry and 55 hospitals preferring batch file 




Figure 70 BSMS System data entry user-interface 
 
 
Figure 71 BSMS Batch-file upload user interface 
Table 61 Distribution of hospitals that participate in BSMS and percentage of each hospital type 
Hospital Type in Bangkok Total Participate in BSMS (%) 
Private 107 54 (50.47%) 
BMA 12 9 (75%) 
Non-BMA Hospitals, including 
MOPH  
32 25 (78.13%) 




Hospitals with manual data entry choice and those already submitting data to MOPH could start using 
the BSMS immediately. However, hospitals with batch-files submission choice had to submit their 
data-dictionary and with sample data to the BMA team for data mapping preparation. 
In other words, the BMA took the burden of mapping data from the hospitals. As the BMA team 
relieved the burden of the technical difficulty, cooperation was more likely from the hospitals. 
Single unified national data standard for MOPH 
Lack of data standard and technical difficulties were reported as an important obstacle to the MOPH 
reporting system. Ideally, the solution was to announce national data standards that were accepted and 
widely deployed in Thailand, Thai Medical Terminology (TMT) for medication, and Thai Medical 
Laboratory Terminology (TMLT). Both standards were developed based on international standards, 
SNOMED CT and LOINC, and were mapped to support reimbursement in Thailand including 
CSMBS. Both standards were developed and maintained by the Thai Health Information Standards 
Development Center (THIS), currently operating under MOPH and NHSO. 
The MOPH 24 digits medication coding system did not receive timely updates to support the new 
medication in Thailand. We identified the code of the main ARV regimen, TEEVIR (Efavirenz 600 
mg/ Emtricitabine 200 mg/Tenofovir disoproxil fumarate 300 mg) to be missing from the 24 digits 
code system. Missing the main ARV regimen severely compromised ARV usage data and the second 
90-90-90 indicators from the MOPH database.  
The finding was similar to THIS survey across 34 large hospitals in Thailand where 5-10% of 
medications were missing from the 24 digits system (61). On the contrary, TEEVIR was already 
available in TMT in EHR. Moreover, the 24 digits system was not an international standard requiring 
the Thai FDA to maintain and update to support new medications.  
Therefore, we recommended MOPH to migrate to TMT to address medication support, reducing 
technical challenges, and reduce Thai FDA resources spending for maintenance.   
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We expected the TMT transition in the MOPH database to consume time, resources, and to require 
the stakeholders' agreement. Therefore, the MOPH could propose a dummy 24 digits code for ARV 
that were not supported by the 24 digits code to improve ARV data quality in the MOPH database.  
Unlike the TMT, TMLT was being developed by THIS and CSMBS to replace CSMBS' current local 
laboratory coding system. The MOPH could work with CSMBS and THIS to coordinate hospitals 
deploying TMLT at the national level to prevent the data standard problem in the future. 
Limitations 
The study faced several challenges. First, only one day of field visits per hospital was allowed. The 
visit had to cover stakeholder meetings, data extraction, analyze and present results to hospital 
directors to provide a useful recommendation. The amount of time available was very limited and was 
spent on solving the technical problems on data extraction and the DQI Tools during the fieldwork 
leaving little time for the intervention. In addition to logistical challenges, the team was separated into 
two groups for surveying two hospitals at the same time. A much smaller second team severely faced 
limited time and logistical constraints and it was not able to conduct the field interviewing to gather 
qualitative results including the MEASURE DQA Tools. For that reason, qualitative results were only 
available on 12 from 25 hospitals in this study. Overall, the two data sources' difference between the 
two hospitals were similar to other hospitals of the same type. Therefore, we believe the 12-hospital 
selected for the field visits have the representativeness of the hospitals in Thailand. (See Table 62 in 
Appendix Additional figures section) 
Second, HIV information from medical records was considered extremely sensitive data. Hospitals 
will be held responsible for any data breach occurring from the study. This challenge caused several 
limitations in accessing the data sources even with stakeholders’ approval further reducing the 
available visit time and logistics during the study. Therefore, the study was not allowed to explore the 
demographic characteristics of HIV patients in the hospital's local EHR database.  
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Third, to have access to the hospitals for the field visits and to be able to obtain data for the analysis, 
the study team needed special approval from the local authority; BMA for Bangkok Metropolitans 
Administration and provincial health office (PHO) for the non-Bangkok province. The final decision 
of the site selection came from the local authority and this might result in some selection bias. 
However, most sites proposed by the local authority did cover the majority of the HIV patients in the 
province. Therefore, we do not expect this challenge to have an impact on the overall study's 
representativeness. 
For the Bangkok area, we only had access to the BMA affiliated hospitals which might not represent 
the situation in other affiliations (e.g. university hospital and non-MOPH government hospital) from 
logistical challenges. However, for the second phase of the study, 74 additional hospitals were 
approved including several non-MOPH and non-BMA hospitals.  
Forth, the research team had no direct access to SSO VMI and CSMBS databases resulting in HIV 
patients among both databases being missing. However, we assumed that patient records existed in 
the hospital EHR database regardless of the health scheme. All patient visits in the hospital medical 
records were stored in the EHR before entering the designated health coverage protocol, using the 
EHR as additional data sources in the DQI Tools should provide satisfying coverage to SSO and 
CSMBS HIV patients in this study. 
Fifth, the IRB exemption agreement of the study as a government project did not allow an official 
interview with voice recording, transcription, directly observing the HIV process, or for taking a 
photo inside the HIV clinic. This restriction limited our qualitative study results by using “unofficial 
interviews” and field notes. 
Conclusion 
In 2018, Thailand's 90-90-90 indicators were unrealistically high given limited credibility among 
stakeholders. The study was initiated to assess the level of quality in the HIV reporting system to 
identify main factors for quality problems and to provide recommendations to improve the quality of 
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the reporting at all levels of stakeholders. We assessed the reporting quality by comparing the two 
main HIV reporting systems in Thailand, the NAP, and the MOPH. Initially, the first indicator of the 
90-90-90 the difference was narrow. However, the difference was remarkable prominent on the 
second and the third of the 90-90-90 indicators. The third 90-90-90 indicator could not be calculated 
using the MOPH database due to its lack of VL data. However, not only did we found the MOPH was 
not suitable for comparison, but the indicator calculation was also not possible considering the 
absence of a single unified national data standard, the unclear regulation, and several technical 
challenges. We identified Bangkok, Thailand capital city as the highest two-data source difference 
that required prompt action.  
At this stage, we shift our assessment to review the NAP database. The problem resided in the second 
indicator, a patient who was receiving ARV treatment as several patients were defined with loss-
follow-up causing a huge drop between the first and second 90-90-90 indicators.  
Data integration was required to gain insight into the problem, a task not feasible because of the work 
overburden in the local personnel. Therefore, the DQI Tools that was jointly developed by Thai-
MOPH-USCDC Collaboration (TUC) was deployed during the study. We found that the DQI Tools 
were able to trim down approximately half of the loss-follow-up patients' list who could be needed to 
be recruited back to the HIV care system improving Thailand's 90-90-90 indicators and the overall 
system efficiency. In addition to loss-follow-up patients, several reporting issues were also identified 
including misdiagnosis, deaths, invalid SSN, and lack of HIV test results. We analyzed the DQI Tools 
report and proposed four scenarios of data correction to the stakeholders to issue a correction policy at 
a national level.  
Several contributing factors to data quality problems were identified on each data source. Among the 
MOPH reporting system challenges was the technical difficulty, lacking both laboratory and 
medication data standards, unclear regulation, and lack of incentive for reporting. Among the NAP 
reporting system challenges were the legacy data migration problems, discourage data correction 
processes, and not integrating with other data sources. Several recommendations were proposed, 
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including revising the HIV estimation, establishing national data standards, communicate extensively 
the regulation, and streamline the NAP data correction process. Scaling-up the DQI Tools at the 
national level was also recommended.  
Bangkok's challenges were different from other provinces. Unlike the analyzed situation from the 
MOPH database, their data management practice was comparable to hospitals in other provinces. This 
was because of its unique administration status in the health department structure under the Bangkok 
Metropolitan Administration (BMA). MOPH had no authority in the Bangkok hospitals to mandate 
for the MOPH data submission. In addition to NAP and MOPH challenges, Bangkok challenges 
included having several different affiliations of hospitals, a special authority structure, and a data 
stewardship problem. To address Bangkok challenges, the Bangkok Smart Monitoring System 
(BSMS) was established with the Bangkok Metropolitan Administration to overcome the unique 
challenges in Bangkok and for improving the 90-90-90 indicators and for facilitating the data sharing 
to other public health surveillance systems in the future. 
Policy and decision-makers around the world rely on indicators calculated from the reporting data. 
However, the quality of data can distort the current situation, make the policy ineffective further 
challenge the already resource-constrained countries. Assessing the data quality did not mean to only 
address the data themselves to improve the policy, but also reveals gaps in underly processes that 
provide the opportunity for improvement.  
We hope this study demonstrates how assessing the data quality can benefit not only the policy and 
decision-makers but also the local health care personnel and encourage countries to the same. 
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ส่วนที่ I ข้อมูลทั่วไป 
1. แพทย์ประจำคลินิก    ท่าน   
2. HIV coordinator และ พยาบาลประจำคลินิก ARV   ท่าน 
3. ผู้ให้คำปรึกษา   ท่าน 
4. จำนวนผู้รับยาต้านประมาณ   ราย 
5. จำนวนผู้รับบริการเฉลี่ย    ราย/ วัน 
 
ส่วนท่ี II ระบบข้อมูลเอชไอวี 
1. ระบบฐานข้อมูลลงทะเบียนให้บริการผู้ป่วย (Hospital Information System: HIS) 
เคร่ืองมือนี้เป็นแบบสัมภาษณ์ ใช้ประเมินเมื่อมาถึงโรงพยาบาล/สถานพยาบาล  




1.1 ระบบฐานข้อมูลผู้ป่วยของโรงพยาบาล (HIS) ของท่านมีใช้ระบบปฏิบัติการของบริษัทผู้พัฒนาใด และใช้ version ใด  
(ตอบได้มากกว่า 1 ข้อ) 
❑ HOSxP ❑ Hospital OS  ❑ Home C ❑ E-PHIS 
❑ JHOS     ❑ อื่นๆ ระบุ        : ____________ 
Version ที่ใช้..................................................เริ่มใช้เมื่อ         ............................. 
1.2 ระบบฐานข้อมูลผู ้ป่วยของโรงพยาบาล (HIS) และข้อมูลการตรวจทางห้องปฏิบัติการ (Laboratory Information 
System: LIS) ที่เกี่ยวข้องกับการให้บริการรักษาด้วยยาต้านไวรัสเชื้อเอชไอวีได้เชื่อมต่อกันเป็นระบบเดียวกันหรือไม่   
❑   ไม่เช่ือมต่อ    
❑  เชื่อมต่อ โปรดระบุ ช่ือระบบ LIS  _________  
❑  แบบ Auto   
❑  แบบ Manual  ในเรื่องใดบ้าง   
 


























                   
☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
   
 
1.3 โรงพยาบาลของท่านส่งออกข้อมูลรูปแบบ 43 แฟ้ม เข้ากระทรวงสาธารณสุขหรือไม่ อย่างไร 
❑ ส่ง    ❑  ไม่ส่ง ข้ามไปตอบข้อ 1.6 
1.4 ความถี่ของการส่งออกข้อมูลรูปแบบ 43 แฟ้ม  
❑ ทุกวัน  ❑ ทุก 2-6 วัน  ❑ ทุกสัปดาห ์  ❑ ทุก 2 สัปดาห์  
❑ ทุกเดือน  ❑ อื่นๆ ระบุ: ____________ 
1.5 ข้อมูลอะไรบ้างท่ีส่งในรูป 43 แฟ้ม (ตอบได้มากกว่า 1 ตัวเลือก) 
❑ การวินิจฉัย    ❑ ยา  
❑ ผลการตรวจเลือดหาเชื้อเอชไอวี  ❑ ผลการตรวจ Viral load    ❑ ผลการตรวจ CD4 
1.6 โรงพยาบาลไดเ้ก็บข้อมูล back up ไว้หรือไม่  
❑ เก็บ ความถี_่___________  สถานท่ีเก็บ (เช่น cloud, internal storage) ____________ 
❑ ไม่ได้เก็บ 
 
2 ข้อมูลการให้บริการให้ยาต้านไวรัส Anti-Retroviral Therapy (ARV) program data 
2.1 โรงพยาบาลของท่านเก็บข้อมลูใหบ้ริการผู้ติดเชื้อฯ ในฐานข้อมูลใดบ้าง (ตอบได้มากกว่า 1 คำตอบ)  
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❑ ระบบฐานข้อมูลในโรงพยาบาล HIS  
❑ National AIDS program (NAP) 
❑ ทะเบียนอิเลก็ทรอนิกส์ (Electronic-based register) ในรูปแบบ Excel หรือ Access  
❑ สมดุทะเบยีน (Paper-based register) เช่น logbook  




เจ้าหน้าที ่ การวินิจฉัย การสั่งยา การสั่งตรวจทาง







พยาบาล ❑ ❑ ❑ ❑ ❑ ❑ 
เจ้าหน้าท่ีห้องตรวจ
ปฏิบัติการ 
❑ ❑ ❑ ❑ ❑ ❑ 
เภสัชกร ❑ ❑ ❑ ❑ ❑ ❑ 
แพทย ์ ❑ ❑ ❑ ❑ ❑ ❑ 
ระบุ ………… ❑ ❑ ❑ ❑ ❑ ❑ 
 
2.3 โปรดระบุความถี่ในการบันทึกข้อมูลเหล่านีล้งใน HIS  
 ทุกวัน ทุก 2-3 วัน ทุกสัปดาห ์ ทุก 2 สัปดาห์ ทุกเดือน 
ผลตรวจ HIV ❑ ❑ ❑ ❑ ❑ 
ผลตรวจ CD4 ❑ ❑ ❑ ❑ ❑ 
ผลตรวจ VL ❑ ❑ ❑ ❑ ❑ 
 




 การวินิจฉัย การสั่งยา การสั่งตรวจ
ทาง








การบันทึกลงใน HIS   
❑ ❑ ❑ ❑ ❑ ❑ 
มีการตรวจสอบความ
ถูกต้อง/ของรายงานที่ออก




❑ ❑ ❑ ❑ ❑ ❑ 
 






กรณีที่บันทึกข้อมลูลงใน NAP  
2.5 ตามสิทธ์ิการรักษาพยาบาลของผูป้่วย ท่านมีการบันทึกข้อมูลอะไรบ้างลงใน NAP  
สิทธิการรักษา VCT Registration VL testing Follow-up 
ประกันสุขภาพถ้วนหน้า ❑ ❑ ❑ ❑ 
ประกันสังคม ❑ ❑ ❑ ❑ 
สวัสดิการข้าราชการและรัฐวิสาหกิจ ❑ ❑ ❑ ❑ 
จ่ายค่ารักษาเอง ❑ ❑ ❑ ❑ 
ต่างด้าว ❑ ❑ ❑ ❑ 
2.6 โปรดระบุความถี่ในการบันทึกข้อมูลเหล่านี้ ลงใน NAP  
 ทุกวัน ทุก 2-3 วัน ทุกสัปดาห ์ ทุก 2 สัปดาห์ ทุกเดือน 
VCT ❑ ❑ ❑ ❑ ❑ 
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Registration ❑ ❑ ❑ ❑ ❑ 
VL testing ❑ ❑ ❑ ❑ ❑ 
Follow-up ❑ ❑ ❑ ❑ ❑ 
2.7 โปรดระบผุู้รับผิดชอบในการบันทึกข้อมูลใน NAP 
เจ้าหน้าที ่ การวินิจฉัย ยาต้าน
ไวรัส 
การสั่งตรวจทาง







พยาบาล ❑ ❑ ❑ ❑ ❑ ❑ 
เจ้าหน้าท่ีห้องตรวจ
ปฏิบัติการ 
❑ ❑ ❑ ❑ ❑ ❑ 
เภสัชกร ❑ ❑ ❑ ❑ ❑ ❑ 
เจ้าหน้าท่ีธุรการ ❑ ❑ ❑ ❑ ❑ ❑ 
ระบุ _____________ ❑ ❑ ❑ ❑ ❑ ❑ 
 


















☐ ☐ ☐ ☐ ☐ ☐ 
มีการตรวจสอบความ
ถูกต้องของข้อมูลที่
รายงานใน NAP Web 
report  
☐ ☐ ☐ ☐ ☐ ☐ 
 








กรณีที่บันทึกข้อมลูลงในรูปแบบอิเล็กทรอนิกส์ Excel หรือ Access  
2.9 ข้อมูลใดบ้างที่ไดม้ีการบันทึกในรปูแบบอิเล็กทรอนิกซ์ (ตอบได้มากกว่า 1 คำตอบ)  
❑ ข้อมูลส่วนบุคคล (เช่น ช่ือ วันเดือนปีเกิด เพศ)    
❑ เลขบัตรประชาชน 13 หลัก    ❑ NAP ID    ❑ HN 
❑ วันท่ีติดเชื้อเอชไอวี    ❑ วันท่ีมารับบริการที่คลินิก ARV  
❑ วันท่ีมารับยา     ❑ ช่ือยา/สูตรยา 
❑ วันท่ีตรวจ VL    ❑ ผลการตรวจ VL 
❑ วันท่ีนัดมาพบแพทย์ครั้งต่อไป  
☐ ประชากรหลัก ได้แก่ ชายที่มีเพศสัมพันธ์กับชาย (MSM), สาวประเภทสอง (TG), พนักงานบริการชาย (MSW), พนักงาน
บริการสาวประเภทสอง (TGSW), พนักงานบริการหญิง (FSW), ผู้ใช้ยาเสพตดิโดยวิธีฉีด (PWID), ผู้ต้องขัง 
 
2.10 โปรดระบุความถี่ในการบันทึกข้อมูลเหลา่นี้ ลงใน Excel/Access 
 ทุกวัน ทุก 2-3 วัน ทุกสัปดาห ์ ทุก 2 สัปดาห์ ทุกเดือน 
ประชากรหลัก  ❑ ❑ ❑ ❑ ❑ 
วันท่ีมารับ
บริการที่คลินิก 
❑ ❑ ❑ ❑ ❑ 
วันท่ีนัดมาพบ
แพทย ์
❑ ❑ ❑ ❑ ❑ 
ช่ือยา / สูตรยา ❑ ❑ ❑ ❑ ❑ 
วันที่ตรวจ VL ❑ ❑ ❑ ❑ ❑ 




2.10 การตรวจสอบคุณภาพข้อมูลใน Excel/Access (ตอบได้มากกว่า 1 ข้อ) 
 













☐ ☐ ☐ ☐ ☐ 
 





กรณีที่บันทึกข้อมลูในรูปแบบสมดุทะเบียน เช่น logbook  
2.11 ข้อมูลใดบ้างที่ไดม้ีการบันทึกในรปูแบบสมุดทะเบียน เช่น logbook (ตอบได้มากกว่า 1 คำตอบ)  
❑ ข้อมูลส่วนบุคคล (เช่น ช่ือ วันเดือนปีเกิด เพศ)   
❑ เลขบัตรประชาชน 13 หลัก    ❑ NAP ID    ❑ HN 
❑ วันท่ีติดเชื้อเอชไอวี    ❑ วันท่ีมารับบริการที่คลินิก ARV  
❑ วันท่ีมารับยา     ❑ ช่ือยา/สูตรยา 
❑ วันท่ีตรวจ VL    ❑ ผลการตรวจ VL 
❑ วันท่ีนัดมาพบแพทย์ครั้งต่อไป  
☐ ประชากรหลัก ได้แก่ ชายที่มีเพศสัมพันธ์กับชาย (MSM), สาวประเภทสอง (TG), พนักงานบริการชาย (MSW), พนักงาน
บริการสาวประเภทสอง (TGSW), พนักงานบริการหญิง (FSW), ผู้ใช้ยาเสพตดิโดยวิธีฉีด (PWID), ผู้ต้องขัง 
 
2.12 โปรดระบุความถี่ในการบันทึกข้อมูลเหลา่นี้ ลงใน logbook 
 ทุกวัน ทุก 2-3 วัน ทุกสัปดาห ์ ทุก 2 สัปดาห์ ทุกเดือน 
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ประชากรหลัก  ❑ ❑ ❑ ❑ ❑ 
วันท่ีมารับ
บริการที่คลินิก 
❑ ❑ ❑ ❑ ❑ 
วันท่ีนัดมาพบ
แพทย ์
❑ ❑ ❑ ❑ ❑ 
ช่ือยา / สูตรยา   ❑ ❑ ❑ 
วันที่ตรวจ VL ❑ ❑ ❑ ❑ ❑ 
ผลการตรวจ VL ❑ ❑ ❑ ❑ ❑ 
 
2.13 สมุดทะเบีบนถูกเก็บในที่ตู้หรือสถานท่ีปลอดภัยหรือไม่  
❑ ใช่   ❑ ไม่ใช่ 
2.14 การตรวจสอบคณุภาพข้อมลูใน logbook (ตอบไดม้ากกว่า 1 ข้อ) 
 
 ประชากรหลัก  ช่ือยา / สูตรยา ผลตรวจ
HIV 




☐ ☐ ☐ ☐ ☐ 
 




                
  
ต้ังแต่หัวข้อ 3-4 กรุณาระบุ หน่วยงานที่ลงเข้าเยี่ยม  







หรือไม่    
❑ เคย  เรื่อง ...................................................โดยใคร______________________ ครั้งลา่สุด 
____________________ 
เรื่อง ...................................................โดยใคร______________________ ครั้งลา่สุด ____________________ 
เรื่อง ...................................................โดยใคร______________________ ครั้งลา่สุด ____________________ 
❑ ไม่เคย 
3.2 โรงพยาบาลเคยไดร้ับการเข้าเยี่ยมจากเจ้าหน้าที่กระทรวงสาธารณสขุ, สปสช, สสจ, หรือ PEPFAR เพื่อตรวจสอบ
คุณภาพข้อมลูการให้บริการเรื่องยาต้านไวรัส หรือไม่   









4.1 โรงพยาบาลได้มีการส่งรายงานท่ีเกี่ยวข้องกับการให้บริการผู้ตดิเชื้อฯ และ ARV ใหแ้ก่หน่วยงานใด ด้วยรูปแบบใด และ








NAP ❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
กระทรวงสาธารณสุข (43 
แฟ้ม) 
❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
LINKAGES/FHI 360 ❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
กองทุนประกันสังคม ❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
Same-day ARV  ❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
กองทุนผู้มีปัญหาสถานะและ
สิทธิ 
❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
ต่างด้าว (FWF) ❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
คัดกรอง TB/HIV ❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
PMTCT ❑ Web application ❑ ❑ ❑ ❑ 
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❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
อื่นๆ 
ระบุ_________________ 
❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
อื่นๆ 
ระบุ_________________ 
❑ Web application 
❑ Excel ❑ 
ระบุ______________ 
❑ ❑ ❑ ❑ 
 








4.3 ในรอบ 1 ปีท่ีผ่านมา โรงพยาบาล/เจ้าหน้าท่ีที่เกีย่วข้อง เคยไดร้ับการอบรม/การสนับสนุน/ข้อเสนอแนะเรื่องข้อมูล 
(เช่น การบันทึกข้อมูล, คุณภาพขอ้มูล, การจดัการข้อมลู, การรายงาน, ตัวช้ีวัด, เครื่องมือในการบันทึกข้อมูล, ฯลฯ) 
เพื่อเป็นประโยชน์ในการตดิตามผลการดำเนินงาน หรือไม่    










4.4 มีเรื่องใดบ้างทีโ่รงพยาบาล/เจ้าหน้าท่ีที่เกี่ยวข้อง ต้องการการสนับสนุนเพิ่มเติมเรื่องข้อมูล 





4.5 เคยได้รับการเข้าเยี่ยมจากเจ้าหน้าที่กระทรวงสาธารณสุข, สปสช, สสจ, หรือ หน่วยงานอ่ืนๆ เพื่อตรวจสอบคุณภาพ
ข้อมูลการให้บริการเรื่องยาต้านไวรัส หรือไม่   




5.1 โรงพยาบาลมรีะบบการรักษาด้วยยาต้านไวรสั รวมถึงระบบการติดตามผู้ป่วย และความถี่ของการนัดหมาย อย่างไร 
___________________________________________________________________________________________ 
___________________________________________________________________________________________ 
5.2 โรงพยาบาลมเีกณฑ์ในการพิจารณาอยา่งไรว่าผู้รับยาต้านฯ รายไหนควรกลับมารับยาเมื่อไหร่ 
___________________________________________________________________________________________ 
5.3 โรงพยาบาลมเีกณฑ์อะไรบ้างที่ระบุว่าผูร้ับยาต้านฯ มีอาการคงที่แล้ว 
___________________________________________________________________________________________ 
5.4 เกณฑ์เหล่านี้มีเขยีนไว้เป็นลายลักษณ์อักษรหรือไม่ (ผู้ประเมินขอดูเอกสารทีเ่ป็นลายลักษณ์อักษร) 
___________________________________________________________________________________________ 
5.5 โรงพยาบาลจะมีการนดัหมายให้ผู้รับบริการกลับมารบัยา ท่ี 2, 3, 4, 5, หรือ 6 เดือน เนื่องจากเหตุผลใดบ้าง  
___________________________________________________________________________________________ 
___________________________________________________________________________________________ 
5.6 เครื่องมือใดบ้างท่ีใช้ในการติดตามผูร้ับยาต้านฯ เพื่อให้แน่ใจว่าผู้รับบริการเหล่านี้กลับมารับยา/รบับริการตามนัด (เช่น ใบ






5.7 โรงพยาบาลมเีกณฑ์ในการพิจารณาว่าผู้รับยาต้านฯ นั้นขาดการติดตาม (LTFU) (เช่น 28 วัน, 3 เดือน, หรือ 6  เดือนจาก
การนัดหมายครั้งล่าสดุ หรือกี่วันจากการรับยา ต้านฯ) กระบวนการติดตามผู้ที่ LTFU ของโรงพยาบาลเป็นอย่างไร 
___________________________________________________________________________________________ 
___________________________________________________________________________________________ 
5.8 ในทางปฏิบัติ โรงพยาบาลนับผู้รับบริการที่เสียชีวิตแล้วหรือย้ายออกจากสถานพยาบาลโดยไม่บอกกล่าว เป็น "LTFU" 
หรือไม่ และคณุมีความคิดเห็นอยา่งไรในเรื่องนี้  
___________________________________________________________________________________________ 






5.10 ระบบการตรวจ VL ในโรงพยาบาลเป็นอย่างไร (เช่น ตรวจตามระบบการตรวจ VL ของ Lab หรือตรวจตามวันครบ
กำหนดตรวจ VL ของผู้รับบริการ) และมีการตรวจบ่อยแค่ไหน 
___________________________________________________________________________________________ 
___________________________________________________________________________________________ 
5.11 กระบวนการบันทึกผล VL ในโรงพยาบาลเป็นแบบใด มีการแจ้งและให้ผลการตรวจกับผู้รับบริการหรือไม่  
___________________________________________________________________________________________
_ 
5.12 ใน 12 เดือนที่ผ่านมา มีผูร้ับบริการทีไ่ด้รับการตรวจ VL ร้อยละเท่าไหร่ (จำนวนผู้ทีไ่ด้รับการตรวจ VL ใน 12 เดือนที่
ผ่านมา / จำนวนผู้รับบริการที่ไดร้บัยาต้านฯ มาไมต่่ำกว่า 6 เดือน ทั้งหมด) 
และในกลุม่นี้ มีร้อยละเท่าไรที่กดไวรัสได้ (จำนวนผู้ที่มผีลตรวจ VL <1000 copies/ml / จำนวนผู้ที่ได้รับการตรวจ VL ใน 












I - M&E Structure, Functions and Capabilities 
1 There is a documented organizational structure/chart that clearly identifies positions 
that have data management responsibilities at the M&E Unit. 
2 All staff positions dedicated to M&E and data management systems are filled. 
3 There is a training plan which includes staff involved in data-collection and reporting at 
all levels in the reporting process. 
4 All relevant staff have received training on the data management processes and tools. 
5 A senior staff member (e.g., the Program Manager) is responsible for reviewing the 
aggregated numbers prior to the submission/release of reports from the M&E Unit. 
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6 There are designated staff responsible for reviewing the quality of data (i.e., accuracy, 
completeness and timeliness) received from sub-reporting levels (e.g., regions, districts, 
service points). 
7 There are designated staff responsible for reviewing aggregated numbers prior to 
submission to the next level (e.g., to districts, to regional offices, to the central M&E 
Unit). 
8 The responsibility for recording the delivery of services on source documents is clearly 
assigned to the relevant staff. 
  
II- Indicator Definitions and Reporting Guidelines 
9 The M&E Unit has documented and shared the definition of the indicator(s) with all 
relevant levels of the reporting system (e.g., regions, districts, service points). 
10 There is a description of the services that are related to each indicator measured by the 
Program/project.   
The M&E Unit has provided written guidelines to each sub-reporting level on … 
11   ,,, what they are supposed to report on. 
12   … how (e.g., in what specific format) reports are to be submitted. 
13  … to whom the reports should be submitted. 
14   … when the reports are due. 
15 There is a written policy that states for how long source documents and reporting forms 
need to be retained. 
  
III- Data-collection and Reporting Forms / Tools 
16 The M&E Unit has identified a standard source document (e.g., medical record, client 
intake form, register, etc.) to be used by all service delivery points to record service 
delivery. 
17 The M&E Unit has identified standard reporting forms/tools to be used by all reporting 
levels. 
18 Clear instructions have been provided by the M&E Unit on how to complete the data 
collection and reporting forms/tools. 
19 The source documents and reporting forms/tools specified by the M&E Unit are 
consistently used by all reporting levels. 
20 If multiple organizations are implementing activities under the Program/project, they all 
use the same reporting forms and report according to the same reporting timelines. 
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21 The data collected by the M&E system has sufficient precision to measure the 
indicator(s) (i.e., relevant data are collected by sex, age, etc. if the indicator specifies 
disaggregation by these characteristics). 
22 All source documents and reporting forms relevant for measuring the indicator(s) are 
available for auditing purposes (including dated print-outs in case of computerized 
system). 
  
IV- Data Management Processes 
23 The M&E Unit has clearly documented data aggregation, analysis and/or manipulation 
steps performed at each level of the reporting system. 
24 There is a written procedure to address late, incomplete, inaccurate and missing 
reports; including following-up with sub-reporting levels on data quality issues. 
25 If data discrepancies have been uncovered in reports from sub-reporting levels, the 
M&E Unit or the Intermediate Aggregation Levels (e.g., districts or regions) have 
documented how these inconsistencies have been resolved.    
26 Feedback is systematically provided to all sub-reporting levels on the quality of their 
reporting (i.e., accuracy, completeness and timeliness). 
27 There are quality controls in place for when data from paper-based forms are entered 
into a computer (e.g., double entry, post-data entry verification, etc). 
28 For automated (computerized) systems, there is a clearly documented and actively 
implemented database administration procedure in place.  This includes 
backup/recovery procedures, security admininstration, and user administration.  
29 There is a written back-up procedure for when data entry or data processing is 
computerized. 
30 If yes, the latest date of back-up is appropriate given the frequency of update of the 
computerized system (e.g., back-ups are weekly or monthly). 
31 Relevant personal data are maintained according to national or international 
confidentiality guidelines.   
The reporting system avoids double counting people … 
32 … within each point of service/organization (e.g., a person receiving the same service 
twice in a reporting period, a person registered as receiving the same service in two 
different locations, etc).  
33 … across service points/organizations (e.g., a person registered as receiving the same 
service in two different service points/organizations, etc). 
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34 The reporting system enables the identification and recording of a "drop out", a person 
"lost to follow-up" and a person who died. 
35 The M&E Unit can demonstrate that regular supervisory site visits have taken place and 
that data quality has been reviewed.  
  
V- Links with National Reporting System  
36 When available, the relevant national forms/tools are used for data-collection and 
reporting.  
37 When applicable, data are reported through a single channel of the national 
information systems. 
38 Reporting deadlines are harmonized with the relevant timelines of the National Program 
(e.g., cut-off dates for monthly reporting). 
39 The service sites are identified using ID numbers that follow a national system. 
 
Thailand codeing standard releated to HIV  
MOPH Two Digits Laboratory Coding system 
2-digits 7-digits (ICD-10TM) Remark 
01 0531002 01= Fasting Blood sugar   
02 0531004 02= Blood sugar without NPO  
03 0531101 03=DTX with NPO  
04 0531102 04= DTX without NPO  
05 0531601 05= HbA1C 
06 0546602 06= Triglyceride 
07 0541601 07= Total Cholesterol   
08 0541202 08= HDL Cholesterol  
09 0541402 09= LDL Cholesterol   
10 0583001 10= BUN    
11 0581902 11=Creatinine   
12 0581902 12=Urine microalbumin (0=negative, 1=trace, 2=positive) 
13 0581903 13=Urine CREATININE 
14 0446203 14=Urine macroalbumin (0=negative, 1=trace, 2=positive) 
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15 0581904 15= eGFR (CKD-EPI  formula) 
16 0621401 16= Hb  
17 0440205 17=UPCR (Urine protein creatinine ratio) 
18 0511402 18= K (CKD stage 3 or ACEI//ARBs) (serum/plasma) 
19 0510402 19=Bicarb (CKD stage 3) 
20 0511202 20= phosphate (CKD stage 3)  (serum/plasma) 
21 0614402 21= PTH (CKD stage 3)  
 
Thai FDA ARV medication coding ID 
No Class Drug Name 24 Digits ID (2-11th digit) Abbrevation  
1 NRTIs Lamivudine 2488400000 3TC 
2 NRTIs Tenofovir 4433449300 TDF 
3 NRTIs Zidovudine 0022800000 AZT 
4 NRTIs Stavudine 2494800000 D4T 
5 NRTIs Didanosine 0130500000 ddI 
6 NRTIs Abacavir 4042028000 ABC 
7 
NNRTI
s Efavirenz 2291400000 EFV 
8 
NNRTI
s Nevirapine 2491100000 NVP 
9 
NNRTI
s Etravirine 4710500000 ETR 
10 
NNRTI





s Delavirdine  N/A DLV 
12 PIs Atazanavir 4368400000 ATV 
13 PIs Darunavir 4603699900 DRV 
14 PIs Indinavir 2420428000 IDV 
15 PIs Lopinavir/Ritonavir 1005011001 LPV/r 
16 PIs Nelfinavir  2491000000 NFV 
17 PIs Ritronavir  2493000000 RTV 
18 PIs Tipranavir  N/A TPV 
19 PIs Saquinavir 2493500000 SQV 
20 PIs Fosamprenavir  N/A   
21 II Elvitegravir  N/A ELV 
22 II Raltegravir 4750900000 RAL 
23 II dolutegravir  N/A DTG 
24 II Enfuvirtide 4370500000 ENF 
25 CRR5 Maraviroc 4692700000 Stavudine 
26 FDC GPO-vir S 1005011004 d4T/ 3TC/NVP 
27 FDC GPO-vir Z 1005011006 AZT/ 3TC/NVP 




Emtricitabine / Tenofovir / 
Efavirenz 1005011009 FTC/TDF/EFV 
30 FDC 
Emtricitabine / Rilpivirine / 
Tenofovir  N/A FTC/RPV/TDF 
31 FDC 
Elvitegravir/Emtricitabine/ 
Tenofovir  N/A ELV/FTC/TDF 
32 FDC Zidovudine+Lamivudine 1005011003 AZT/3TC 
33 FDC rilpivirine/ Emtricitabine   RPV/FTC  
34 FDC Abacavir/Lamivudine 1005011005 ABC/3TC 
35 FDC 
Zidovudine/Lamivudine/aba
cavir 1005011002 AZT/3TC/ABC 






DQI Tools features 
 
Figure 72 One of the four DQI Lost case reporting tables. The table consisted of the case list of 
whom their SSN (CID) is invalid. The table variables consisted of NAP ID, SSN (CID), 





Thailand HIV patients characteristics 
 
Figure 73 Demographics distribution of HIV patients stratified by Health coverage scheme 
reported by NAP in 2018, Thailand. 
 
 
MOPH Patients demographic 
 





NAP patients characteristics 
 
Figure 75 NAP Loss-follow-up HIV patients’ demographic distribution among study sites 
 
 
Two data sources difference among study sites 
Table 62 Two data sources difference among all 25 study sites 








between two data 
sources 
Median NAP 














155 (7-713) 23.50 % (3.38-
212.84) 
575 (139-1,294) 533 (167-1,921) 
MOPH General 
hospital (1) 

















Table 63 Two data sources difference among 12 field visit sites 








between two data 
sources 
Median NAP 





412 (179-698) 43.8 % (22.82-
1000) 




155 (28-627) 22.59 % (5.97 – 
48.45) 







4,111 (3,931 – 
4,292) 
5,161 (5,114 – 
5,209) 
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